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Abstract 
 
X-linked Severe Combined Immunodeficiency (X-SCID) caused by mutations in the 
common cytokine receptor γ chain (γc) is a fatal disease in which the immune system 
is severely compromised as T and NK cells are absent or profoundly diminished. 
Although dendritic cells (DCs) are key antigen presenting cells and are crucial for 
the induction of normal immune responses, little is known about their function in this 
disease. This is of specific importance as the myeloid compartment, including DCs, 
frequently remains of host origin, and therefore γc-deficient, after bone marrow 
transplant or gene therapy for this form of SCID. Curiously, even after curative 
treatment, patients with X-SCID continue to have a long-term susceptibility to 
human papilloma virus infection. We hypothesised that this could be due to 
persistent myeloid defects. 
 
Using a murine model of X-SCID, we demonstrated that, in the absence of functional 
γc, DCs are less efficient at priming antigen-specific responses in γc-expressing 
CD4+ T cells. Despite the widely held view that IL-15Rα is the chain responsible for 
IL-15 transpresentation to NK and CD8+ T cells, here we have shown that 
expression of the γc by DCs is necessary for effective transpresentation to CD4+ T 
cells.  In a novel system of supported planar bilayers mimicking the T cell interface, 
we demonstrated that DC-expressed γc colocalises with MHC II clusters and 
mediates IL-15Rα recruitment to the immunological synapse (IS). This depended on 
simultaneous TCR engagement with MHC-bound antigen, suggesting that IL-15 
transpresentation may have important costimulatory function for T cell activation. 
Altogether, these data indicate that γc-deficiency impairs DC functions and reveal a 
novel mechanism for recruitment or stabilization of DC IL-15/IL-15Rα complexes at 
the IS leading to localized transpresentation of IL-15. The contribution of myeloid 
γc-deficiency to persistent immunodeficiency in transplanted X-SCID patients 
warrants further investigation. 
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1.1 γc-family Cytokines and Related Immunodeficiencies 
 
1.1.1 γc-family Cytokine Receptors 
1.1.1.1 Cytokines and Cytokine Receptor Families 
Cytokines are broadly defined as group of soluble molecules secreted by one cell and 
acting on others1. The term cytokine is quite general but includes many interleukins 
and interferons, as well as haematopoietic and growth factors. By binding to specific 
surface receptors, cytokines can initiate important cellular functions including 
differentiation, survival and apoptosis.  
 
According to their structure, cytokines have been categorized in different structural 
groups including four-helical cytokines, β-trefoil growth factors, trimeric tumor 
necrosis factor (TNF) family and cysteine knot growth factors2. Cytokines have also 
been classified according to the receptor they bind to. Six major families of cytokine 
receptors have been identified; class I cytokine receptors, class II cytokine receptors, 
TNF receptors, IL-1 receptors, tyrosine kinase receptors and chemokine receptors. 
Class I cytokine receptors form the largest group and bind to class I cytokines, 
defined by a four-helix bundle motif.  
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1.1.1.2 Shared Receptors of the Class I Cytokine Receptor Family 
A distinguishing feature of class I cytokine receptors is the use of a common, shared 
receptor subunit. Receptors belonging to this family are classified on the basis of 
their ability to associate with one of three different types of shared signaling 
components; gp130, β chain (βc) or γ chain (γc)2. gp130 is the shared receptor for  
“gp130 long-chain cytokines” such as IL-6, IL-11, oncostatin M (OSM), 
cardiotrophin 1 (CT-1), CNTF (ciliary neurotrophic factor), and LIF (leukaemia-
inhibitory factor). The βc is the common signaling component for cytokines such as 
IL-3, IL-5 and GM-CSF whereas the γc is the shared cytokine receptor for IL-2,  
IL-4, IL-7, IL-9, IL-15 and IL-21. 
 
Class I cytokine receptors share similar structural properties (Figure 1.1).  A 
significant feature of most members of this receptor family is a conserved 
extracellular domain of approximately 200 amino acids which contains a cytokine-
binding homology region (CHR) consisting of two fibronectin type III domains (D) 
interconnected by a linker. In contrast, the intracellular domains of the class I 
cytokine family members are not as well conserved as the extracellular ones, 
although they display some sequence similarities3.  
 
While γc consists only of the basic extracellular structure comprising a single CHR 
region, the gp130 and βc shared receptors possess additional domains which are 
required for cytokine binding and signal transduction2.  For example, the 
extracellular portion of gp130 contains six β-sandwich domains coated with a single 
amino-terminal immunoglobulin (Ig)-like domain, followed by one CHR domain and 
by three fibronectin type III domains. The βc extracellular portion instead consists of 
two consecutive CHR domains in an antiparallel orientation. 
 
With the exception of certain class I cytokine receptors such as the hepatocyte 
growth factor (hGF) and erythropoietin receptors, receptor homodimerization is 
normally insufficient for signal transduction. Shared receptors of the class I cytokine 
receptor family typically display very low cytokine binding affinity on their own and 
therefore need to associate with hetero-subunits to bind and transduce cytokine 
signals. Unlike many other cytokine receptors, class I cytokine receptors lack 
  20 
intrinsic enzymatic activity but signal mainly through the Janus-activated kinase 
(JAK)/signal transducer and activator of transcription (STAT) pathway3.  
 
 
 
 
 
 
Figure 1.1 Schematic representation of the conserved structure of βc, gp130 and γc shared class 
I cytokine receptors and of their respective interacting cytokines. Classically, within the CHR of 
class I cytokine receptors, the N-terminal fibronectin domain (D) contains 4 conserved cysteine 
residues whereas the more proximal domain has a conserved Trp-Ser-X-Trp-Ser (WSXWS) motif, all 
of which are important for tertiary structure. Adapted from “Structural Biology of Shared Cytokine 
Receptors”, Wang et al., 20092. 
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1.1.1.3 γc-family Cytokine Receptors 
In general, γc-family cytokine receptors are heterodimers composed of the common 
γc and of cytokine-specific α chains (IL-4R, IL-7R, IL-9R and IL-21R)4. The 
situation is slightly different for the IL-2R and IL-15R which instead heterotrimerise 
the common γc with cytokine-specific α chains and shared IL-2/15Rβ chains (Figure 
1.2). Another interesting feature of γc-family cytokine receptors is the ability of the α 
chains to associate with different subunits to form alternative receptors. The IL-4Rα 
chain, for example, can also bind to the IL-13Rα1 to form type II IL-4R, which is the 
functional receptor of both IL-4 and IL-135. Similarly, IL-7Rα can associate with 
TSLPR (thymic stromal-derived lymphopoietin receptor) to recognise TSLP6. 
 
 
 
 
 
Figure 1.2 Schematic representation of the γc-family cytokine receptors. Shown are the receptors 
for IL-2, IL-4, IL-7, IL-9, IL-15 and IL-21. Each receptor is composed of the common γc and of a 
unique α chain. IL-2 and IL-15R also have an additional subunit; the shared IL-2/15Rβ chain. 
Adapted from “New insights into the regulation of T cell by γc family cytokines”, Rochman et al., 
20094. 
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1.1.1.4 Structure of the Trimeric γc-family Cytokine Receptors  
The γc was first identified as a component of the IL-2R7. Subsequent studies showed 
that IL-2R has a very similar architecture to the one of the other trimeric γc-family 
receptor, IL-15R8. Both receptors consist of unique cytokine specific α chains, 
shared IL-2/15Rβ and common γc which together form the high-affinity receptor. In 
both cases, association of IL-2/15Rβ and γc gives rise to the intermediate-affinity 
receptor, which is expressed on T and NK cells. Isolated IL-2Rα has low binding 
affinity for IL-2 and has been termed low-affinity receptor.  In contrast, IL-15Rα 
binds IL-15 with high affinity even in the absence of the IL-2/15Rβ and γc receptor 
subunits9 (Figure 1.3). Unlike other subunits of the class I cytokine receptor family 
which mediate cytokine binding through the classic CHR domains, both IL-2Rα and 
IL-15Rα bind their respective cytokines through unique sushi domains10-12. Notably, 
IL-2Rα’s extracellular domain has two sushi domains whilst IL-15Rα only has one.  
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Figure 1.3 Schematic representation of the three types of IL-2 and IL-15Rs. Low-affinity IL-2R 
consists of a unique α chain only and has a dissociation constant (Kd) of 10nM13 . In contrast,  
IL-15Rα binds IL-15 with high affinity (10 pM)9. Intermediate-affinity receptors contain the shared 
IL-2/15Rβ and common γc (Kd =1nM); high-affinity IL-2R and IL-15R contain unique α, shared IL-
2/15Rβ and common γc (Kd = 10pM).  
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1.1.1.5 Assembly of the Trimeric γc-family Cytokine Receptors  
The structural paradigms for γc-family cytokine receptor assembly are derived from 
the prototypical IL-2R system. Studies of IL-2 ligand/receptor interactions were 
initiated in the early 1980s but surprisingly, we still do not have a full understanding 
of the mode of assembly of this receptor. The assembly of the quaternary IL2-α-β-γ 
receptor complex is in fact discussed very controversially in the literature and 
various alternative assembly pathways have been suggested14. 
 
The “stepwise binding model” proposes that IL-2Rα and IL-2/15Rβ exist 
unassociated and that IL-2 initially binds to IL-2Rα, due to its faster association rate, 
followed by stepwise binding of the IL-2/15Rβ and γc to form the quaternary 
complex. In contrast, the “α-β chain preassembly model” suggests that IL-2Rα and 
IL-2/15Rβ exist in a preformed “pseudo-high” affinity state that serves as the initial 
interaction complex for IL-2 and then as a docking site for final γc recruitment to 
form the quaternary complex. More recently, a third model, the  “β-γ chain 
preassembly model”, has been proposed and suggests that IL-2/15Rβ and γc 
preassemble and that IL-2 binding induces the translocation of this preassembled 
complex in lipid rafts15. Although IL-2Rα has been observed to be mainly localised 
in lipid-enriched membrane microdomains16, this models postulates that the few free 
IL-2Rα would bind at last to the ternary IL-2/ IL-2Rβ/γc complex locking IL-2 in a 
membrane-bound state. 
 
Given that the architecture of the quaternary IL-15R complex is thought to be similar 
to that of the IL-2R, similar mechanistic assembly pathways remain possible17. 
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1.1.1.6 Signaling Downstream of γc-family Cytokine Receptors 
As noted in section 1.1.1.2, γc-family class I cytokine receptors signal through the 
JAK/STAT pathway. There are a total of four JAK (JAK1, JAK2, JAK3 and TYK2) 
and seven STAT (STAT1–4, STAT5A, STAT5B and STAT6) proteins3,18. JAKs are 
large cytoplasmic proteins containing a conserved kinase domain and an inactive 
pseudo-kinase domain.  JAK1, JAK2 and TYK2 are ubiquitously expressed whereas 
JAK3 expression is restricted to hematopoietic cells and is inducible. STAT proteins 
are cytoplasmic transcription factors which are recruited to cytokine receptors 
through their conserved SRC homology 2 (SH2) domain. In addition, STAT proteins 
also comprise a transactivation domain and a homologous DNA-binding domain. 
 
JAKs constitutively associate to Box 1 and 2 motifs in the intracellular domains of 
γc-family class I cytokine receptors. The more cytokine specific IL-2Rβ, IL-4Rα,  
IL-7Rα, IL-9R and IL-21Rs associate with JAK1 whereas the γc associates with 
JAK33. Cytokine binding induces the activation of JAK1/JAK3, resulting in  
JAK-assisted phosphorylation of specific tyrosines in the intracellular domains of  
γc-cytokine receptors, which then serve as docking sites for the SH2 domains of 
STAT proteins19-22. Receptor associated STAT proteins are in turn phosphorylated 
resulting in homodimerization (STAT1, STAT2, STAT3, STAT4, STAT5A, 
STAT5B and STAT6) or heterodimerization (STAT1 and STAT2,  STAT5A and 
STAT5B, STAT1 and STAT3). Dimerised STAT proteins translocate to the nucleus 
where they bind to DNA and act as nuclear transcription factors (Figure 1.4). 
Whereas STAT3 and STAT5A/B are activated by most γc-family cytokines, STAT6 
is specifically activated by IL-4 (Table 1.1). 
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Figure 1.4 Schematic representation of signaling through the JAK/STAT pathway by typical 
class I cytokines such as IL-2 and IL-15. For IL-2Rβ, the location of tyrosines (Y392 and Y510) 
required for the docking and activation of STAT proteins are indicated23. 
 
 
           
         
Ligands  JAKs    STATs 
  
IL-2   JAK1, JAK3   STAT5, STAT3 
IL-4   JAK1, JAK3   STAT6 
IL-7   JAK1, JAK3   STAT5, STAT3  
IL-9   JAK1, JAK3   STAT5, STAT3 
IL-15   JAK1, JAK3   STAT5, STAT3 
IL-21   JAK1, JAK3   STAT3, STAT5, STAT1  
            
 
Table 1.1 Cytokine-specific JAK and STAT activation. γc-family cytokines transduce signals 
through unique sets of JAK/STAT proteins. STAT5 refers to both STAT5A and STAT5B. Adapted 
from “Cytokines and immunodeficiency diseases”, Kovanen et al., 200422.  
 
  27 
Genes regulated by γc-family cytokines regulate a vast array of biological functions, 
mainly related to cellular differentiation and proliferation. Consistent with the notion 
that cytokine signals sustain and amplify antigen-induced stimulation, γc-family 
cytokines tend to activate gene patterns which are highly overlapping with those 
induced by TCR-like signals24. In addition, another major set of genes regulated by 
γc-family cytokines are those implicated in the negative regulation of JAK/STAT 
signaling. Amongst these are members of the SOCS (suppressors of cytokine 
signaling) and DUSP (dual specificity phosphatases) gene family25,26. SOCS inhibit 
cytokine signaling either by direct inhibition of JAK catalytic activity (SOCS1 and 
SOCS3) or by binding to STATs thereby preventing their association with cytokine 
receptors (SOCS2) whereas DUSP hydrolise phosphorylated residues.  
 
In addition to the JAK/STAT pathway, the IL-2, IL-4, IL-7 and IL-15 γc-family 
cytokines can also activate other signaling pathways such as the mitogen-activated 
protein kinase (MAPK) and phosphoinositide 3-kinase (PI-3K)/Akt pathways. Here, 
coupling of cytokine receptors to these signaling pathways is thought to be mediated 
by the SH2 domain-containing (SHC) adapter protein22. 
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1.1.1.7 Unique Functions of Non-classical γc-family Cytokine Receptors 
As discussed in section 1.1.4, owing to replacement of the typical extracellular CHR 
domains with sushi domains, both IL-2Rα and IL-15Rα are not regarded as classical 
type I cytokine receptors. For a long time, both were considered non-signaling 
receptors mainly because of the lack of signaling motifs or docking sites in their 
intracellular tails. It has more recently been discovered that IL-15Rα has functions 
other than cytokine binding, such as receptor recycling27. IL-15Rα can also signal 
independently of the β and γ chains, as shown in several hematopoietic and non- 
hematopoietic cells line28-30. Little is known about the downstream signaling 
pathways but in fibroblasts, IL-15 mediates anti-apoptotic activities and these are 
achieved through the constitutive association of IL-15Rα with the tyrosine kinase, 
Axl, which induces PI3K/Akt activation and upregulation of Bcl-2 and Bcl-xl31.  
 
Another distinguishing feature of the non-classical IL-15R is its ability to present  
IL-15 by two distinct mechanisms. The IL-15Rα ectodomain consists of a single 
sushi domain which is interconnected by a linker to a membrane-proximal proline-
threonine-rich (PT) region10. This unique architecture confers IL-15Rα with a 
particularly flexible structure which allows it to present IL-15 both in cis and in 
trans32. Antigen-presenting cells (APCs) are especially important for IL-15Rα-
mediated transpresentation. In these cells, IL-15/ IL-15Rα complexes are assembled 
intracellularly, prior to delivery to the surface33,34, then presented in trans to β/γc 
expressing Natural Killer (NK) and CD8+ T cells upon cell-cell interaction.  
Transpresentation of IL-15 is now known to be critical for both NK and CD8+ T cell 
homeostasis and priming, as demonstrated both in vitro and in vivo35-40. IL-2Rα has 
also been shown to transpresent IL-2 but surprisingly, the biological importance of 
this process remains unexplored41.  
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1.1.2 X-linked Severe Combined Immunodeficiency 
1.1.2.1 The common γc is mutated in X-SCID 
Severe combined immunodeficiency diseases (SCID) represent the most severe 
forms of primary immunodeficiency disorders42. They are characterised by defects in 
the T and B cell immune compartments and by variable abnormalities of NK cells. 
The majority of SCIDs are caused by mutations in genes affecting cytokine signaling 
(γc, JAK3, IL-7R), antigen receptor recombination (RAG1, RAG2, ARTEMIS) or 
metabolism (ADA)22 (Table 1.2).  
 
           
          Phenotype 
 
Gene defect  Mechanism   Human  Mouse 
γc   Cytokine signaling  T-B+NK-  T-B-NK- 
JAK3   Cytokine signaling  T-B+NK-  T-B-NK- 
IL7R   Cytokine signaling  T-B+NK+  T-B-NK+ 
RAG1   Ag receptor recombination T-B-NK+  T-B-NK+ 
RAG2   Ag receptor recombination T-B-NK+  T-B-NK+ 
ARTEMIS  Ag receptor recombination T-B-NK+  T-B-NK+ 
ADA   Metabolim   T-B-NK-  T-B-NK- 
 
            
 
Table 1.2 Severe Combined Immunodeficiencies. Adapted from “Cytokines and Immunodeficiency 
diseases”, Kovanen et al., 200422. 
 
 
X-SCID is the most common form of SCID with an incidence of 1 in 50,000 to 
100,000 live births42. The finding that the genetic locus of the γc mapped to the same 
region as the X-SCID locus (Xq1343) led to the discovery that mutations in the γc are 
the cause of X-SCID44. In this study, all of the genotyped X-SCID patients had 
different nonsense mutations in the γc, each resulting in premature stop codons or in 
truncations of the cytoplasmic/signalling domain, underlining the importance of this 
region for γc-cytokine-mediated functions. More than 100 γc-defects causing  
X-SCID are now known45. The majority of mutations lead to a complete loss of 
function and to a severe clinical phenotype. These span along the whole length of the 
protein and comprise nonsense and missense point mutations as well as 
insertion/deletion frameshift mutations (Figure 1.5). Mutations in the extracellular 
domain, for example, result in loss of cytokine binding whereas those in the 
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intracellular domain inhibit binding of signalling partners, therefore interfering with 
signal transduction45,46. A few cases of hypomorphic mutations have also been 
described leading instead to milder disease47.   
 
An identical clinical phenotype to severe X-SCID is seen with loss of function 
mutations in the γc-binding partner JAK348, highlighting the importance of  
γc-cytokine signaling for development of this disease. 
 
 
 
 
 
Figure 1.5 Schematic representation of the mutations found in X-SCID patients, obtained from 
the IL2Rbase of the Human Genome Research Institute, National Institutes of Health.  
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1.1.2.2 Critical Role of γc-family Cytokines for the Immune System  
The γc was first identified as a component of the IL-2R4. The finding that both 
humans and mice lacking IL-2 had normal lymphoid development49,50 led to the 
logical conclusion that the γc must be a shared component of other cytokine 
receptors. As previously described in section 1.1.1.3, the γc is now known to be a 
functional component of the IL-4, IL-7, IL-9, IL-15 and IL-21R.  
 
γc deficiency results in a T-B+NK- form of SCID in which human T and NK cells 
are absent or profoundly diminished and B cells are present but poorly functional22. 
These profound immunological impairments are due to the wide range of biological 
functions exerted by γc-family cytokines, especially IL-2, IL-7 and IL-15. IL-2, for 
example, has multiple effects. It is mainly known as T-cell growth factor, as was first 
established in vitro51, but also promotes NK cytolitic activity and regulates Ig 
production by B cells49,50. IL-7 is probably the most important of the γc-family 
cytokines for lymphocyte development. As seen with γc-deficient mice52, in mice 
deficient in IL-7 or IL-7Rα both T and B cell development are abrogated53,54. In 
contrast, IL-7Rα-deficient patients lack T cells but have normal B-cell numbers55, as 
do γc-deficient patients, highlighting the important differences in IL-7 function 
between humans and mice. In humans, intrinsic B-cell defects (defective B-cell 
activation and abnormal class switching) are instead thought to be the result of a 
combination of lack of T cell help and of absent IL-4 and IL-21 signaling22. These 
cytokines work together to control B-cell function by regulating Ig production and 
IgG and IgE class switching. IL-15 is also important for immunity and owing to the 
similar structure of the IL-2 and IL-15 receptors, IL-15 exerts similar functions to  
IL-2. In vitro, both cytokines can stimulate T and NK cell proliferation and NK 
cytolytic activity22. However, in vivo, these cytokines differ in their effects; as noted 
above, whereas mice deficient in IL-2 have normal lymphoid development, those 
deficient in IL-15 or IL-15Rα instead lack NK cells, thus pointing to a critical role 
for IL-15 in NK cell development56,57. In addition, IL-15 and IL-15Rα-deficient mice 
also lack naïve and memory CD8+ T cells, therefore highlighting the importance of 
IL-15 as regulator of CD8+ T cell homeostasis. IL-15Rα knock-out mice also have 
reduced numbers of CD4+ T cells. Although the defect is less dramatic than that 
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observed with CD8+ T cells, it still suggests a possible involvement for IL-15 in 
CD4+ T cell homeostasis.  
 
Taken together, these findings point to a complex interaction of cytokine dysfunction 
in γc deficiency resulting in a severe combined immunodeficiency. 
 
1.1.2.3 Treatment of X-SCID 
Haematopoietic stem cell transplantation (HSCT) is the treatment of choice for the 
cure of X-SCID. Allogeneic stem cell transplantation can be carried out between 
HLA-identical donors with high survival rates (>90%)58. Due to the lack of T cells in 
X-SCID patients, successful transplantation does not require myelosuppressive 
conditioning. Where HLA-matched donors are not available, haploidentical 
transplants remain one of the few alternatives. However, even after the introduction 
of T-cell depleted transplants which efficiently prevent graft-versus-host disease, the 
success rates of HLA-mismatched transplants remain lower (66%). 
 
An alternative therapeutic approach to X-SCID is gene therapy. This treatment 
involves ex vivo retroviral-mediated gene transfer into hematopoietic progenitor 
cells. Various clinical trials have established the efficacy of this treatment for 
immune reconstitution59. The development of leukemia as a result of insertional 
mutagenesis in one of the clinical trials has however raised issues on the 
safety/applicability of this approach60,61.  
 
1.1.2.4 Persistent Immunodeficiency in Patients with γc/JAK3 Forms of SCID 
Although SCID patients cured with HSCT generally have a good prognosis, they can 
suffer from long-term complications. Two independent studies have reported a high 
incidence of severe cutaneous Human Papilloma Virus (HPV) disease, late after 
treatment. In the first case, 9/41 SCID patients who were alive 10 years or longer 
after HSCT developed severe cutaneous HPV disease62, whereas in the second, 9/76 
immunodeficiency patients who successfully received HSCT developed chronic 
HPV infection63. Interestingly, the only risk factor associated with the development 
of HPV disease was molecular diagnosis as all of the affected patients had either γc 
or JAK3 forms of SCID. On the contrary, susceptibility to chronic HPV was not 
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predicted by transplantation conditions or subsequent immune reconstitution, 
therefore suggesting a residual defect related to the original genotype of this group.  
 
Of note is the fact that, as many SCID patients receive transplants without any 
chemotherapy conditioning, in the majority of cases, the B-lymphocyte and myeloid 
lineages, including dermal dendritic cells (DCs) and their epidermal counterpart, 
Langerhans cells (LC), remain of recipient origin64 and therefore γc-deficient. 
Furthermore, both of these cells are known to be maintained by local populations of 
proliferating precursors under steady state conditions65,66, thus making it is even more 
likely that defective host DC/LC may persist post-transplant. As HPV is mainly 
confined to epithelial layers, a major role for these cells, which in fact are the antigen 
presenting cells (APCs) of the skin67, is predicted in the induction of anti-HPV 
immunity. This supports the possibility that residual DC/LC defects may account for 
persistent immunodeficiency and HPV disease in γc- and JAK3-deficient SCID 
patients.  
 
Interestingly, keratinocytes, have also been suggested to contribute to residual 
immunodeficiency in transplanted SCID patients62. Apart from being the point of 
entry to HPV, keratinocytes also represent one of the first lines of defence to 
pathogens in general. Together with resident immune cells of the skin, keratinocytes 
orchestrate innate immune surveillance. In response to stimulation, keratinocytes 
produce antimicrobial peptides and immunoregulatory cytokines67. The latter induce 
the recruitment of other immune cells from the blood. Keratinocytes sense the 
environment through pattern recognition receptors such as Toll-Like Receptors 
(TLRs)68. Signaling cascades downstream of the activation of TLRs regulate the 
expression of proinflammatory cytokines that act on the endothelia to further 
facilitate the extravasation of leukocytes into the skin. Notably, keratinocyte biology 
also appears to be regulated by γc-dependent signaling. Keratinocytes have been 
shown to express and signal through γc-containing receptors69-72. Ligation of 
keratinocyte IL-4 and IL-15R, for example, results in proinflammatory cytokine 
release and enhances expression of several chemokines leading to leukocyte 
recruitment and local T cell expansion70,73,74. Thus, these findings raise the possibility 
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that defective γc signaling in keratinocytes may also contribute to the susceptibility 
to HPV in γc and JAK3 deficient patients.  
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1.2 Origin and Development of Dendritic Cells (DCs) 
 
1.2.1 DCs; Biology and Subsets 
1.2.1.1 Introduction to DCs 
DCs are widely distributed cells of hematopoietic origin critical for the initiation of 
non-specific (innate) and specific (adaptive) immune responses and for the 
maintenance of tolerance to self-peptides75. DCs were first discovered in preparations 
of adherent cells from murine lymphoid organs76 and were distinguished from other 
splenic mononuclear cells for their unique morphology. DCs in fact derive their 
name from thin and long processes, termed dendrites, which extend and retract in a 
non-polarised fashion from the cell body. Owing to their unique shape and motility, 
DCs are specialised APCs77. In the immature state, they act as sentinels of the 
immune system patrolling peripheral tissues for the presence of antigen. Encounter 
with a microbial product or with a danger signal, triggers their activation and 
enhanced migration to the draining lymph nodes where they present processed 
antigen, in the form of a surface peptide-major histocompatibility complex (MHC) to 
antigen-specific T cells. In addition, DCs express costimulatory molecules which are 
essential for the induction of immunity.   
 
1.2.1.2 Categories of DCs 
DCs are very heterogeneous cells. Since their original discovery, various DC subsets 
have been identified, both in mice and in humans, each with a distinct location and/or 
function in the immune system. DCs have been categorised according to their 
developmental stage, location, origin and function. Although these criteria broadly 
apply to both mouse and human DCs, there are differences in DC subsets between 
the species78. This chapter will focus on murine DC subsets and development. 
 
 One initial distinction that can be made in mouse DC populations is between 
conventional DCs (cDCs), ie cells at a mature developmental stage, and pre-DCs, 
meaning cells that need further differentiation79. Whilst cDCs occur at the steady-
state, pre-DCs typically need an inflammatory signal to complete their development. 
The classical example of pre-DCs are type I interferon-producing plasmacytoid DCs 
(pDCs). pDCs can be isolated from the spleen, lymph nodes and thymus and are poor 
inducers of T cell proliferation80. Upon activation, pDCs develop into mature DCs 
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with enhanced levels of MHC II and T cell stimulatory capacity. On the other hand, 
cDCs can be already found in a mature state in the circulation and in both 
lymphoid/non-lymphoid tissues. cDCs can be further subdivided into migratory DCs 
(classical text book DCs which collect antigen from the periphery and migrate to the 
lymph nodes) and lymphoid-tissue resident DCs, whose function and origin are 
restricted to the lymphoid organ itself. In addition to cDCs and pre-DCs, a third 
group is represented by inflammatory DCs, ie DCs that are generated from 
monocytes in response to an inflammatory signal. These are termed TipDCs as they 
produce tumor-necrosis factor (TNF) and inducible nitric-oxide synthase (iNOS)81.  
 
1.2.1.3 cDC subtypes 
cDCs are mature DCs that express CD11c (integrin α-chain) and moderate to high 
levels of MHC II, according to their level of activation78. cDCs also display “T-cell 
markers” such as CD4 and the CD8α dimer, which should not be confused with the 
TCR-associated CD8αβ isoform. Other markers used to classify cDCs are CD11b 
(integrin β-chain) and CD205 (multilectin domain molecule DEC205). These 
markers are especially useful in the segregation of lymphoid-resident DCs in distinct 
functional subsets. Spleen DCs, for example, can be divided into 3 major subsets, 
according to the differential expression of CD4 and CD882 (Table 1.3). The first is 
represented by CD8+CD205+ cells which are mainly located in the T-cell area and 
whose main function is to present antigens from dying cells and bacteria on MHC I 
molecules. The second comprises CD8- CD11b+ cells which can be instead found in 
the red pulp and present antigens on MHC II molecules. Finally, CD8-CD4+ cells 
represent the third category and are the dominant population of DCs in the spleen.  
The lymph nodes also contain CD8+CD205+ DCs and CD8-CD11b+ DCs83. In 
addition to these populations, the lymph nodes also contain migratory DCs which 
typically express Langerin, a characteristic marker of LCs, and carry antigen from 
the periphery to then transfer it to CD8+ resident DCs. 
 
Migratory DCs, which originate from a multitude of non-lymphoid tissues such as 
the skin, intestine, lung, liver and kidney, are typically classified according to the 
expression of the epithelial cell-specific alpha E integrin, CD10383. The skin contains 
LCs in the epidermis and either CD103+ CD11blo Langerin+ DCs or CD103- 
CD11bhi Langerin- DCs in the dermis. Whilst CD103+ CD11blo Langerin+ DCs have 
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been shown to be involved in antiviral responses84, the functions of the other two are 
still unclear. DC populations in the intestine are also varied. CD103+ CD11blo DCs 
are found in Peyer’s patches whilst CD103- CD11bhi and CD103+ CD11b+ cells 
populate the lamina propria and have been implicated in the transport of intestinal 
bacteria to the mesenteric lymph nodes. Together with CD103- CD11bh, CD103+ 
CD11b- DCs also constitute one of the two main DC subsets in the lung, liver and 
kidney and have been recently been shown to be developmentally related to CD8+ 
CD205+ DCs present in the spleen.  
 
           
Organ   DC subset  Phenotype 
           
 
Spleen   CD8+   CD8+CD4-CD205+CD11b- 
   CD8-   CD8-CD4-33D1+CD11b+ 
   CD8-   CD8-CD4+CD205-CD11b+ 
 
Lymph node  CD8+    CD8+ CD205+ 
   CD8-   CD8-CD11b+ 
Migratory DC  Langerin+CD40hiCCR7+  
 
Skin   Epidermal LC  Langerin+CD1a+ 
   Dermal CD103+ CD103+CD11bhi Langerin+ 
   Dermal CD103- CD103-CD11blo Langerin- 
   
 
Intestine  CD103+  CD103+CD11b-   
CD103+  CD103+CD11b+ 
CD103-   CD103-CD11b+ 
 
 
Lung, liver, kidney CD103+  CD103+CD11b-   
CD103-   CD103-CD11b+ 
           
 
Table 1.3 cDCs in Lymphoid and Non-Lymphoid Tissues. Adapted from “Origin and Development 
of Dendritic Cells”, Liu et al., 201083. 
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1.2.2 Development of DCs 
 
1.2.2.1 Bone Marrow Origin of DCs  
Initially, it was thought that monocytes might be the direct precursors of DCs.  It is 
now accepted that steady state DCs originate from BM-derived hematopoietic stem 
cells (HSCs) rather than from monocytes83. The current view of steady-state DC 
development has relied on the identification of common monocyte-DC progenitor 
(MDP) in the BM85. MDPs express specific markers, including c-kit/CD117,  
flt-3/CD135 and c-fms/CD115, and give rise either to monocytes or to DC-restricted 
progenitors (CDP). CDPs generate both pDCS and pre-cDCs; the latter then migrate 
from the BM to the periphery where they undergo further differentiation into mature 
cDCs (Figure 1.6). 
 
 
 
 
Figure 1.6 BM origin of DCs. DC precursors in the BM are myeloid progenitors (MP), common 
monocyte-DC progenitors (MDP) and the DC-restricted progenitors (CDP). cDCs are thought to 
derive from CDP-derived precursors that migrate from the BM though the blood to the lymphoid 
organs. pDC are also generated in the BM from CDPs. Monocytes derive from the MDPs and, upon 
activation, give rise to inflammatory Tips-DCs in the periphery. Adapted from “Origin and 
Development of Dendritic Cells”, Liu et al., 201083. 
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1.2.2.2 In Vitro Models of DC Development  
DC development has been extensively studied through the use of in vitro cytokine-
dependent culture systems. The most classical example of in vitro generated DCs are 
those derived from human monocytes and early progenitor cells cultured with 
granulocyte/monocyte colony-stimulating factor (GM-CSF)86. Similarly, treatment of 
mouse BM cells with GM-CSF also leads to the generation of antigen-presenting 
DCs displaying high levels of CD11c and MHC II87. As GM-CSF levels are normally 
low in the steady state, it has been postulated that GM-CSF derived DCs might 
model an inflammatory rather than homeostatic type of DC78.  
 
DCs can also be generated from mouse BM by culture with FMS-like tyrosine kinase 
3 ligand (flt-3)88. Differently from GM-CSF, this cytokine is critical for homeostatic 
DC development and accordingly, flt-3-derived DCs mimic steady-state pDCs and 
cDCs79. Although these in vitro models have greatly assisted the understanding of 
DC development, it is important to underline that they however fail to faithfully 
recapitulate the more relevant in vivo DC phenotypes observed with whole animal 
studies. 
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1.3 Immunoregulation by DCs  
 
Historically, the main function of DCs is to initiate T-cell dependent immune 
responses77,89. The classical model of DC-mediated regulation of T cell responses 
includes a role for DCs both in steady-state and inflammatory conditions. In the first 
scenario, a constant low-level entry of DCs into the lymphoid tissues maintains 
peripheral tolerance to self-antigens. In the second case, sensing of a pathogen-
associated danger signal induces the maturation of DCs from antigen-capturing to 
antigen-presenting cells and enhances their migration to the lymphoid organs where 
they can then prime antigen-specific immune responses. In addition, DCs have also 
been shown to be important for humoral immunity, both though direct and indirect 
activation of B cells. Furthermore, recent accumulating evidence has demonstrated 
that, in addition to regulating adaptive immunity (T and B cells), DCs also play a 
critical role in orchestrating the first lines of defense against infection; ie, innate 
immunity. This chapter will focus on the mechanisms by which DCs regulate T and 
NK cells.  
 
1.3.1 Immunogenic Properties and Functions of DCs  
1.3.1.1 Antigen Uptake by Immature DCs 
The main function of immature DCs is to search peripheral tissues for the presence 
of pathogens, which they sense either by recognizing pathogen-associated 
components or by receiving signals from the activated innate immune system. 
Immature DCs have distinctive features that make them ideal antigen-capturing cells. 
First of all, chemokine responsiveness and chemokine receptor expression allow 
immature DC recruitment to areas of inflammation. Notably, immature DCs express 
the chemokine receptors CCR1, CCR2, CCR5, CCR6 and CXCR1 and are attracted 
to inflammation sites by MIP-1/3α, MIP5 and RANTES89. Secondly, functions such 
phagocytosis, macropinocytosis and receptor-mediated uptake render immature DCs 
fully competent for antigen capture. DC membrane invagination and ruffling enable 
the uptake of solid and liquid material through phagocytosis90 and 
macropinocytosis91, respectively. Endocytosis-receptors capture and direct antigen to 
specialized DC antigen-processing compartments. The major representatives of this 
group are members of the C-type lectin family. These include both type I  
  41 
C-lectins, such as DEC-20592, and type II C-lectins, including DC immunoreceptor 
(DCIR)93, DC-associated C-type lectin-2 (dectin-2)94 and C-type lectin receptor 1 
(CLEC-1)95. Additional receptors for antigen uptake include the macrophage 
mannose receptor (MR)86 and Fcγ and Fcε receptors for immunoglobulins86. 
Antigen-capturing functions are downregulated upon activation further confirming 
their specific roles in immature DC biology77. 
 
1.3.1.2 Activation of DCs by Danger Signals  
Once DCs have captured antigen, they undergo a series of changes that allow their 
maturation into antigen-presenting cells77,89. These comprise i) changes in 
morphology including loss of adhesive structures and cytoskeletal changes which 
confer DCs with higher motility ii) decreased uptake capacities due to 
downregulation of receptors for endocytosis iii) increased secretion of chemokines 
such as IL-8, MIP-1α and β iv) upregulation of adhesion (LFA-3, ICAM-1) and 
costimulatory molecules (B7-1, B7-2, CD40, CD58) v) translocation of MHC II 
compartments to the cell membrane vi) secretion of cytokines that recruit effector 
cells. 
 
In addition to antigen, DCs also require a second “danger signal”, such as microbial 
components, to elicit powerful immune responses. Pattern recognition receptors 
(PRRs) on DCs recognize conserved molecular patterns, referred to as pathogen-
associated molecular patterns (PAMPs), on a broad group of microbial species 
including Gram+/- bacteria, viruses, mycoplasma and yeast. Examples of PAMPs are 
unmethylated CpG motifs in bacterial DNA, single and double-stranded viral RNA, 
lipopolysaccharide (LPS) of Gram- bacteria and bacterial flagellin. Examples of 
PPRs expressed on DCs are Toll-Like Receptors (TLRs), cell surface C-type lectin 
receptors (CLRs) and intracytoplasmic nucleotide oligomerization domain (NOD)-
like receptors (NLRs).  
 
TLRS are the best-characterized PRRs. They were first identified as important 
developmental regulators in Drosophila embryos96. Their mammalian homologue 
(now termed TLR4) was then discovered in humans where it was shown to regulate 
inflammatory responses97. The TLR family now consists of 13 members (TLR1–
TLR13) of which TLRs 1–9 are conserved in humans and mice, TLR10 is expressed 
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only in humans, TLR11 is functional in mice and TLRs 12-13 have still not yet been 
fully characterized98. TLRs can be categorized according to their location and DC-
subtype expression; TLR1, 2, 4, 5 and 6, for example, are expressed on the surface 
and are specialized mainly in the recognition of bacterial products whereas TLR3, 7, 
8 and 9 localise in intracellular compartments and typically recognise nucleic acids99. 
Whereas in humans there are clear distinctions in TLR expression amongst DC 
classes, in mice there is less specificity. cDCs, for example, express all TLRs, with 
the exception of splenic CD8+ T cells which lack TLR7. Similarly, pDCs express 
mRNAs for all TLRs but display preferential expression for TLR7 and TLR9100 
(Table 1.4).  
 
            
 
CD4+  CD8+  pDCs 
 
TLR1   ++  ++  ++ 
TLR2   ++  ++  ++ 
TLR3   +  +++  +/- 
TLR4   +  +  + 
TLR5   +++  +  ++ 
TLR6   +++  ++  ++ 
TLR7   ++  -  +++ 
TLR8   ++  ++  ++ 
TLR9   ++  ++  +++ 
            
 
Table 1.4 TLR expression by murine splenic DC subsets. The expression of the TLRs was 
confirmed by mRNA expression. Adapted from “Toll-like receptors and dendritic cells: for whom the 
bug tolls”, Reis e Sousa, 2004101. 
 
Signaling through TLRs, via MyD88 or TRIF pathways, regulates a vast array of 
crucial DC functions such as migration, expression of cell-surface molecules and 
secretion of cytokines and chemokines101.  Remarkably, TLRs differ in their ability to 
induce cytokine secretion. For example, signaling through MyD88-dependent TLRs 
induces the secretion of cytokines such as IL-12, IL-6, TNF whereas MyD88-
independent TLRs lead to type I IFN (IFN-α/β) secretion. IFN-β release has also 
been implicated in signaling via the MyD88-dependent pathway102 and all together, 
type I IFN release occurs predominantly in pDCS and to a much lesser extent in 
cDCs. Another interesting aspect of TLR signaling is that cytokine release can be 
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differentially regulated by the binding of different ligands to the same TLR. This is 
the case of IL-12p70, the bioactive form of IL-12, which is triggered by TLR2 
ligands contained in mycobacteria but not from atypical LPS from P. gingivalis, also 
ligand for TLR2101. 
 
DCs can also undergo indirect microbial activation through capture of necrotic 
products of cells dying in response to infection. All together, these necrotic products 
are referred to as damage-associated molecular pattern molecules (DAMPs) and 
include heat-shock proteins (HSPs), high-mobility group box 1 proteins (HMGB1), 
β-defensins and uric acid, which can all enhance the immunostimulatory capacity of 
DCs103.  
 
Indirect activation of DCs by microbes can also be achieved by cells of the innate 
immune system which are activated by pathogen invasion89. Through the release of 
soluble factors, innate cells can modulate both the type and function of DCs. This has 
been observed for neutrophils and macrophages (IL-1, IL-6 and TNF), mast cells 
(GM-CSF, IL-4 and TNF), pDCS (type I IFN), keratinocytes (IL-15, GM-CSF, 
TSLP) and NK cells (TNF, IFN-γ, GM-CSF and HMGB1). 
 
1.3.1.3 Antigen Processing and Presentation  
Mature DCs are uniquely equipped for the processing and presentation of peptide 
fragments on surface MHC molecules and are therefore very efficient at processing a 
vast array of both foreign and self-peptides, even when at low concentrations. 
Typically, DCs present exogenous antigens on MHC II and endogenous antigens on 
MHC I.  It is generally accepted that peptides of exogenous origin are loaded on 
MHC II in late endocytic compartments whereas antigens present in the cytoplasm 
are loaded on MHC I in the endoplasmic reticulum (ER)104. 
 
For class II presentation, internalized proteins are enzymatically degraded in 
endosomes and lysosomes by proteases which function at the low pH of these 
organelles. MHC II molecules are synthesized in the ER and are then transported to 
endosomal vesicles in association with the invariant chain (Ii), which occupies the 
peptide-binding pocket of MHC II. These vesicles have shared lysosomal/endosomal 
features, are rich in HLA-DM (H-2M in mice) and hydrolytic enzymes and are 
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specifically termed MHC class II-rich compartments (MIIC)105.  Here, Ii is 
proteolytically cleaved and the remaining CLIP fragment is removed by HLA-DM 
molecules so that processed peptides can be loaded on MHC II, before being 
transported to the surface. Historically, lysosomes were considered very inefficient 
sites for antigen recycling to the membrane but it is now evident that they are critical 
regulators of MHCII-peptide assembly and delivery to the surface. Exactly how these 
lysosomal immunogenic complexes reach the membrane is still unclear. One 
possibility is that is that MHCII-peptide complexes are delivered from lysosomes to 
the plasma membrane via vesicular structures which become progressively devoid of 
lysosomal components as they reach the cell surface106. Another view is that MHC II 
transport occurs through tubulation of MHC II-containing lysosomal compartments 
which then fuse with the plasma membrane107.  
 
As discussed earlier, antigen presentation is regulated by maturation status. Mature 
DCs are very efficient in the formation/accumulation of MHC class II–peptide 
complexes within lysosomal compartments and in their delivery to the membrane, 
whereas this process is instead very inefficient in immature DCs108.  In addition, DC-
LAMP, a lysosomal-associated glycoprotein specifically expressed in MIICs, is  
upregulated in mature DCs and is thought to promote the transport of antigen-loaded 
MHC II complexes to the cell surface109. DC maturation also influences MHC II 
turnover as demonstrated by less ubiquitination and greater stability at the surface110. 
 
For the induction of anti-viral and anti-tumoral cytotoxic T cell (CTL)-mediated 
immunity, DCs instead need to present antigens in association with MHC I. This is 
quite straightforward when a virally-infected cell uses its own machinery to 
synthesize viral proteins and then transports them to the surface via the classical 
MHC class I presentation pathway; ie, proteasome-digested products are translocated 
from the cytosol to the ER where they are loaded on newly synthesized MHC I-
molecules and then shuffled through the Golgi apparatus to the surface. Targeting of 
MHC I on endocytosed proteins which have no access to the cytosol requires a more 
complicated intracellular mechanism, commonly referred to as “cross-
presentation”111. Cross-presentation of extracellular antigens on MHC I has been 
shown to occur in stable early or recycling endosomes which are distinct from the 
classical ER MHC class I-loading pathway. A variety of cell surface receptors have 
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been implicated in uptake of antigen for cross-presentation including Fc receptors 
and members of the C-type lectin family and similarly to class II presentation of 
soluble antigens, class I cross-presentation is also enhanced by DC maturation112.  
 
1.3.1.4 DC Migration In Vivo 
As noted in section 1.3.1.1, immature DCs are attracted to sites of inflammation by 
cytokines that bind to CCR1, CCR2, CCR5, CCR6 and CXCR1. The maturation of 
DCs is instead associated with their migration from the peripheral tissue to the 
draining lymphoid organ. Systemic administration of LPS or cytokines such as  
TNF-α and IL-1α induces the mobilization of DCs from the heart, kidney and 
skin113. Mobilization to the lymphoid tissues depends on the upregulation of the 
lymph node homing receptor CCR7 which confers responsiveness to CCL19 and 
CCL21 chemokine ligands expressed on lymphatic vessels and secondary lymphoid 
organs114. Classically, CRR7 was thought to be an essential mediator of dermal and 
epidermal DC migration. More recently, CCR7 has also been shown to influence the 
migration of a population of CD40 lo CD80 lo CD86lo DCs therefore indicating that it 
is a regulator of skin DC trafficking not only in inflammatory but also in steady-state 
conditions115. 
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1.3.2 DCs and the Control of Immune Responses 
 
1.3.2.1 DC-T cell Cross-talk in the Context of Immune Responses 
DCs are the key APCs capable of priming naïve T cells and are very important both 
for the induction and regulation of T-cell immune responses77. In vivo, activated DCs 
migrate to the lymphoid organs where they can interact with antigen-specific naïve 
CD4+ and CD8+ T cells. To initiate a productive T cell response, DCs deliver at 
least two signals to naïve T cells: presentation of peptide-MHC complexes to the T 
cell receptor (TCR) provides the antigen-specific “signal l” whereas ligation of B7 
molecules by CD28 on the T cell provides the costimulatory “signal 2”116.  A third 
cytokine-related signal also contributes to the activation of naïve (CD8+) T cells and 
is provided by IL-12 and type I IFN117. Recognition of these DC-mediated signals by 
naïve T cells induces cytokine secretion, clonal expansion (as a result of IL-2 
induced autocrine proliferation) and differentiation into either effector or memory 
cells. In the effector phase of the response, naïve CD4+ cells undergo differentiation 
into different T helper (Th) effector cells (Th1, Th2 or Th17), whilst CD8+ T cells 
differentiate into CTLs with the ability to kill infected cells, either through the 
release of cytotoxic granule proteins, such as granzymes and perforin, or by  
Fas-ligand mediated pathways118.  Alternatively, naïve T cells develop into memory 
CD4+ or CD8+ memory T cells, responsible for accelerated immune responses upon 
re-exposure to the same pathogen119. 
 
Similar to DC-mediated regulation of T cell functions, T cells can also regulate the 
function of DCs. An important mechanism is achieved through ligation of DC CD40 
and TNF with TNF family proteins expressed on activated and memory T cells  
(ie. CD40L). In the case of CD40/CD40L interaction, this leads to DC upregulation 
of B7-1 and B7-2, secretion of IL-12 and expression of other TNF family members 
such as CD70, 4-1BBL and OX40L89.  This has feedback effects on T cell function 
as CD70 and 4-1BBL are both important for the priming and differentiation of naïve 
CD8+ T cells120,121 and OX40L induces Th2 differentiation122. Another way that T 
cells can alter DC functions is through CD28 and cytotoxic T-lymphocyte antigen-4 
(CTLA-4), which both bind to CD80 and CD86 and deliver activating/inhibitory 
signals, respectively89.   
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1.3.2.2 DCs Direct T Helper Cell Responses  
DCs have the capacity to direct the T cell response by activating distinct CD4+ T cell 
subsets which provide different “helper” functions to the immune system (Figure 
1.7). Upon TLR triggering, DCs secrete IL-12 and induce the differentiation of naïve 
CD4+ T cells into IFN-γ producing Th1 cells, which in turn promote the 
differentiation of CD8+ T cells in CTLs and cellular immunity to intracellular 
pathogens and viruses. In contrast, with IL-4 secretion, DCs regulate the 
differentiation of CD4+ T cells into Th2 cells, which principally secrete IL-4 and IL-
5, most notable for their involvement in humoral immunity mainly to extracellular 
pathogens123.  
 
The situation is likely to be more complex than this as different TLR signals can 
result in different DC responses. Activation of DCs with LPS from E. Coli induces 
IL-12 production and Th1 responses whereas exposure to LPS from P. gingivalis 
skews T cell response towards the Th2 type124. In addition, the polarization of the Th 
cell response can also be influenced by which DC subtype is activated. This is the 
case for splenic DCs as demonstrated by the fact that CD8α- DCs induce a Th2-type 
response, whereas CD8α+ DCs lead to Th1 differentiation and cytokine secretion125. 
 
Advances in the field of T-cell immunity have added a third developmental branch to 
the dual Th1/Th2 differentiation model. Secretion by DCs of IL-23, another IL-12 
family molecule, has recently implicated in the development of another Th subtype; 
the IL-17-producing effector CD4+ T cell (Th-17). These cells differentiate along a 
developmental program that is distinct from that of Th1 and Th2 lineages and which 
is inhibited by IFN-γ and IL-4126. Th17 cells trigger potent proinflammatory 
responses and have been implicated in the pathogenesis of autoimmune and 
inflammatory disease such as rheumatoid arthritis, lupus, asthma and allograft 
rejection127. In contrast, DC-derived IL-27, another member of the IL-12 cytokine 
family, has been shown to inhibit the differentiation of Th17 cells and to act as an 
anti-inflammatory agent in vivo128.  
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Figure 1.7 DCs direct the T cell response. CD4+ T helper (TH) cells are important regulators of T 
cell-mediated immune responses and inflammatory diseases. Mature DCs present MHCp in 
association with costimulatory signals to naive CD4+ Th cells and control their differentiation into 
TH1,  TH2 and TH17 effector cells by secreting IL-12, IL-4 and IL-23, respectively. TH1 cells 
produce IFN-γ and mediate cellular immunity, TH2 cells produce IL-4/5 and mediate humoral 
immunity and allergic responses, TH17 cells secrete IL-23 and are involved in autoimmune and 
inflammatory diseases. 
 
1.3.2.3 DCs and the Control of T Cell Tolerance 
Besides being critical initiators of T cell immunity, DCs also play an important role 
in tolerizing T cells to self-derived antigens through the induction and maintenance 
of central and peripheral tolerance.  
 
Central tolerance is mainly achieved by thymic DCs, which together with the thymic 
medullary epithelium, induce the deletion (negative selection) of thymocytes bearing 
high-affinity TCRs for self pMHC complexes129.  
 
Peripheral tolerance is instead required to ensure the elimination of self-reactive T 
cells that escape deletion in the thymus, possibly because of their lower affinity for 
self-antigens. DCs play a critical role in the induction of this process. One 
mechanism by which this is achieved is through the maintenance of an immature 
phenotype. In the absence of inflammation, immature DCs uptake, process and 
present tissue antigens leading to antigen-specific T-cell unresponsiveness (also 
known as clonal anergy) or deletion130. This mechanism appears to be especially 
important for tolerization to tissue-specific self-antigens which have no access to the 
thymus131. Mature DCs can also participate in the maintenance of peripheral 
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tolerance by facilitating the clonal expansion of the naturally occurring thymus-
derived Foxp3+CD4+CD25+ regulatory T cells132. 
 
Recent advances in this field of study now also support a role for specialized 
tolerogenic DC subsets in the maintenance of peripheral tolerance through the 
induction of T cells with suppressive properties133. Differentiation into tolerogenic 
DCs can be specifically regulated by pathogenic agents. Infection with Respiratory 
Syncytial Virus (RSV) induces DC expression of inhibitory Ig-like transcripts (ILT) 
and of programmed cell death ligand-1 (PD-L1)134, molecules implicated in the 
delivery of T cell inhibitory/anergic signals, whilst Bordetella Pertussis stimulates 
DC IL-10 secretion leading to the induction of IL-10 releasing regulatory T cells135. 
 
1.3.2.4 DCs and the Control of NK Cell Activation 
In addition to initiating and regulating adaptive immunity, DCs are also important for 
the innate arm of immunity, in particular for NK cells. NK cells are specialised in the 
elimination of pathogen-infected and tumor cells, either by direct lytic mechanisms 
(granule exocytosis and death-receptor engagement) or by cytokine secretion (for 
example, IFN-γ)136. 
 
One way DCs can regulate the functions of NK cells is through cytokines. By 
secreting IL-2, IL-12, IL-15 or IL-18, DCs have been shown to participate in NK cell 
activation137-139. Notably, soluble DC-derived IL-15 is known to synergise with IL-12 
in inducing NK cell IFN-γ production whereas membrane-bound IL-15 on DCs is 
essential for NK cell survival and function, as already discussed in section 1.1.17.  
 
Cell-contact also plays an important role in DC-mediated activation of NK cells. Of 
note is the fact that NK activation is regulated by a balance between signals delivered 
through activating and inhibiting receptors and that DCs can regulate the expression 
of ligands for these receptors140. For example, immature DCs constitutively express 
ligands for the activating receptors 2B4 and CD27 (CD48 and CD70, respectively) 
whilst mature DCs upregulate ligands with analogous activating functions under 
inflammatory conditions. This is the case of NKG2D (natural-killer group 2, member 
D) ligands which are specifically expressed in response to type I IFNs141. On the 
other hand, mature DCs can also downregulate the expression of ligands for 
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inhibitory receptors such as NKR-P1B (NK-cell receptor protein 1B) and NKR-
P1D66142. Furthermore, DC adhesion molecules also play a role in NK cell contact 
dependent activation; for example, LFA-1 (lymphocyte function-associated antigen 
1) interacts with ICAM-1 (intercellular adhesion molecule 1) in the context of the 
DC-NK immunological synapse143,144. This will further discussed in chapter 1.4. 
 
1.3.2.5 Orchestration of Immune Responses by DC Chemokine Expression 
DCs are thus critical orchestrators of both the innate and adaptive arms of the 
immune system. One way DCs can coordinate all of these processes to finally 
produce an effective immune response is through regulated chemokine expression.  
This has recently been demonstrated for human blood DCs in response to viral 
infection and has been shown to occur in 3 sequential waves of chemokine 
secretion145. Here, the first cytokines were produced within 2 to 4 hours from 
pathogen exposure and attracted innate effectors such as neutrophils (CXCL8) and 
NK cells (CXCL1-3), thereby limiting the initial spread of infection. The second 
wave was instead produced within 8 to 12 hours and recruited effector memory T 
cells to sites of infection (CXCL9-11 and CCL3-5). Finally, the third wave occurred 
at a later stage (after 24 hours), once DCs had reached the secondary lymphoid 
organs, and attracted B and follicular T helper cells for the induction of a humoral 
response (CXCL13), naïve cells to amplify the immune response (CCL19, CCL22) 
and finally regulatory T cells to control it (CCL22).  
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1.4 Structure and Functions of Immunological Synapses (IS) 
 
1.4.1 Molecular Definition of the IS 
The study of the molecular organization of the T-APC interface, which we now refer 
to as the immunological synapse (IS), began with in vitro imaging of fixed cellular 
conjugates. The first molecular reorganization to be observed was the polarization of 
the microtubule organizing centre (MTOC) to the interface between CD8+ T cells 
and their target cells146. This initial finding was followed by a series of studies which 
demonstrated a marked redistribution of the TCR, its co-receptor CD4, the integrin 
LFA-1 and the integrin-associated signaling protein talin at the T-APC contact 
zone147-149. Although very valuable, these findings failed to provide information on 
the spatial organization of these molecules. Springer et al. were the first to address 
this issue by proposing a size-dependent segregation of molecular complexes in 
distinct domains at the interface between T cell and APCs150. Here, they introduced 
the idea that contact zones enriched in TCR/MHC and CD2/CD58 interactions would 
be divided from those containing LFA-1/ICAM-1 interactions or large CD45 
phosphatases according to ectodomain size. This model was later confirmed by 
Kupfer in a series of experiments which employed image deconvolution of a 
collected stack of images151. This technique allowed detailed 3-dimensional views of 
the structure of the interfaces and revealed the formation of a bull’s eye arrangement 
with a central cluster of TCR/MHCp, referred to as cSMAC (central supramolecular 
activation cluster), surrounded by a peripheral ring of LFA-1/ICAM-1, the peripheral 
SMAC (pSMAC). Subsequent studies later revealed the existence of a third zone, the 
distal SMAC (dSMAC), containing CD45 phosphatase152 (Figure 1.8). 
  
Deeper insights into the molecular organization of contact interfaces were achieved 
thanks to the supported planar bilayer technology, established by McConnell153,154 
and discussed in more detail in 1.4.2. The first dynamic view of SMAC formation 
was derived from studies with supported planar bilayers containing adhesion 
molecules155. Here, CD58 and ICAM-1 were anchored to the bilayers via 
glycosylphosphatidylinositols (GPIs). Fluorescent tagging of these molecules then 
allowed direct visualization of the interaction with their binding partners through 
total internal reflection microscopy (TIRFM).  These studies demonstrated similar 
phenomena to the ones described above ie, segregation of CD2-CD58 interactions 
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from LFA-1/ICAM-1 interactions, and led to the initial definition of the IS as a 
specialized junction defined by adhesion, polarization and stability. The following 
year, supported planar bilayers containing fluorescent MHCp complexes and LFA-1 
and ICAM-1 provided further insight into the dynamics of the IS and showed that 
nascent TCR microclusters (MCs) formed in the dSMAC are transported to the 
cSMAC, within a few minutes from their formation, in an F-actin dependent 
manner156. These findings recapitulated the patterns observed by Kupfer151 but also 
provided an additional twist to the story in that they showed that IS formation 
correlates with full T cell activation and is important for sustained signaling.   
 
 
 
 
 
 
 
 
Figure 1.8 Structure of the IS. En face view of the “organized IS” with a bull’s eye pattern of 
supramolecular activation complex (SMACs). In the center is the cSMAC, which contains TCR, CD4, 
CD8 and CD2 receptors. More recently, the cSMAC has been resolved in an inner compartment 
containing the TCR and in an outer one containing CD28 and PKC-θ (not shown). Surrounding the 
cSMAC is the pSMAC which is populated by LFA-1 and outside of the pSMAC is an even more 
peripheral domain known as the dSMAC. Besides segregating CD45 phosphatases from TCR, it is 
becoming increasingly clear that the dSMAC is also a site of active membrane movement and 
signaling. Adapted from “Understanding the Structure and Function of the Immunological Synapse”, 
Dustin et al, 2010157.
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1.4.2 Supported bilayers for the study of IS 
 
Supported planar bilayers are an important technological tool for the study of 
molecular interactions at contact interfaces. Glass-supported bilayers were initially 
developed in the early 1980s158 and were subsequently applied to study of the IS153. 
Glass-supported bilayers are generated by the deposition of a phospholipid bilayer on 
a glass surface. Bilayer deposition can be achieved either by fusion of preformed 
liposomes or by monolayer transfer from an air-water interface159. In the first case, 
liposomes absorb and fuse on the surface generating a continuous phospholipid 
bilayer whilst in the second, the phospholipid bilayer is deposited one leaflet at a 
time. Nowadays, in addition to glass, other commonly used forms of substrates are 
quartz, mica and silica. Irrespective of the method of assembly or type of substrate, 
the common underlying principle of supported planar bilayers is the creation of a 
balance of attractive and repulsive forces between the bilayer and the substrate to 
ensure trapping of the bilayer next to the surface. 
 
A distinguishing feature of lipid bilayers is their mobility. In fact, all lipids and lipid-
associated proteins exhibit remarkable lateral mobility within the bilayer. This 
includes streptavidin-labeled molecules attached to biotinylated lipids and His-
tagged molecules linked to Ni2+ chelating lipids, such as nickel-nitrilotriacetic acid 
(Ni-NTA)-modified lipids.  
 
With respect to the cell-based system, the advantages of supported lipid bilayers are 
controlled composition, superior resolution and simplicity of interpretation of 
bilayer-derived images. Furthermore, by virtue of their planar geometry and close 
distance to the substrate, supported lipid bilayers can be imaged via a multitude of 
microscopy techniques including conventional epifluorescence, confocal imaging, 
TIRFM, reflection and fluorescence interference and Förster resonance energy 
transfer (FRET). Wide field epifluorescence imaging is normally used to test the 
mobility of the bilayers; reflection and fluorescence interference are instead 
particularly useful to resolve the topography of structures whilst FRET provides 
important information on intermolecular distances. A very valuable advance in this 
field has been the application of TIRFM to planar bilayers and was first achieved by 
McConnell allowing successful visualization of MHC/TCR interactions154. TIRFM 
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relies on illuminating an interface with a laser at such an angle that the incident light 
is totally internally reflected and creates an evanescent wave which decays 
exponentially thereby penetrating only a short distance from the interface. This short 
evanescent wave (≈200nm) reduces background fluorescence and increases contrast 
on planar events at the bilayer interface offering unique imaging advantages in terms 
of resolution and image-derived information.  
 
1.4.3 TCR signaling and Activation in the Context of the IS 
T cell activation is a very well characterized process which consists of a defined 
series of molecular events160.  Ligation of the TCR by peptide-MHC complexes is an 
essential stimulus for T cell activation. Upon peptide recognition, the TCR relocates 
within specialized glycolipid-enriched membrane microdomains, known as lipid 
rafts, where active signaling molecules reside161. The Src protein kinase Lck is 
located within these rafts and mediates the phosphorylation of tyrosine residues 
within the immunoreceptor tyrosine-based activation motifs (ITAMs) of the invariant 
CD3 and ζ –chains of the TCR complex. Phosphorylated ITAMs then act as docking 
sites for the zeta-chain-associated protein kinase 70 (ZAP-70) tyrosine kinase which 
is in turn activated and phosphorylates multiple adapter proteins including Linker for 
activation of T cells (LAT) and SH2 domain-containing leukocyte phosphoprotein of 
76 kDa (SLP-76). LAT also resides within lipid rafts and is critical for the 
recruitment/activation of a number of signaling proteins such as PLC-γ1, PI-3K and 
Ras162. Active PLC-γ1 leads to Ca2+ release, calcineurin activation and Protein 
Kinase C (PKC) activation; PI3K is responsible for the generation of inositol 
phospholipids and the Ras-dependent signaling pathway mediates activation of MAP 
kinases. SLP-76, the other adaptor protein, is also required for TCR activation and by 
interacting with Grb2 and PLC-γ1 has been reported to provide a functional link with 
the Ras and Ca2+ signaling pathways163. Altogether, these signaling pathways 
participate in the activation of transcription factors, such as nuclear factor of 
activated T cells (NFAT), AP-1 and nuclear factor-kB (NF-kB), which control cell 
proliferation, death and differentiation. All of these proximal intracellular events 
occur within 5 min from T cell activation, which is the time frame in which the IS 
forms160.    
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In recent years, efforts have focused on understanding the importance of IS 
formation for TCR signaling and T cell activation. Initially, the cSMAC was thought 
to be important to sustain T cell signaling. This was suggested by early studies in 
which signaling molecules, such as PKC-θ and Lck, were observed within cSMACs 
formed by T-APC cells151. However, experiments with planar bilayers demonstrated 
that Ca2+ signaling is initiated before cSMAC formation and that phosphorylated Lck 
localizes in the pSMAC rather than in the cSMAC156. These findings led to the 
current model of T cell activation whereby TCR MCs represent the signaling units of 
T cells. TCR MCs have been implicated in TCR signaling by the way of elegant 
experiments in which treatment with anti-MHC, which blocks new MC formation, 
eliminates Ca2+ signaling after 2 min, the time frame in which MCs assemble in the 
dSMAC and reach the cSMAC164. Rather than a site of signal initiation, the cSMAC 
is now viewed as one of signal termination and TCR degradation165. Altogether, these 
findings suggested that signaling is sustained solely during the lifetime of these MCs 
and that prolonged signaling requires continuous MC formation and translocation. 
MC involvement in TCR signaling was further confirmed by parallel studies 
demonstrating their colocalization with signaling molecules, including ZAP-70, LAT 
and SLP-76, in fixed cells166,167. Altogether, these studies demonstrate that IS 
formation it not required for the initiation of TCR signaling but that it is instead 
critical for sustained signaling and full T cell activation. 
 
1.4.4 Adhesion and Costimulation in IS formation and T cell activation 
In addition to TCR/MHC-peptide interactions, IS formation and T cell activation also 
require the engagement of costimulatory receptor pairs. The most important 
costimulatory receptors on T cells and their ligand on APCs are LFA-1– ICAM-1 
and CD28-B7. 
 
The LFA-1–ICAM-1 adhesion receptor pair plays an important role in both IS 
formation and T cell activation. By binding to ICAM-1, its DC counterpart, LFA-1 
facilitates IS formation168. In addition to promoting adhesion of T cells to APCs 
thereby facilitating TCR/MHCp interactions, LFA-1 can also enhance TCR 
activation by lowering the amounts of antigen necessary for T cell activation169.  
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Similar to LFA-1, CD28 is an important costimulatory molecule which promotes full 
activation of T cells, in this case by way of direct effects on gene activation, cell 
cycle and survival170. CD28 has been observed to enhance both the earliest processes 
associated with TCR signaling pathways, such as increase in Ca2+ levels171,172, 
activation of NFAT171 and NF-KB173, as well as later processes such as IL-2 
release174. At present, the molecular mechanism by which CD28 amplifies TCR-
mediated T cell activation is still unclear but its localization in the IS suggests it may 
manipulate TCR signaling through spatial coordination. In fact, in contrast to LFA-1, 
CD28 resides in the cSMAC. Within the cSMAC, CD28 has been observed to 
colocalise with PKCθ and to be segregated from inactive TCRs175. This has led to a 
new functional concept of the cSMAC, defined by a separate inner compartment of 
inactive TCR and an outer compartment containing CD28 and the associated PKCθ 
component. Furthermore, CD28 has been shown to facilitate the transport of peptide-
MHC complexes at the IS suggesting that increased MHC-TCR receptor densities at 
the membrane might account for its costimulatory effect176. 
 
The CD2 is a transmembrane protein that also participates in T cell activation and 
functions both as an adhesion and costimulatory receptor. CD2–CD58 interactions 
have been shown to promote APC–T cell adhesion and to lower the threshold 
required for T cell activation177. In addition to its role in adhesion, CD2 engagement 
also promotes signaling through unique phosphorylation of PLCγ1 via Fyk kinase178. 
A recent study has shown that CD2 signals in a manner which is reminiscent of that 
described for the TCR in that it also induces the clustering of TCR-ζ, Lck, and LAT 
into microdomains179. Due to the similar interface distance created between 
CD2/CD58 and TCR/MHC receptor pairs155, CD2 was initially though to reside 
exclusively within the cSMAC and to facilitate T cell signal transduction through 
exclusion of CD45 phosphatases. This notion has been challenged by the finding that 
active CD2 localises in the periphery and that it is spatially segregated from the 
TCR-enriched cSMAC zone179. 
 
1.4.5 The Actin Cytoskeleton in T Cell Activation and in IS Formation 
The actin cytoskeleton plays an important role in T cell activation. One of the ways 
this is achieved is through changes in T cell polarity and shape, including formation 
of the IS. Importantly, the T cell cytoskeleton participates in the assembly of both the 
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classical IS, a stable T-APC junction, and the immunological kinapse, a moving cell 
junction180.  
 
Prior to antigen encounter, chemokine induced T cell polarization takes place at the 
leading edge of the T cell leading to loss of a rounded shape. This results in the 
establishment of an asymmetric synapse (kinapse) and to fast cell migration and 
scanning. Migrating T cells are characterized by an F-actin rich leading edge 
(lamellipodium) trailed by a myosin II-rich uropod160. These two structures mediate 
actin polymerization and retraction respectively, resulting in oscillatory contractions. 
Although the kinapse has not been extensively studied, lamellipodia have been 
associated to dSMACs which push the actin meshwork (lamellas) to one side 
(pSMAC) leading to asymmetry and migration. The uropod is instead thought to 
correspond to the cSMAC, in that both structures are relatively devoid of F-actin 
(Figure 1.9)181. Altogether, these changes at the leading edge of polarized 
lymphocytes are also important for increased sensitivity to antigen as demonstrated 
by studies in the which lamellipodia were found to be at least 10 times more 
sensitive than the uropod to antigen182. Polarization is also required for effective 
adhesion as shown by enhanced integrin engagement at the leading edge and by 
disruption of adhesive interactions at the uropod183. 
  
Upon TCR engagement, there is a reversal in the polarity of actin movement 
resulting in a symmetric IS; actin starts moving centripetally assisting the inward 
transport of distinct SMACs, as has been demonstrated for TCR MCs176,184. The 
current view of actin-assisted IS formation envisages that upon their formation in the 
dSMAC, both TCR and LFA-1 MCs are shuffled to the pSMAC by an actin flow 
which then dissipates in the pSMAC allowing the diffusion of LFA-1 in this region. 
In contrast, TCR MCs are incorporated into the cSMAC and this has recently been 
demonstrated to be mediated by Tsg101, a protein that recognizes ubiquitinated 
substrates and mediates their transport into multivesicular bodies (MVBs)185.   
 
Another intriguing feature of the cytoskeleton is that it can mediate the 
interconversion between the stable IS and the migratory kinapse180. In the first case, a 
centripetal actin flow maintains an axis of radial symmetry and allows cells to slow 
or stop their motility upon encounter of a strong TCR signal. In the second, 
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retrograde actin flow breaks the symmetry of the synapse and restores motility 
leading to net migration and scanning of APC surfaces.  In this model, PKC-θ is 
thought to promote symmetry breaking (kinapses) through myosin II contraction in 
the pSMAC whereas Wiskott Aldrich Protein (WASp) is believed to suppress 
myosin II contraction thereby promoting symmetry of the contact area (stable IS)186. 
 
 
 
 
Figure 1.9 Pairing the Structures of the Immunological synapse/kinapse. The kinapse is a 
motile/asymmetric T-APC junction which consists of an F-actin rich leading edge/lamellipodium 
(corresponding to the dSMAC) and of an F-actin depleted trailing uropod (corresponding to the 
cSMAC). Retrograde actin flow leads to condensation of lamella on one side (pSMAC) and resultant 
asymmetry/migration. Adapted from the book “Multichain Immune Recognition Receptor 
Signaling:  From Spatiotemporal Organization  to Human Disease”. 
 
Besides their participation in IS formation and stability, another important function 
of actin filaments is the formation of a scaffold for signaling components.  PKC-θ, 
for example, is recruited to TCR clusters within the mature IS and this seems to 
depend on Vav-mediated actin polymerization187. Furthermore, the actin scaffold has 
also been implicated in the recruitment and stabilization of glycolipid membrane 
domains enriched in signaling molecules, thereby influencing TCR activation188,189. 
An emerging concept is that T cell activation and the actin cytoskeleton reciprocally 
regulate each others functions, as suggested by the fact that actin polymerization 
itself can be influenced by TCR signaling190. For example, upon TCR ligation, 
activated SLP-76 recruits Vav1, the guanine exchange factor for Rho-family  
G-proteins Cdc42 and Rac. Activated Cdc42 interacts with WASp to induce actin 
polymerization and consequent enhancement of T cell activation via clustering of 
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glycolipid-rich membrane domains and concentration of signaling components, as 
noted above. 
 
Further evidence of actin involvement in TCR signaling is given by the fact that 
upon reaching the F-actin depleted c-SMAC, the signaling components dissociate 
from TCR MCs leading to signal termination and TCR degradation183. The actin 
cytoskeleton therefore confers the IS with an organized structure based on symmetry 
and on an actin-depleted central zone, important for vesicle trafficking to and from 
the plasma membrane. 
 
1.4.6 Functions of the IS 
Due to the many definitions of the IS, its purpose has for long been a very 
controversial issue. It is now generally agreed that the IS can have various functions, 
which depend on its architecture and on the cell type involved. This section will 
therefore focus on those functions of the IS that depart from those discussed above 
(signal amplification, termination and costimulation) but instead relate to contact 
stability, directed secretion and cell fate determination. 
 
One role of the IS is to act as a brake on T –cell motility allowing T cells to dwell on 
APCs for long periods of time. Full T cell activation is known to require stable 
contacts of up to several hours191,192. The high durability of the IS, which can last up 
to approximately 15 hours193, reinforces the idea that one the functions of the IS 
might be to allow stable interactions necessary for full T cell activation. 
 
In addition to a role in contact formation, the organized structure of the IS has been 
suggested to act as a conduit for directed secretion of components, such as lytic 
granules and cytokines. This has been observed for CTLs where directed IS-
mediated secretion seems to play a major role in cytolytic killing. Here, the F-actin, 
depleted cSMAC is thought to represent a site of polarized secretion of cytokines and 
cytolytic agents whereas the pSMAC might function as a tight seal to prevent the 
escape of these molecules from the cSMAC157. The polarization of the MTOC at the 
IS has been implicated in the directed secretion of cytokines and cytolytic granules 
towards the target cell contact site194 and direct evidence of the involvement of the IS 
in directed secretion was first provided by a study clearly demonstrating that the 
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pSMAC plays a role in reorienting the MTOC195. Accordingly, LFA-1-ICAM-1 
interactions in the pSMAC were later shown to be essential for directed cytolytic 
granule release at the contact site with APCs196.  
 
Targeted secretion of cytokines is not unique to CD8+ T cells but can also be 
mediated by other cells of the immune system. Synaptic delivery of IL-12 by DCs197 
and of IL-2 and IFN-γ by CD4+ T-cells194,198 suggests that a specific cytokine micro-
environment at the IS is likely to be important for DC or T-cell effector functions. 
Though not in soluble form, IL-15 might also plays a role in specific cell-cell 
interactions at the IS through transpresentation, as suggested by localization of  
IL-15Rα at DC-NK cell synapses199. 
 
Another interesting feature of the IS is that it appears to play a role in establishing 
effector CD4+ T cell fates. For example, the receptor for IFN-γ (classic Th1 
cytokine) has been shown to be asymmetrically distributed at the IS and to be 
asymmetrically partitioned during asymmetric cell division. This has been suggested 
to promote differentiation into Th1 rather than Th2/Th17 cellular fates200. 
Furthermore, Th1 and Th2 cells have been observed to be predisposed to by 
hyperstable or unstable synapses, respectively186, thereby suggesting that to retain 
potential for both Th1 and Th2 phenotypes, naïve CD4+ cells must maintain a 
balance between stable and symmetry breaking immune synapses/kinapses. 
 
1.4.7 The Natural Killer IS 
Although the IS was initially described as a specialized junction of adhesion, 
polarization and stability between a T cell and an APC, these definitions also apply 
to the NK-cell IS. Studies on the NK-cell IS paralleled those on the T-cell IS 
highlighting some interesting comparisons between these two synapses. However, 
owing to NK specialization in cytolytic killing, certain functions of the IS, such as 
directed secretion of lytic granules, seem to be prevalent in NK synapses201. 
 
NK cell effector functions are regulated by a balance between activating and 
inhibitory surface receptors. NK cells can form activating or inhibitory IS depending 
on the molecules recruited. Inhibitory IS are rich in inhibitory receptors that 
recognize self-determinants and prevent the lysis of healthy cells. In contrast, 
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activating NK cell immunologic synapses (NKIS) mediate cytotoxic killing144. In 
humans, NK activating receptors, such as NKG2D202, bind to stress-inducible 
polymorphic MHC I-like molecules (MICA) and associate with immunoreceptor 
tyrosine-based activatory (ITAM-bearing signal transduction chains). Activating NK 
receptors signal in a way which is comparable to the TCR in that they initiate a 
signaling cascade involving Syk, ZAP-70 and Lck203. Similarly to T cell IS, the 
activating NKIS also recruits signaling molecules to a central cluster. In addition, the 
NKIS cSMAC distinctively accumulates perforin and the pSMAC contains CD2, 
CD11a, CD11b and F-actin204. Notably, actin reorganization at the NKIS leads to 
receptor clustering and lipid raft aggregation whilst the redistribution of lytic 
granules to the contact area with the target cell depends on MTOC polarization144. 
 
1.4.8 The other side of the IS; the DC 
The IS is a bipartite structure composed of a T/NK cell and a DC. Most studies on 
the IS have focused on the T/NK side of the IS whereas the DC IS has received much 
less attention. This was partly due to the initial belief that DCs played a passive role 
in IS formation as well as to the lack of specific tools, such as the well defined lipid 
bilayer system which has instead been fundamental for imaging and describing the T 
cell IS. Experiments with cultured or primary DCs have shown that the structure of 
the DC IS departs from the canonical bull’s eye arrangement observed with planar 
bilayers in that DCs preferentially forms multifocal patterns of MHC-TCR 
interactions rather than a central one205. The main distinction between the T-DC and 
the T-bilayer system is the active contribution of the DC cytoskeleton to IS 
formation, as demonstrated by the finding that paralysation of the DC cytoskeleton 
impairs T cell activation206. It is now well accepted that DCs participate in IS 
formation though cytoskeletal rearrangement, as confirmed by various reports207-210. 
 
In support of its important role during IS formation, the DC cytoskeleton actin has 
also been observed to be critical for MHC recruitment to the DC IS. DC cytoskeletal 
reorganization has been shown to be required for both the delivery of MHC/peptide 
complexes to the surface106 and for their clustering at the contact interface with T 
cells211. This is in contrast to studies with other APCs such as B cells which have 
instead shown that disruption of the actin cytoskeleton has no effect on MHC II 
accumulation at the synapse212 and that MHC II aggregation occurs only through 
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TCR-mediated trapping of raft-associated MHC II-peptide complexes213. 
 
In addition to its function in the formation of IS, the DC cytoskeleton is also thought 
to play an active role in the multifocal patterning of the IS. In fact, by interacting 
with MHCp clusters, the DC cytoskeleton has been proposed to limit the free 
diffusion of TCR MCs to the cSMAC209. Altogether, these findings highlight the 
importance of the DC cytoskeleton for both IS function and patterning. 
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2.1 Materials 
Unless otherwise stated, all tissue culture reagents were supplied by Gibco 
(Invitrogen) and all general chemicals by Sigma-Aldrich. 
 
2.1.1 Buffers and Solutions 
 
Blocking buffer    5% milk solution in 0.1% Tween/ PBS 
DNA loading buffer   10mM Tris pH 7.5, 50mM EDTA, 10% Ficoll 
     400, 0.4% Orange G 
FACS buffer  1% FCS/PBS 
Loading buffer * 4× NuPage sample buffer, 1× NuPage sample 
reducing agent (Invitrogen) 
Loading buffer ** 1.5× NuPage loading buffer, 1× NuPage sample 
reducing agent (Invitrogen) 
Luria-Bertani (LB) Broth  2g LB in 1L H20 
Lysis buffer  1% NP40 (AppliChem), 50 mM HEPES pH 
7.4, 150 mM NaCl, 1mM EDTA, 1/40 protease 
inhibitor cocktail 
Running Buffer    50ml NuPAGE 20X MOPS SDS running  
     buffer (Invitrogen), 950ml H20 
TAE buffer (50×) 242g Trizma base, 100ml 0.5M EDTA pH8.0, 
57.2ml glacial acetic acid in final volume of 1L 
Transfer Buffer  30ml methanol, 30ml NuPAGE Transfer Buffer 
(Invitrogen), 240 ml H20 
Wash buffer      0.1% Tween/ PBS 
 
 
* WB (Western Blotting)  
** IP (Immunoprecipitation)  
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2.1.2 Primary antibodies (Table 2.1) 
 
Antibody Clone Manufacturer 
rat anti-mouse B220-FITC RAF-6B2 BD Pharmingen 
mouse anti-mouse CD4-PE-Cy7 SK3 BD Pharmingen 
rat anti-mouse CD4-APC RM4-5 BD Pharmingen 
rat anti-mouse CD8α-PercP 53-6.7 BD Pharmingen 
rat anti-mouse CD11b-PE M1/70 BD Pharmingen 
hamster anti-mouse CD11c-APC HL3 BD Pharmingen 
rat anti-mouse CD16/CD32 2.4G2 BD Pharmingen 
hamster anti-mouse CD69-PE-Cy5 H1.2F3 BD Pharmingen 
rat anti-mouse CD86-FITC GL1 BD Pharmingen 
rat anti-mouse CD132 4G3 BD Pharmingen 
mouse anti-GADPH 6C5 Santa Cruz Biotechnology 
rat anti-mouse I-A/I-E M5/114.15.2 BD Pharmingen 
rat anti-mouse I-A/I-E-PE 2G9 BD Pharmingen 
rat anti-mouse IL-2Rα-FITC PC61.5 BD Pharmingen 
rat anti-mouse IL2Rβ-FITC TM-b1 BD Pharmingen 
rabbit anti-IL-2Rγ M-20 Santa Cruz Biotechnology 
biotin rat anti-mouse IL-12p40/p70 C17.8 BioLegend 
goat anti-mouse IL-15Rα-FITC FAB551F R&D Systems 
goat anti-mouse IL-15Rα AF551 R&D Systems 
goat anti-IL-15Rα N-19 Santa Cruz Biotechnology 
rabbit anti-IL-15Rα H-107 Santa Cruz Biotechnology 
rat anti-mouse IL-21R-PE eBio4A9 BD Pharmingen 
rabbit anti-JAK3 C-21 Santa Cruz Biotechnology 
mouse anti-mouse NK1.1-APC PK136 BD Pharmingen 
rabbit anti-phospho-AKT (Ser473)  D9E Cell Signaling Technology 
rabbit anti-phospho-JAK3(Tyr785) ab61102 Abcam 
anti-phospho-PLCγ1 (Ser1248) 4G10 Cell Signaling Technology 
rabbit anti phospho-STAT5(Tyr694)  C71E5 Cell Signaling Technology 
rabbit anti phospho-STAT5(Tyr694) D47E7 Cell Signaling Technology 
mouse anti-pSTAT5-PE (Tyr694) 47 BD Pharmingen 
rabbit anti-STAT5 3H7 Cell Signaling Technology 
anti-TCRζ Alexa 647    Dustin Lab 
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2.1.3 Cell Lines 
 
293T    Human embryonic kidney cell line 
B017.4   Kindly provided by Dr. Derek Minney, Department of  
   Medicine, Dalhousie University, Halifax, Canada. This cell 
   line is a T cell hybridoma with a TCR specific for OVA323-339 
   peptide in the context of I-Ab.  
ED7R   Kindly provided by Prof. Ian Alexander at the Children’s  
   Hospital, Westmead, Sydney, Australia. This cell line is  
   derived from a γc-deficient human leukaemia T cell line  
   ED40515214. 
 
2.1.4 Mice 
All experiments were approved by and performed according to UK Home Office 
Animal Welfare Legislation. Mice were C57BL/6 wild-type mice and OTII 
transgenic mice (OVA323–339 peptide-specific CD4) and were obtained from Charles 
River (Kent, UK). γc/Rag 2-/- mice were backcrossed at least 10 times with C57BL/6 
and were kindly provided by Dr F. Colucci (Babraham Institute, Cambridge, UK) 
and bred at Institute of Child Health facilities. 
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2.2 Methods 
 
2.2.1 Cell Culture 
2.2.1.1 Culture of Adherent Cell Lines 
Adherent cell lines used in this study were 293T cells. Cells were maintained in 
Dulbecco’s Modified Eagle Medium (DMEM) containing GlutaMAX supplemented 
with 10% foetal calf serum (FCS) and 1% Penicillin/Streptomycin (complete 
DMEM). Cells were grown in 25 cm2, 80 cm2 or 175cm2 tissue culture flasks at 37°C 
with 5% CO2.  Cells were passaged when 80% confluent: the monolayers were first 
washed with phosphate buffered solution (PBS), then incubated for 5 minutes at 
37°C with trypsin/EDTA. Cells were split 1:5 in complete DMEM and transferred to 
a new flask.  
 
2.2.1.2 Culture of Non-adherent Cell Lines 
Non-adherent cell lines used in this study were B017.4 and ED7R cells. Cells were 
maintained in RPMI medium 1640 supplemented with 10% FCS and 1% 
Penicillin/Streptomycin (complete RPMI). 1% HEPES was also added to the 
medium for culture of B017.4 cells. Cells were grown in 25 cm2, 80 cm2 or 175cm2 
tissue culture flasks (standing upright) at 37°C with 5% CO2.  Cells were passaged 
every 3-4 days; cells were split 1:10 in complete RPMI and transferred to a new 
flask.  
 
2.2.1.3 Generation of Murine Dendritic Cells (DCs) 
Using a syringe, BM cells were flushed from the femurs and tibia of C57BL/6 wild-
type mice or γc/Rag 2-/- mice with culture medium (complete RPMI) on a 70µm cell 
strainer. Cells were mushed and passed through the cell strainer with a plunger then 
centrifuged at 1400rpm. Cell pellets were resuspended in 5mls Red Cell Lysis Buffer 
for 5 minutes at 37°C. Cells were then washed with culture medium and pelleted by 
centrifugation. 4×106 cells were plated in 10 cm2 plates in 10ml of culture medium 
containing 20ng/ml GM-CSF (BioSource). BM cells were left to differentiate into 
DCs over a period of 7 days. 5ml of culture medium containing 20ng/ml GM-CSF 
were also added on day 3 and 5 of culture. 
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2.2.1.4 Culture of Murine DCs  
On day 7 of culture, DCs were scraped from the tissue culture plates, washed and 
pelted by centrifugation. 2×106 DCs were then plated in 6-well tissue culture plates 
and matured by overnight stimulation with 100ng/ml LPS. For experiments with 
CD4+ T cells, DCs were also pulsed with 100µg/mL ovalbumin (OVA). 
 
2.2.1.5 Isolation of CD4+ T cells  
CD4+ T cells were obtained from the spleens of OTII transgenic mice. Single cell 
suspensions were generated from spleens by mushing and passing whole cell 
material through a 70µm cell strainer using a plunger. Cells were pelleted by 
centrifugation at 1400rpm and resuspended in 5ml Red Cell Lysis Buffer for 5 
minutes at 37°C. Cells were then washed with culture medium. CD4+ T cells were 
subsequently isolated by negative selection using a CD4+ T Cell Isolation Kit and 
magnetic bead separation according to manufacturer’s instructions (Miltenyi 
Biotech).  
 
2.2.1.6 Isolation of NK cells  
NK cells were obtained from the spleens of C57BL/6 mice. Spleens were treated as 
described in 2.2.1.5. NK cells were subsequently isolated by positive selection using 
CD49b (DX5) MicroBeads according to manufacturer’s instructions (Miltenyi 
Biotech).  
 
2.2.2 Molecular Cloning 
2.2.2.1 Polymerase Chain Reaction (PCR) 
The PCR reaction was performed to create a γcmut –GFP protein lacking 77 amino 
acids at the carboxy terminus of the γc. Primers for the PCR reaction were designed 
so as to introduce an AgeI site at amino acid 289 of γcWT cDNA and were ordered 
from MWG Eurofins. The following primers were designed: 
 
Forward primer: GAAGACACCGACTCTAGAGCCACCATGTTG 
Reverse primer: CAACCGGTGGGCATCGTCCGTTCCAG 
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Each primer was made to 100pmol/µl in distilled H2O. 100ng of DNA template were 
incubated with 5µl 10× reaction buffer, 100pmol forward primer, 100pmol reverse 
primer, 1µl dNTP mix (all from Promega) to a final volume of 50µl. 1µl of Pfa DNA 
Polymerase (Promega) was added to the sample and the reaction was then cycled at 
the following conditions:  
 
Cycle 1 95°C  2 minutes initial denaturation 
Cycle 2-30 95°C  45 seconds denaturation 
  58°C  45 seconds annealing 
  72°C  1 minute extension 
Cycle 31 72°C  5 minutes final extension 
 
The PCR product was then purified using the QIAGEN PCR Purification Kit and 
finally resuspended in 35µl of distilled H2O. 
 
2.2.2.2 Plasmid DNA Digestion 
The PCR product and 2µg of γcWT –GFP cDNA were both digested for 2 hours with 
2µl of Age1 and 1µl of Xba1 enzymes. Digests were performed in a final volume of 
30-50µl in the buffers and at the temperature recommended by the manufacturers 
(Promega and New England Biolabs). 
 
2.2.2.3 Agarose Gel Electrophoresis 
DNA fragments were resolved by electrophoresis. 2µl of DNA samples were 
resuspended in loading buffer and loaded in 1-2% agarose gels. A 1 Kb plus ladder 
was loaded alongside the samples. Gels were stained with 1µl Ethidium Bromide and 
run in 1× TAE buffer using a voltage of 50-100V (up to 150 mA) for 1-2 hours 
depending on the size of the fragment to be resolved. The separated DNA fragments 
were visualised by exposure to UV light using an UVIdoc gel documentation system. 
 
2.2.2.4 Gel Purification of DNA 
Following electrophoresis, DNA fragments were excised from agarose gels and 
purified using the Gel Extraction Kit according to manufacturer’s instructions 
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(QIAGEN). DNA concentration was measured by reading the absorbance at OD 
260nm using a Genequant Calcular (Pharmacia). 
 
2.2.2.5 Ligation 
Ligation reactions were performed using 1:5 vector to insert ratio (100ng vector 
DNA) in a final volume of 12µl containing 10× T4 ligase buffer and 1µl T4 DNA 
lligase (Promega). Reactions were incubated for 4 hours at room temperature. 
 
2.2.2.6 Transformation of Competent Bacteria 
5µl of the ligated DNA were incubated on ice with 100µl Stbl3 competent E.Coli 
(Invitrogen) for 30 minutes. Bacteria were heat-shocked at 42°C for 45 seconds then 
held on ice for 1 minute. 1ml of LB was added to the bacteria and incubated at 37°C 
for 1 hour at 225rpm on a shaking incubator. 25-100µl from each transformation 
were then spread on pre-warmed Agar ampicillin plates and incubated overnight at 
37°C. 
 
2.2.2.7 Plasmid DNA Purification 
Selected colonies were incubated overnight in 5ml LB containing ampicillin 
(50µg/ml) in a shaking incubator at 37°C. Purification of plasmid DNA was 
performed using the Mini-prep kit according to manufacturers’ instructions 
(QIAGEN). The DNA was digested to confirm the presence of the correct plasmid 
DNA construct within the bacteria. 
 
2.2.2.8 Large-scale Plasmid DNA Production 
500ml LB-ampicillin were inoculated with 500µl of a fresh bacterial culture and 
incubated overnight in a shaking incubator at 37°C. For lentiviral production, 
plasmid DNA was prepared using Maxi-prep kit according to manufacturers’ 
instructions (QIAGEN). For transfections, DNA was prepared using the Endo-Free 
Plasmid Maxi Kit according to manufacturers’ instructions (QIAGEN). 
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2.2.3 Lentiviral Preparation, Transductions and Transfections 
2.2.3.1 Lentiviral Production 
Recombinant lentiviruses were produced by transient transfection of subconfluent 
293T cells. 30µg of the packaging plasmid pCMV-dR8.7, 10µg of the envelope 
plasmid pMDG2 (VSV-G) and 50 µg of one the transfer vectors encoding LifeAct-
Ruby, γcWT-GFP or  γcMut-GFP DNA were added to 5ml OPTIMEM and filtered 
through a 0.22 µm filter then combined with 5ml filtered OPTIMEM supplemented 
with 1µl polyethylenimine (10mM). The transfection reaction was incubated at room 
temperature for 20 minutes, during which time 293T cells were washed with 
OPTIMEM. 10 ml of the transfection mixture were then added to each flask and cells 
were incubated for 4 hours at at 37°C with 5% CO2, after which time the media was 
replaced with fresh complete DMEM. After 48 and 72 hours, the viral supernatant 
was harvested, filtered through a 0.22 µm filter then concentrated by 
ultracentrifugation at 100,000g for 2 hours using a Beckman Centrifuge. Lentiviral 
pellets were resuspended in OPTIMEM and stored at -80°C. 
 
2.2.3.2 Titration of Lentiviral Supernatants  
Viral titre was determined by infection of 293T cells. 5 x 105 cells (in 200µl) were 
seeded in 24-well plates and left to adhere overnight. 100µl of medium containing 
serially diluted lentiviral supernatant were then added to the cells. After 72 hours, the 
cells were harvested and analysed by flow cytometry to determine the percentage of 
of transgene positive cells. The titre was calculated by diving the number of infected 
cells by the amount of virus used (ml) and was expressed as infectious units/ml. 
 
2.2.3.3 Lentiviral Transduction of Cell Lines 
Lentiviral infection was achieved by seeding cells at a density of 0.3 x 106 cells/ml in 
complete medium. Concentrated lentiviral supernatant was directly added to the cells 
in culture at the required molteplicity of infection (MOI). 
 
2.2.3.4 Lentiviral Transduction of DCs 
DCs were grown as described in section 2.2.1.3. On day 6, cells were scraped off and 
resuspended at 1.5× 105 cells/ml. Lentiviral infection was performed by adding viral 
supernatant (MOI 25) and protamine sulphate (8ug/ml) to 1.5× 106 cells in a 15ml 
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Falcon tube. Cells were spun with virus at 1200g for 2 hrs at 25°C then plated in 
conditioned medium in a 6-well plate. Experiments with transduced cells were 
performed 48 hours after infection.  
 
2.2.3.5 Lentiviral Transfection of DCs 
DCs were grown as described in section 2.2.1.3. On day 6, cells were scraped off and 
resuspended at 2.5× 105 cells/ml. Lentiviral transfection was achieved by 
nucleoporating 2.5×105 DCs per transfection with 5ug lentiviral DNA or 2ug 
pmaxGFP control vector using the Amaxa Mouse Dendritic Cell Nucleofector Kit 
(Lonza), according to manufacturers instructions. Cells were then seeded in 48-well 
plates and cultured at 37°C with 5% CO2. Experiments with transfected cells were 
performed 24 hours after nucleoporation.  
 
2.2.4 Protein Isolation, Immunoblotting and Immunoprecipitation 
2.2.4.1 Western Blotting (WB) 
1×106 cells were lysed for 15 minutes on ice in 20µl lysis buffer and cleared by 
centrifugation in a table-top centrifuge (13 000 rpm for 10 min). 5µl of loading 
buffer were added to the cell lysates and the samples were heated for 5 minutes at 
100°C. The proteins were then separated by sodium dodecyl sulfate polyacrylamide 
gel electrophoresis (SDS-PAGE) for 1 hour at 120V in running buffer and 
transferred on a PVDF membrane (Millipore) using a semi-dry transfer method for 
30 min at 18V in transfer buffer. Membranes were blocked in blocking buffer for 1 
hour at room temperature, then incubated in blocking buffer containing a 1:100 
dilution of primary antibody (anti-IL-15Rα N-19 and anti-IL-2Rγ M-20). 
Membranes were then washed 5 times with wash buffer before incubation for 45 
minutes in blocking buffer containing a 1:1000 dilution of secondary horseradish 
peroxidise-conjugated antibody. The blots were washed 5 times. Protein bands were 
visualised by incubating the membrane with enhanced chemiluminescence (ECL) 
solution for 1 minute and digitally captured using a gel documentation system 
(UVITEC) and software (UVISOFT). When necessary, membranes were stripped by 
washing with 0.2M glycine, 0.5M NaCl for 5 minutes before rinsing with 0.1M 
NaOH for 10 minutes. Membranes were then re-probed for GADPH (1:500 dilution) 
as a loading control. 
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2.2.4.2 Immunoprecipitation (IP) 
Prior to immunoprecipitation, 50µl of Protein G Dynabeads (Invitrogen) were 
transferred to an appendorf, placed on a magnet and washed in PBS. 4µg of antibody 
(anti-IL-15Rα H-107) diluted in 500µl PBS were then added to the beads and 
incubated with rotation for 1 hour at room temperature. The bead-antibody complex 
was then resuspended in 200µl lysis buffer and added to the cell lysates. Cell lysates 
were derived from 5×106 cells lysed for 15 minutes on ice in 500µl lysis buffer and 
cleared by centrifugation (13 000 rpm for 10 min). Samples were incubated with 
rotation at 4°C overnight then washed 5 times with PBS. Beads were finally 
resuspended in 30µl loading buffer, boiled for 5 minutes at 100°C and placed on a 
magnet. The supernatants were then separated by SDS-PAGE and immunoblotted 
with anti-I-A/I-E (M5/114.15.2) as described in 2.2.4.1.   
 
2.2.5 Flow cytometry 
Cells were analysed using a Cyan flow cytometer (Dako) and either Summit software 
(DakoCytomation) or FlowJo software. 
 
2.2.5.1 Surface Staining of Primary Cells  
Prior to staining, 2×105 cells were resuspended in 100µl PBS containing a 1:50 
dilution of rat anti-mouse Fc Receptor Block (CD16/CD32) and incubated for 30 
minutes on ice. Cells were then pelleted by centrifugation at 1200 rpm for 5 minutes, 
resuspended in 100µl FACS buffer containing a 1:25 (unconjugated), 1:25 (FITC-
conjugated) or 1:50 (PE-, APC-, PE-Cy5- and PercP-conjugated) dilution of the 
appropriate antibody and incubated on ice for 30 minutes in the dark. For analysis of 
DC surface expression, cells were stained with the following antibodies: CD132, 
B220-FITC, CD86-FITC, IL-2Rα-FITC, IL-15Rα-FITC, IL2Rβ-FITC, CD11b-PE, 
MHC II-PE, IL-21R-PE, CD11c-APC and CD8α-PercP. For analysis of T cell 
surface expression, cells were stained with the following antibodies: CD4-APC, 
CD69-PE-Cy5. For analysis of NK cell surface expression, cells were stained with 
the following antibodies: NK1.1-APC. Where an unconjugated antibody was used, 
cells were washed once with 1ml FACS buffer, pelleted by centrifugation and 
resuspended in 100µl FACS buffer containing a 1:50 dilution of secondary antibody 
for 30 minutes on ice in the dark. Following staining, cells were washed once with 
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1ml FACS buffer, pelleted by centrifugation, resuspended in 300µl FACS buffer and 
analysed by flow cytometry. If cells were not analysed immediately after staining, 
they were resuspended in 300µl 1% paraformaldehyde (PFA)/PBS and stored in the 
dark at 4°C. 
 
2.2.5.2 Intracellular Staining of Primary Cells   
Prior to staining, 2×105 cells were fixed in 100µl 2% PFA/PBS for 30 minutes at 
room temperature. Cells were then washed with PBS, pelleted by centrifugation and 
permeabilised in 100µl 0.1% saponin/PBS containing a 1:50 dilution of FcR block 
for 30 minutes on ice. Staining was then performed as described in 2.2.5.1. 
Antibodies used were IL-15Rα-FITC. 
 
2.2.5.3 Intracellular Cytokine Staining  
2×105 DCs were seeded in 96-well plates and stimulated for 18 hours in 200µl 
complete RPMI containing 100ng/ml LPS alone or in combination with 100ng/ml 
murine IL-21 (R&D Systems).  The following day, cells were treated for 4 hours 
with 10 µg/ml Brefeldin A. Cells were washed 3 times with PBS and subsequently 
stained for surface CD11c (1:50 dilution in PBS) for 30 minutes on ice. Cells were 
washed once in PBS then resuspended in 200µl Cytofix/Cytoperm solution (BD 
Pharmingen) for 30 minutes on ice. Cells were washed once with Perm/Wash 
solution (BD Pharmingen) then stained with biotinylated anti-IL-12 p40/p70 or 
isotype control (1:50 dilution in Perm/Wash) for 30 minutes on ice. Cells were 
washed once with Perm/Wash solution then stained with Streptavidin PE (BD 
Pharmingen)  (1:100 dilution in Perm/Wash) for 30 minutes in the dark on ice. 
 
2.2.5.4 Intracellular Phalloidin Staining  
5 x 105 DCs were fixed in 100µl 4% PFA for 30 minutes at room temperature then 
washed in PBS. Cells were resuspended in 100µl Perm/Wash solution, incubated for 
5 minutes at room temperature then washed. Subsequently cells were resuspended in 
100µl Perm/Wash solution containing 2µL Rhodamine Phalloidin (Molecular 
Probes, Invitrogen) and incubated for 20 minutes on ice in the dark. Cells were 
washed and analysed. 
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2.2.5.5 Analysis of Endocytic Activity 
2 x 105 DCs were incubated in 100µl complete RPMI with or without 50ng/ml LPS 
for 30 minutes at 37°C in polysterene round-bottom tubes. Cells were washed in PBS 
then cultured with 2 mg/ml FITC dextran on ice for 30 min. Samples were incubated 
at 37°C for the indicated timepoints, then washed twice with PBS and analysed at the 
flow cytometer. 
 
2.2.6 Analysis of Cytokine Release  
2.2.6.1 Analysis of Cytokine Release by Luminex 
DCs were CD11c selected using magnetic bead separation according to 
manufacturer’s instructions (Miltenyi Biotech). 1×105 CD11c selected DCs were 
cultured overnight in 100µl RPM1 1% FCS with one of the following TLR ligands at 
the indicated final concentrations: 0.5µg/ml Pam3CSK4 (TLR1/2), 108 cells/ml 
HKLM (TLR2), 25µg/ml Poly I:C (TLR3), 100ng/ml LPS E.Coli (TLR4), 1µg/ml 
Flagellin (TLR5), 0.5µg/ml FSL-1 (TLR6/2), 1µg/ml ssRNA40 (TLR8), 5µM CpG 
(TLR9).  Supernatants were assayed using the Luminex Beadlyte® system or on 
mouse IFN-α (PBL Biomedical Labs), TNF-α and IL-6 (eBioscience) ELISAs. 
Optimal TLR ligand concentrations for stimulation were pre-determined by assessing 
the release of the surrogate marker IL-12 by ELISA (eBioscience). 
 
2.2.6.1 Enzyme-linked Immunosorbent Assay (ELISA) 
ELISAs were performed according to manufacturers’ instructions and absorbances 
were measured at 450 nm using a FLUOstar OPTIMA (BMG LABTECH). 
 
2.2.7 Analysis of JAK/STAT Signaling 
2.2.7.1 Detection of JAK/STAT Signaling by Immunofluorescence. 
Prior to cytokine stimulation, 1×105 DCs were starved for 30 minutes on ice in RPMI 
medium then plated in RPMI 1% FCS on polylisine coated slides and left to adhere 
for 30 min. Cells were stimulated for 10 min with 20ng/ml murine IL-2 (Peprotech) 
or murine IL-21 (R&D Systems) at 37°C then fixed in ice-cold 1% PFA for 5 
minutes. Cells were permeabilised with 0.5% Triton X100 for 5 min, washed and 
blocked with 2% normal mouse serum for 30 minutes. Cells were stained with rabbit 
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anti-pJAK3 (10µg/ml) or rabbit anti-pSTAT5 (C71E5) (1:100) for 1 hour, washed 
then stained with anti-rabbit Alexa Fluor 488 (10µg/ml) and rhodamine phalloidin 
for 45 min (1:100) (all from Molecular Probes, Invitrogen). Washes and antibody 
stains were performed in PBS. Coverslips were mounted on slides with DAPI-
containing mounting medium (Vector Laboratories) and examined using a laser 
scanning confocal microscope (TCS SP2 Leica).  
 
2.2.7.2 Detection of JAK/STAT Signaling by Flow Cytometry 
For intracellular detection of pSTAT5 in DCs and ED7R cells, cells were starved for 
60 minutes in RPMI medium. Subsequently, 2×105 cells were cultured for 10 minutes 
in 100μl medium with or without murine/human IL-2 (20ng/ml and 100ng/ml, 
respectively) at 37°C then fixed with FACS lyse/fix buffer (BD Pharmingen) for 10 
minutes at 37°C. Cells were pelleted by centrifugation and permeabilised with cold 
Perm Buffer III (BD Pharmingen) for 30 min on ice. Cells were washed with FACS 
buffer then stained with anti-pSTAT5-PE (47) and analysed at the flow cytometer. 
 
For intracellular detection of pSTAT5 in CD4+ T cells, cells were starved for 3 hours 
in RPMI medium.  1×105 T cells (in 100μl) were then mixed in polysterene round-
bottom tubes at a 1:1 ratio with DCs, which had been pre-treated for 30 minutes with 
20µg/ml anti-IL-15Rα (AF551) or with isotype matched control at 37°C. Cells were 
centrifuged for 2 minutes at 600 rpm to encourage conjugate formation, incubated 
for 10 minutes at 37°C then fixed with FACS lyse/fix buffer. For intracellular 
detection of pSTAT5, cells were treated as described above. Conjugates were also 
stained with anti-CD4-PE-Cy7 and anti-CD11c-APC (to discriminate between T 
cells and DCs) then analysed at the flow cytometer.  
 
2.2.7.3 Detection of JAK/STAT Signaling by Western Blotting 
1×106 DCs were cultured with or without 100ng/ml IL-21 and analysed by 
immunoblotting as previously described in in 2.2.4.1.  Immunoblotting was 
performed with rabbit anti p-STAT5 (C71E5) (1:1000 dilution) and anti-rabbit IgG 
horseradish peroxidise. Membranes were stripped and reprobed with rabbit anti-
STAT5 (1:1000 dilution). 
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2.2.8 Analysis of Uptake and Processing of OVA 
2.2.8.1 Analysis of DQ-OVA Uptake and Processing 
0.25×106 LPS-matured DCs were seeded in 48-well plates and incubated in 300μl 
complete RPMI medium (without Phenol Red) containing 5µg/ml DQ-OVA 
(Molecular Probes, Invitrogen). The fluorescence was then measured at the 
FLUOstar OPTIMA (BMG LABTECH) over a period of 16 hours.  
 
 
2.2.8.2 Analysis of OVA Presentation  
1×105  DCs were incubated for 2 hours at 37°C in 100μl complete RPMI medium 
containing OVA323-339 peptide (AnaSpec) (0.1μM, 1μM or 10μM final concentration). 
B017.4 T cells were then cultured with OVA-pulsed DCs at a 10:1 ratio for 18 hours. 
Supernatants were assayed for IL-2 using an anti-mouse IL-2 ELISA kit (R&D 
Systems). 
 
2.2.9 DC: T cell In Vitro Experiments 
2.2.9.1 Analysis of DC-mediated T cell priming 
1×106 CD4+ T cells were resuspended in 1ml RPMI, labeled with 5µM CFSE 
(Molecular Probes, Invitrogen) for 20 min at 37°C then washed twice in complete 
media. Cells were then seeded in 96-well plates (1×105 cells/well in 100ul) and 
cultured at 1:1, 1:5 and 1:10 DC:T cell ratios  with LPS-matured, OVA-pulsed DCs 
in a 37°C/5%CO2 incubator . For IL-15Rα blocking experiments, DCs were pre-
treated for 30 minutes 37°C with anti-IL-15Rα (AF551) or with isotype matched 
control at concentrations ranging from 1.25µg/ml to 20µg/ml, prior to coculture with 
T cells.  After 24 hours, cocultures were washed, pelleted by centrifugation, stained 
with anti-CD4 and anti-CD69 and analysed at the flow cytometer. Alternatively, 
after 72 hours, cocultures were washed and pelleted by centrifugation; this time, the 
cell pellets were stained with anti-CD4 and CFSE dilution was measured at the flow 
cytometer whilst the supernatants were assayed for IL-2 production using a mouse 
IL-2 ELISA kit. 
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2.2.9.2 Analysis of DC-T cell Adhesion by Flow Cytometry 
2×106 DCs (LPS-matured, pulsed with or without OVA) were resuspended in 5ml 
RPMI and labeled with 0.2 µM CMFDA (Molecular Probes, Invitrogen). 5×106 
CD4+ T cells were resuspended in 5ml RPMI and labeled in 1 µg/ml DDAO 
(Molecular Probes, Invitrogen). Both cell types were cultured for 30 min at 37°C, 
then washed and resuspended in complete RPMI for 30 min at 37°C.  1×106 DCs 
were blocked with Fc Receptor block (1:50) for 30 min on ice then washed and 
resuspended in 1ml complete RPMI containing 20 µg/ml anti-ICAM-1 or isotype 
control Ab for 30 min at 37°C.   CD4+ T cells were also resuspended in 1ml 
complete RPMI then mixed 1:1 with DCs in polysterene round-bottom tubes and 
centrifuged for 10 min at 600 rpm to encourage conjugate formation. Cells were 
incubated for 1 hour at 37°C then analysed at the flow cytometer.  
 
2.2.9.3 Analysis of DC-T Cell Conjugates by Confocal Microscopy 
0.5×106 CD4+ T cells and 0.5×106 DCs (LPS-matured, pulsed with or without OVA) 
were mixed 1:1 in polysterene round-bottom tubes (1ml total volume) and were 
centrifuged for 10 min at 600 rpm to encourage conjugate formation. After 
incubation at 37°C for 1 hour, cells were fixed with 2% PFA and allowed to adhere 
briefly on polylysine-coated coverslips. Cells were permeabilised with 0.1% saponin, 
quenched with 50mM glycine and blocked with blocking buffer (10% FCS, 2% Fc 
block in PBS). Cells were stained with anti-TCRζ Alexa 647 (1:50) and rat anti-
LFA-1 (15µg/ml) for 1 hour, washed then stained with anti rat Alexa 488 (10µg/ml) 
(Molecular Probes) for 45 minutes. Washes were performed in wash buffer (2% FCS 
in PBS) and antibody stains in staining buffer (0.01% saponin in wash buffer). After 
staining, coverslips were mounted on glass slides with ProLong Gold Antifade 
mounting medium (Invitrogen) and examined using Zeiss LSM 510 confocal 
microscope (63x, 1.4 NA, oil immersion objective).  
 
2.2.9.4 Analysis of Contact Stability and T Cell Ca2+ Signaling by Live Cell 
Imaging 
1×105 DCs (LPS-matured, pulsed with or without OVA) were resuspended in 0.5ml 
complete RPMI, plated in 35mm FluoroDishes (World Precision Instruments) and 
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left to adhere for 30 minutes at 37°C. In the mean time, 1×106 CD4+ T cells were 
resuspended in 1ml RPMI, labeled with 2µM Fluo4-AM (Molecular Probes, 
Invitrogen) for 20 min at 37°C, then washed twice in complete media. 5×105  T cells 
were resuspended in 0.5ml complete RPMI and co-cultured with the adhered DCs at 
37°C/5%CO2 in the environmental chamber of a Zeiss LSM 710 confocal 
microscope (25x, 0.8 NA, oil immersion objective). Cellular interactions and Ca2+ 
fluxes were monitored simultaneously by differential interference contrast (DIC) and 
fluorescence over 30 minutes at 10-second intervals using Zeiss software.  
 
2.2.10 DC: NK cell In Vitro Experiments  
2.2.10.1 Analysis of DC-mediated NK cell Survival and Activation 
DCs were matured overnight with 1µg/ml LPS. The following day, cells were 
washed, seeded in 96-well plates (2×105 cells/well in 100ul) and cultured at a 2:1 
ratio with DX-5 selected NK cells at 37°C. After 24 hours, DC:NK cocultures were 
washed and pelleted by centrifugation. Cell pellets were stained with anti-NK1.1 and 
analysed for cell viability using the Annexin V-PE Apoptosis Detection Kit 
according to manufacturer’s instructions (BD Pharmingen). The supernatants were 
instead assayed for IFN-γ using a mouse IFN-γ ELISA kit (Invitrogen). 
 
2.2.10.2 Analysis of DC-mediated NK cell Proliferation. 
0.5×106 NK cells were resuspended in 1ml RPMI, labeled with 2.5µM CFSE for 20 
min at 37°C then washed twice in complete media.  Cells were seeded in 96-well 
plates (1×105 cells/well in 100μl) and cultured at 1:1 and 1:5 ratios with LPS-matured 
DCs for 48 hours at 37°C. Cell pellets were then stained with anti-NK1.1 and CFSE 
dilution was measured at the flow cytometer. 
 
2.2.11 Lipid Bilayer Experiments 
Experiments involving the lipid bilayer/TIRFM platform are part of a collaboration 
with Prof. Michael Dustin at the Skirball Institute of Biomolecular Medicine, New 
York University. For experiments with CD4+ T cells, the lipid composition of the 
bilayers was the following: 0.4mM DOPC, 12.5 mol% Ni-NTA (all from Avanti 
Polar Lipids). I-Ab/OVA, IL-15/ IL15Rα and ICAM-1 are His6-tagged and were 
  80 
linked to the bilayer via Ni-NTA. For experiments with DCs, the lipid composition 
of the bilayers was the following: 0.4mM DOPC, 0.05 mol% Cap-bio, 12.5 mol% 
Ni-NTA (all from Avanti Polar Lipids). The aMHCII Fab-bt1 fragment was attached 
to the bilayer using streptavidin as a bridge. The LFA-1-His6-domain was attached 
to the bilayer via Ni-NTA. Preparation of lipid bilayers and image acquisition (Nikon 
Ti TIRFM, x100 Apo TIRF objective, NA 1.49) are the work of Dr. Kaushik 
Choudhuri. For these experiments, I have performed cell culture, transfection, cell 
preparation, immunofluorescence staining and data analysis, as detailed below. 
 
2.2.11.1 Experiments with CD4+ T cells 
CD4+ T cells were incubated at 37°C on glass-supported planar bilayers containing 
500 molec/µm2 ICAM-1, 300 molec/µm2 CD80, molec/µm2 I-Ab pOVA and 2µg/ml 
IL-15/ IL15Rα complex (eBioscience) in the presence of fluorescent anti-TCR Fab. 
After 30 minutes, cells interacting with lipid bilayers were fixed by injecting 2% 
PFA into the flow chamber. Cells were then permeabilised with 0.1% saponin/PBS 
for 5 minutes, quenched with 50mM glycine for 30 minutes and blocked with 5% 
BSA/PBS for 1 hour. Washes were performed in 2% BSA in PBS and stains in 2% 
BSA, 0.1% saponin/PBS. Primary antibodies were incubated for 1 hour and were 
rabbit anti-phospho-STAT5 (D47E7), anti-phospho-PLCγ1 and anti-phospho-AKT 
(all at 1:50 dilution). Secondary antibodies were incubated for 45 minutes and were 
anti-rabbit AlexaFluor488 (10µg/ml) (Molecular Probes, Invitrogen). 
 
2.2.11.2 Experiments with DCs 
LPS-matured, OVA-pulsed DCs were incubated at 37°C on glass-supported planar 
bilayers containing LFA-1 and Alexa-568-I-Ab Fab. Cells interacting with lipid 
bilayers were fixed at the indicated timepoints by injecting 2% PFA into the flow 
chamber. Cells were then permeabilised and stained as described in section 2.2.11.1. 
Primary antibodies were rabbit anti-IL-15Rα (H-107) (10µg/ml). Secondary 
antibodies were anti-rabbit AlexaFluor488 (10µg/ml) (Molecular Probes, 
Invitrogen). Cells were also stained with Alexa 488-phalloidin (1:50) (Molecular 
Probes, Invitrogen).  
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2.2.12 Image Processing and Data Analysis 
For live cell imaging, images were analysed using Volocity Version 5.3.0 software. 
Only cells that could be observed for at least 30 seconds after the formation of a tight 
T cell-DC contact were analysed. Contact times are presented either as cumulative or 
individual contact times of T cells interacting with DCs. The total Fluo-4 intensity 
per T cell was quantified as F/Fo, where F is the integrated fluorescence intensity 
during contact with a DC and Fo corresponds to the mean integrated fluorescence 
intensity of non contacting T cells. Ca2+ oscillations are presented as the variance of 
Fluo-4 intensities of contacting T cells. For presentation, images were corrected 
using the “gamma” option of ImageJ software. 
 
For analysis of cell-conjugates, confocal images were first background subtracted. 
The enrichment of molecules at the interface was then determined using the “ROI” 
option of the Metamorph v6.1 software and is expressed as ratio of fluorescence 
intensity at contact interface with DC versus non contact regions of the plasma 
membrane.  For en face synapse reconstructions, z-stacks of appropriately oriented 
cell conjugates were collected at 150nm steps to a distance of ~15µm. Z-stacks were 
deconvolved using the Iterative Deconvolve 3D algorithm in ImageJ to produce XZ 
reconstructions of the contact interface. 
 
For analysis of TIRFM images, images were first background subtracted. T cell 
signaling was measured by identifying regions of cell contact using a threshold on 
TCR intensity. Total (integrated) and average fluorescence of pSTAT5, pAKT and 
pPLCγ1 was measured within these regions. For analysis of MHC II accumulation at 
DC interfaces, total and average fluorescence, representing accumulation of bound 
MHC II at the contact interface, was measured for each DC in a 60-minute timeseries 
acquired at 4 frames/minute. A similar method was used for GFP accumulation. 
Colocalisation in fixed and live cells was measured using Pearson’s correlation 
coefficient (Rr). This was calculated by intensity correlation analysis using the 
“colocalization” option in ImageJ. Image analysis was performed using a 
combination of Metamorph v6.1 and ImageJ.  
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2.2.13 Statistical Analysis 
Prism Version 5 (GraphPad Software) was used for statistical analysis. Two-tailed 
student’s t-test with 95% confidence bounds was applied when comparing the means 
of two normally-distributed samples; linear regression analysis was used to analyse 
the relationship between two variables x and y; one-way analysis of variance 
(ANOVA) (Bonferroni’s multiple comparison test) was performed to test for 
significant differences amongst two or more independent groups. Mean values are 
shown and error bars represent s.e.m. (standard error of the mean). P-values greater 
than 0.05 are indicated as n.s. (nonsignificant). 
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Chapter Three- Analysis of the Role of the Common Cytokine 
 Receptor γc in Dendritic Cell Biology and Functions 
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3.0 Aims 
• Assess γc expression and signaling in DCs. 
• Assess the importance of the γc for DC functions. 
 
3.1 Introduction 
Mutations in the γc cause X-SCID. X-SCID patients lack T and NK cells thereby 
indicating that γc-family receptors play a critical role in the development of these 
cells. A clinically indistinguishable phenotype is seen with loss of function mutations 
in the γc signaling mediator JAK348,215, highlighting the importance of γc-related 
signaling for the homeostasis of these lymphocyte subsets.  
 
DCs are still present in X-SCID patients. Although little is known about DCs in this 
disease, in the literature there is an increasing body of evidence suggesting that γc 
expression and signaling are important for DC functions. Murine DCs express 
various γc-family receptors such as IL-2R, IL-4R, IL-15R and IL-21R37,216-220 and the 
related cytokines have been reported to play a role in murine DC biology. IL-2, for 
example, augments IFN-γ production by DCs217 and enhances antigen uptake via  
IL-2R mediated endocytosis218. IL-4 is instead a survival factor and in combination 
with GM-CSF skews monocyte differentiation into DCs, thus pointing to a role for 
γc signaling in DC development221. Unlike IL-4, IL-21 is not required for DC 
differentiation but can alter DC functions by keeping DCs in an immature, low 
immunogenic state220. When stimulated with IL-21, DCs in fact develop a phenotype 
characterised by reduced MHC II and co-stimulatory molecule expression, high 
antigen uptake and reduced release of pro-inflammatory cytokines. Similarly, IL-7 
also downregulates MHC II expression and thereby maintains DC in an immature 
state222. In contrast, IL-15 has an activating effect on DC functions. Notably, 
stimulation of DCs with IL-15 results in the increased survival of mature DCs, in the 
upregulation of co-stimulatory molecules and increased antigen presentation. IL-15 
also acts during DC development and been reported to skew human monocyte 
differentiation into DCs with LC phenotype in vitro223 and into mature DCs ex 
vivo224.  
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Taken together, these reports provided strong evidence of a critical role of γc-family 
cytokines in regulating DC physiology and pointed to the possibility that DC 
function might be impaired in X-SCID. To address this hypothesis, the functional 
importance of the γc and of its associated receptors was assessed in murine bone-
marrow derived DCs (BM-DCs).   
  86 
3.2 γc-family Cytokine Receptor Expression and Signaling in 
Dendritic Cells 
 
3.2.1 DCs Express the γc and Signal through the JAK-STAT Pathway 
Whereas murine BM-DCs have previously been reported to express γc RNA219, 
protein expression of the γc has not been examined. To confirm γc protein 
expression, DCs were generated from the BM of WT C57BL/6 mice cultured over 7 
days with GM-CSF then stained with an antibody against γc. γc protein expression 
was confirmed by flow cytometry in CD11c+ DCs (Figure 3.1). 
The γc is a component of the receptors for IL-2, IL-4, IL-7, IL-9, IL-15 and IL-214. 
All of these cytokines signal through the JAK/STAT pathway. Cytokine binding 
results in JAK1/JAK3 tyrosine phosphorylation and in downstream activation and 
phosphorylation of STAT molecules which then localize to the nucleus and act as 
transcription factors19-22. To determine whether JAK/STAT signaling occurs 
downstream of γc in DCs, cells were stimulated with IL-21 and stained with 
antibodies specific for phosphorylated forms of JAK3 (Y785) and STAT5 (Y694). 
By confocal microscopy we observed that IL-21 stimulation results in an increase in 
the phosphorylation of both JAK3 and STAT5 proteins compared to unstimulated 
controls, thereby indicating that γc signaling through the JAK/STAT pathway occurs 
in DCs. As expected, phosphorylated JAK3 was mostly membrane associated 
whereas phosphorylated STAT5 predominantly accumulated in the nucleus (Figure 
3.2A,B).   
 
A 
 
Figure 3.1 DCs express the γc. DCs derived from the BM of WT C57BL/6 mice were stained with 
anti-γc (CD132) or with an isotype control antibody. Right panel indicates surface expression of the 
γc in DCs gated according to size (R1) and CD11c expression (R2) (left and middle panel, 
respectively). 
CD11c 
Isotype 
CD132 
FS γc 
R1 R2 
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Figure 3.2. DCs express the γc and signal though the JAK/STAT pathway. DCs were cultured for 
10 min with or without IL-21 (20ng/ml). Representative images showing expression of pJAK3 (green) 
(A) and pSTAT5 (green) (B) (left and middle panel) and localization of pJAK3 (A) and pSTAT5 (B) 
(right panel). The right panel is a high order magnification of cells shown in red box. Nuclei and F-
actin were stained with DAPI and with rhodamine phalloidin, respectively. 
 
pJAK3 
- IL-21 + IL-21 +IL-21 
pSTAT5 
- IL-21 + IL-21 +IL-21 
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3.2.2 Generation of DCs from Bone Marrow of γc-deficient Mice (γc -/- DCs). 
To assess the functional importance of γc expression and signaling in DCs, BM-DCs 
were generated from a murine model of γc-deficiency: the γc/RAG-2-/- mouse. 
These mice harbour a deletion spanning from exon 2-6 of γc corresponding to the 
extracellular and transmembrane domains of the protein, which results in aberrant 
protein expression. These mice also lack lymphoid restricted recombinase activating 
gene 2 (RAG-2), to eliminate low levels of persisting T cells seen in γc single knock 
out strains225, whereas RAG-2 deficiency is instead predicted not to influence 
myeloid lineages. By flow cytometry analysis, we observed that BM-DCs derived 
from these γc-deficient mice (γc-/- DCs) expressed similar levels of CD11c 
compared to WT (Figure 3.3A).  As expected, γc-/- DCs completely lacked γc 
expression, as demonstrated by WB analysis (Figure 3.3B).   
 
A 
 
B 
 
Figure 3.3 DCs from BM of γc/RAG-2-/- mice. DCs were generated from the BM of WT and 
γc/RAG-2-/- C57BL/6 mice cultured for 7 days with GM-CSF. (A) Surface expression of CD11c (B) 
Immunoblot analysis of γc expression. Cell lysates were separated by SDS-page and immunoblotted 
with anti-γc. The blot was stripped and re-probed with anti-GADPH (lower lane) to demonstrate 
protein loading in each lane. 
CD11c 
81% 85% 
WT γc-/- 
WT γc -/- 
γc (62KDa) 
 GADPH (37 KDa) 
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3.2.3 γc-/- DCs Express Normal Levels of the other Subunits of the IL2/IL-15R. 
The γc was first discovered as a component of the receptor for IL-27. The IL-2 
receptor complex (IL-2R) is closely related to the IL-15 receptor complex (IL-15R) 
in that they share common β and γ chains2. In addition each receptor has its own 
private α subunit which together with the IL-2/15Rβ and γc heterodimer forms the 
complete high affinity IL-2 or IL-15R4. To verify whether the absence of the γc 
might affect surface expression of the other components of the IL-2/15R complex, 
DCs were stained with antibodies against IL-2Rα, IL-15Rα or IL-2/15Rβ. Analysis 
at the flow cytometer confirmed that γc-/- DCs express these receptor chains at 
comparable levels to WT (Figure 3.4A). IL-2Rα expression is known to be induced 
by a variety of stimuli, including antigens, pathogens and cytokines226. In keeping 
with the literature, our data also shows that IL-2Rα is upregulated upon LPS 
stimulation and that this occurs similarly in WT and γc-/- DCs (≈3-fold increase in 
mean fluorescence intensity) (Figure 3.4A,B). Expression levels of IL-15Rα and IL-
2/15Rβ were also comparable in LPS-treated WT and γc-/- DCs but in contrast to IL-
2Rα, these subunits failed to be upregulated upon stimulation. Taken together, these 
results indicate that γc deficiency does not affect surface expression of the other IL-2 
and IL-15R subunits on the surface of DCs. 
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Figure 3.4 γc-/- DCs express the other components of IL-2/IL-15R. DCs were cultured overnight 
with or without LPS (A) Representative plots showing surface expression of IL-2Rα, IL-15Rα and 
IL2/15Rβ in CD11c+ gated cells (MFI=mean fluorescence intensities) (B) Fold increase (MFI values) 
of the indicated receptors upon LPS stimulation relative to unstimulated cells. Data are from 3 
independent experiments (mean ± s.e.m). P-values, two-tailed students t-test.  
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3.2.4 γc -/- DCs Fail to Transduce IL-2 Signals through the JAK-STAT Pathway 
The IL-2R is the prototype for the family of γc-receptors and the best characterised. 
As a result of combining the various IL-2R subunits, several forms of receptor 
complexes with different cytokine affinities exist on the cell surface. Isolated IL-
2Rα, ie low-affinity receptor, is not be involved in signal transduction whereas the 
IL-2Rβ/γc heterodimer, ie intermediate-affinity receptor, is necessary and sufficient 
to transduce IL-2 signals19. We were therefore interested to confirm that the absence 
of DC γc would abrogate signaling downstream of the IL-2R, despite normal 
expression of the other receptor subunits. To this end, DCs were stimulated with IL-2 
and analysed for STAT5 activation by flow cytometry and confocal microscopy. 
This showed that, in contrast to WT DCs, γc-/- DCs mice fail to signal through the γc 
in response to stimulation with IL-2, as demonstrated by absent pSTAT5 staining 
(Figure 3.5A,B). 
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Figure 3.5 γc-/- DCs fail to transduce IL-2 signals. DCs were cultured for 10 min with or without 
IL-2 (20 ng/ml). Cells were then fixed and stained with an anti pSTAT5. (A) Flow cytometry analysis 
of pSTAT5 expression on CD11c+ gated cells. R3 is set relative to unstained control (B) Confocal 
microscopy analysis of pSTAT5 expression (green). Nuclei and F-actin were stained with DAPI and 
with rhodamine phalloidin, respectively. Data presented is from 2 independent experiments. 
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3.2.5  γc/RAG-2-/- Mice Have Fewer Splenic DCs  
In order to assess the influence of γc receptors on DC development in vivo, DC 
numbers and subtype composition were analysed in γc/RAG-2-/- mice. This revealed 
that there are significantly fewer CD11c+ DCs in the spleens of these mice when 
compared to WT controls (p≤0.05); γc/RAG-2-/- mice typically had 30% of the DC 
numbers found in WT mice (Figure 3.6A). However, within the CD11c-enriched 
fraction, WT and γc/RAG-2-/- mice had similar frequencies of CD11c+ CD11b+ and 
CD11c+ CD8α+ conventional DCs. CD11c+ B220+ plasmacytoid DC were also 
present in comparable numbers in the spleens of WT and γc/RAG-2-/- mice (Figure 
3.6B). Thus, these results suggest that, in vivo, whereas γc is probably dispensable 
for the DC differentiation, it is instead required for DC development. Further 
investigation is required to establish whether this is due to a direct effect of γc-family 
cytokines on DCs or to an indirect effect determined by the lack of T cells. 
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Figure 3.6 DC numbers and subtype composition in γc/RAG-2-/- mice. Single cell suspensions 
were obtained from the spleens of WT and γc/RAG-2-/- C57BL/6 mice and enriched in CD11c+ DCs 
by magnetic bead selection. (A) CD11c+ DC frequency per spleen (B) Density plot of DCs (gated on 
CD11c+ cells) stained with anti-CD11b, CD8α and B220 to identify CD11c+ CD11b+ CD8α-, 
CD11c+ CD8α+ CD11b- and CD11c+ B220+ cells. Mean percentage of CD11c+ CD11b+, CD11c+ 
CD8α+ and CD11c+ B220+ out of total CD11c+ cells in spleens of 3 WT and γc/RAG-2-/-. P values, 
two-tailed students t-test.  
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3.3 Absence of the γc in Dendritic Cells Does Not Affect Antigen 
Uptake or Maturation in Response to Activation Stimuli  
 
3.3.1 γc -/- DCs Exhibit Normal Endocytic Activity 
Classically, immature DCs are antigen-capturing cells. To verify whether this 
function is affected by γc deficiency, we compared the endocytic activity of 
immature WT and γc-/- DCs using a fluorescent antigen. Briefly, DCs were 
incubated with FITC-dextran for 10 minutes and uptake was measured at early 
timepoints at the flow-cytometer. Antigen uptake is expressed as percentage of 
maximum endocytosis (ie, fluorescence intensity at a given timepoint relative to 
maximal fluorescence throughout the experiment) and was shown to be comparable 
between WT and γc-/- DCs over a period of 1hour (Figure 3.7).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.7 γc-/- DCs exhibit normal endocytic activity. DCs were cultured with FITC dextran for 
20 min on ice followed by incubation at 37 °C for the indicated timepoints. Cells were then washed 
and internalised FITC-dextran was measured by flow cytometry after gating on CD11c+ gated cells.  
% of maximal endocytosis is expressed in mean fluorescence intensity (MFI). Data is from 3 
independent experiments (mean ± s.e.m). P values, two-tailed students t-test.  
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Although an accepted hallmark of DC maturation is eventual downregulation of 
antigen uptake, transient enhancements of endocytic activity have been observed 
immediately after maturation, peaking 45 minutes after LPS stimulation227.  We were 
therefore interested to test whether γc deficiency might alter the acute response to 
bacterial stimulation in terms of antigen uptake. To this end, DCs were activated 
with LPS and analysed for endocytic activity of FITC-dextran. To our surprise, we 
failed to detect an increase in FITC-dextran uptake upon LPS stimulation, as has 
been previously reported (Figure 3.8). A similar uptake of FITC-dextran was 
however observed in LPS-stimulated γc -/- DCs compared to the LPS-stimulated WT 
counterpart (Figure 3.8). Taken together, these results suggest that γc deficiency does 
not alter the endocytic activity of DCs, regardless of their activation status. 
  
 
 
Figure 3.8 DC endocytic activity is not affected by LPS stimulation. DCs, with or without prior 
exposure to 50ng/ml LPS (for 10 min at 37 °C), were cultured with FITC dextran for 20 min on ice, 
followed by incubation on ice or at 37 °C for 45 min. Mean fluorescence intensity (MFI). One 
representative experiment of 3 is shown.  
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3.3.2 γc-/- DCs Express Normal Levels of CD86 and MHCII Molecules 
Upon encounter of bacterial products such as LPS, DCs acquire a mature phenotype 
and upregulate MHC II and co-stimulatory molecules such as CD80 and CD86 for 
presentation and costimulation to T cells77. To assess whether γc signaling affects the 
maturation of DCs, cells were cultured with or without LPS and assessed for the 
expression of CD86 and MHCII. This showed that, at steady state, γc-/- DCs express 
similar levels of CD86 and MHC II molecules to WT DCs (Figure 3.9A). Upon LPS 
stimulation, γc-/- DCs were observed to upregulate both CD86 and MHC II (≈2 and 
3-fold increase in mean fluorescence intensity, respectively) and this was also 
comparable to WT (Figure 3.9A,B). 
 
A 
 
B 
 
 
Figure 3.9 γc -/- DCs express normal levels of CD86 and MHCII molecules. DCs were cultured 
overnight with or without LPS. (A) Representative plots showing surface expression of CD86 and 
MHCII molecules on CD11c+ gated cells (MFI=mean fluorescence intensities)  (B) Fold increase 
(MFI values) upon LPS stimulation for CD86 and MHCII staining relative to unstimulated DCs. Data 
presented are from 3 independent experiments (mean ± s.e.m).  P-values, two-tailed students t-test. 
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3.3.3 γc-/- DCs Display Normal Cytokine Secretion Profiles  
A hallmark of DC activation by bacterial products is the release of proinflammatory 
cytokines. To assess whether this is affected by γc signaling, DCs were exposed to 
ligands for TLRs 1-9 and cytokine release profiles were tested using the Luminex 
cytokine bead array (Beadlyte®) system and by ELISA. Prior to ligand exposure 
cells were selected for CD11c expression through magnetic bead selection, thus 
ensuring high levels of DC purity (approximately 90%) (Figure 3.10). Optimal TLR 
ligand concentrations for stimulation were pre-determined by assessing the release of 
the surrogate marker IL-12 by WT DCs. Collectively, the data shown in 3.11, 
highlights normal levels of proinflammatory  (IL-1β, IL-2 ,IL-6, IL-12, IFN-α, TNF-
α) and anti-inflammatory (IL-10) cytokine secretion by γc-/- DCs upon stimulation 
with ligands to TLR2 (HKLM), TLR3 (Poly I:C), TLR4 (LPS), TLR6/2 (FSL-1) and 
TLR9 (CpG). Interestingly, as already reported for JAK3-/-DCs228, γc -/- DCs were 
observed to release significantly greater amounts of IL-12 upon LPS stimulation 
(p≤0.05). No cytokine release was detected, even in WT DCs, by stimulation with 
ligands for TLR1 (Pam3CSK4), TLR5 (Flagellin S.typhimurium) and TLR8 (ssRNA) 
and therefore these results are not shown.  
 
 
 
 
Figure 3.10 DC purity after CD11c selection. CD11c+ DCs isolated through magnetic bead selection 
from BM cultures were stained with anti-CD11c to confirm purity. 
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Figure 3.11 Cytokine secretion profile of DCs in response to stimulation with TLR ligands. 
CD11c selected DCs were cultured overnight with a panel of TLR ligands at optimal concentrations. 
The supernatants were assayed using the Beadlyte® system (IL-1β, IL-2, IL-10, IL-12) and on ELISA 
(IL-6, IFN-α and TNF-α). Data are from 8 independent experiments (mean ± s.e.m).  P values, two-
tailed students t-test.  
IL 1β
un
sti
m
HK
LM
Po
ly 
I:C LP
S
FS
L-1 Cp
G
0
50
100
150
pg
/m
l
IL 2
un
sti
m
HK
LM
Po
ly 
I:C LP
S
FS
L-1 Cp
G
0
1000
2000
3000
4000
pg
/m
l
IL-6
un
sti
m
HK
LM
Po
ly 
I:C LP
S
FS
L-1 Cp
G
0
1000
2000
3000
4000
pg
/m
l
IL 10
un
sti
m
HK
LM
Po
ly 
I:C LP
S
FS
L-1 Cp
G
0
2000
4000
6000
pg
/m
l
IL 12
un
sti
m
HK
LM
Po
ly 
I:C LP
S
FS
L-1 Cp
G
0
1000
2000
3000
4000
p < 0.05
pg
/m
l
IFN α
un
sti
mu
lat
ed
HK
LM
Po
ly 
I:C LP
S
FS
L-1 Cp
G
0
20
40
60
80
pg
/m
l
TNF α
un
sti
m
HK
LM
Po
ly 
I:C LP
S
FS
L-1 Cp
G
0
1000
2000
3000 WT DC
γc-/- DC
  100 
3.4 Absence of the Common Cytokine Receptor γc Impairs Dendritic 
Cell Responses to IL-21-mediated Inhibitory Effects 
 
3.4.1 γc-/- DCs Express but Fail to Signal through the IL-21R  
Like IL-2, IL-21 has its own private high-affinity receptor chain and shares the 
common γc cytokine receptor. To analyse whether γc deficiency affects surface IL-
21R expression, DCs were stained with an antibody against IL-21R. This showed 
that γc-/- DCs express IL-21R at comparable levels to WT (Figure 3.12A). 
Furthermore, we observed that surface IL-21R expression is not affected by LPS 
stimulation, both in WT and γc-/- DCs (Figure 3.12B).  
 
A       B  
  
      
     
 
 
 
Figure 3.12 DCs express the IL-21R. DCs were cultured overnight with or without LPS.  
(A) Representative plots showing surface expression of IL-21R on unstimulated DCs (gated on 
CD11c+ cells). The percentages of IL-21R-expressing DCs and MFI (in parenthesis) are shown  
(B) Fold increase (MFI values) of the IL-21R upon LPS stimulation relative to unstimulated cells. 
Data presented are from 3 independent experiments (mean ± s.e.m).  P-values, two-tailed students  
t-test.  
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Next, to confirm that γc deficiency abrogates signaling downstream of the IL-21R, 
DCs were stimulated for 10 minutes with IL-21, then analysed for STAT5 activation 
by WB analysis. This showed that γc -/- DCs fail to phosphorylate STAT5 protein 
upon IL-21 stimulation, regardless of normal levels of total STAT5 (Figure 3.13). 
 
 
 
 
Figure 3.13 γc-/- DCs fail to signal through the IL-21R. DCs were cultured for 10 min with or 
without IL-21 (100ng/ml) prior to lysis. DC lysates were then separated by SDS-page and 
immunoblotted with anti-pSTAT5. The blot was stripped and re-probed with anti-STAT5 (lower lane) 
to demonstrate levels of total STAT5 in each lane.  
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3.4.2 γc -/- DCs Fail to Downregulate IL-12 Production in Response to IL-21 
Stimulation  
It is well known that IL-21 prevents functional aspects of LPS-induced DC 
maturation, including pro-inflammatory cytokine release219. To test whether γc 
deficiency makes DCs unresponsive to IL-21 immunosuppressive effects, DCs were 
stimulated overnight with LPS alone or in combination with IL-21 and assessed for 
intracellular expression of the IL-12 inflammatory cytokine by flow cytometry.  This 
showed that, unlike WT DCs, γc-/- DCs did not downregulate LPS-induced 
production of IL-12 upon IL-21 stimulation (Figure 3.14A,B). Taken together, these 
results suggest that IL-21 stimulation fails to inhibit the functional maturation of γc-
deficient DCs, in terms of IL-12 cytokine secretion. 
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Figure 3.14 IL-21 fails to inhibit LPS-induced IL-12 production in γc-/- DCs. DCs were either left 
unstimulated or stimulated overnight with LPS alone or in combination with IL-21(100ng/ml). Prior 
to analysis, cells were treated with Brefeldin A for 4 hours, fixed and stained with anti-IL-12. (A) 
Representative plots showing intracellular expression of IL-12 in CD11c+ gated cells. Bars represent 
IL-12-expressing cells and are set according to isotype control (B) Bar graph indicating IL-12 
expressing cells (A). Data are from 3 independent experiments (mean ± s.e.m).  P values, two-tailed 
students t-test.  
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3.5 Conclusions 
In this chapter, the importance of γc signaling for basic DC functions was assessed. 
Although, this has already been suggested by others through functional responses to 
γc-containing cytokines37,216-220,222-224, here we provided first direct evidence of γc 
protein expression and downstream signalling in WT BM-DCs. In addition, to 
directly address the role of γc in DC functions, our study relied on a murine model of  
γc-deficiency (γc/RAG-2-/- mouse) and as expected, DCs generated from the BM of 
these mice (γc-/- DCs) lacked γc  expression and downstream signaling, despite 
expressing normal levels of other γc-containing receptor subunits. Otherwise, γc-/- 
DCs were indistinguishable from their WT counterpart in terms of expression of the 
CD11c phenotypic marker, MHC II and the CD86 co-stimulatory molecule.  
 
γc signaling was dispensable for several specific functions of DCs examined, such as 
antigen uptake and maturation in response to activation stimuli. When stimulated by 
LPS (ligand for TLR4), γc-/- DCs underwent normal upregulation of maturation 
markers (CD86 and MHC II). Cytokine release, as measured by Luminex, was also 
normal in response to stimulation by LPS as well as by ligands for TLR2, 3, 6 and 9. 
We did not find reduced levels of IL-2 secretion in response to LPS as suggested by 
others229. We did however observe enhanced IL-12 release by LPS-stimulated  
γc-/- DCs, in agreement with similar findings in JAK3-deficient DCs228. This 
difference was detected by Luminex and not by intracellular cytokine staining, 
possibly because the latter is a less sensitive method for detection and quantification 
of cytokines. Notably, low levels of IFN-α secretion were observed for all ligands 
shown and this could be due to the fact that type I IFNs are mainly secreted by 
plasmacytoid DCs as opposed to more conventional type DCs, such as BM-DCs. 
Furthermore, negligible levels of cytokine release were detected upon stimulation 
with ligands for TLR1, 5 and 8.  A possible explanation for this is that ligand 
concentrations were titrated according to the release of IL-12 and this may not have 
been an ideal readout for all TLR ligands as it is preferentially induced by 
stimulation through the TLR4 and TLR9 pathways. Regardless of these technical 
limitations, the results presented here suggest that altogether, TLR-mediated 
cytokine release is not generally affected by the γc-JAK/STAT signaling pathway. 
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Although several general functions of DCs were unaffected by γc-deficiency, 
specific functional responses to γc-family cytokines were observed. This is in 
keeping with reports indicating that signaling in response to γc-family cytokines is 
important for DC functions such as differentiation, survival and induction of both 
immunogenic and non-immunogenic phenotypes4. In this chapter, functional deficits 
were specifically demonstrated for the IL-21 immunosuppressive cytokine, which 
failed to inhibit LPS-induced IL-12 secretion in γc-/- DCs. In the light of these 
findings, it therefore seems plausible to hypothesise that in vivo, upon exposure to a 
rich inflammatory cytokine milieu, γc-deficiency may affect many DC functions. 
Failure of γc-family cytokine signaling also appeared to affect DC homeostasis, as 
demonstrated by reduced numbers of DCs in the spleens of γc/RAG-2-/- mice (70% 
reduction). This is consistent with a previous report in which RAG-2-/- and γc-/- 
mice (both T cell deficient) were also shown to have fewer epidermal and lymph 
node DCs (75% reduction)230. Here, defects in DC numbers were corrected by the 
infusion of normal T cells suggesting that T cell-derived signals, including γc-family 
cytokines, affect the survival of DCs. Further investigation is required to determine 
the direct contribution of γc-family cytokines on DC homeostasis and/or 
development in vivo. 
 
 
 
 
3.6 Final Conclusions 
• Murine BM-DCs express and signal through the γc.  
• Despite normal expression of other γc-containing receptor subunits, BM-DCs 
derived from γc/RAG-2-deficient mice (γc-/- DCs) fail to signal through the 
γc-JAK/STAT pathway. 
• γc-/- DCs undergo normal antigen uptake and maturation. 
• γc-/- DCs fail to respond to IL-21-mediated inhibitory effects. 
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Chapter Four- Analysis of the Role of the Common Cytokine Receptor 
γc in Dendritic Cells for Antigen-Specific CD4+ T Cell Activation 
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4.0 Aims  
• Assess whether DC-expressed γc affects antigen-specific activation of γc-
expressing CD4+ T cells. 
• Establish the specific role of DC-expressed IL-15R in promoting CD4+ T cell 
activation 
 
4.1 Introduction 
To explain the mechanisms underlying DC-mediated T cell activation, a multi-signal 
hypothesis has been constructed. This model envisages that, in order to be fully 
activated, T cells must be presented with peptide-MHC complexes (signal 1) and 
must receive co-stimulatory signals (signal 2) from interacting DCs. The integration 
of these signals involves the reorganization of specific adhesion and signaling 
molecules into an immunological synapse (IS). The mature IS is a site of continuous 
TCR signaling and the maintenance of a stable IS is required for full T cell activation 
ie, T cell proliferation and cytokine release156,231-233. Cytokines are also implicated in 
the optimal generation of T cell responses (signal 3) and interestingly, some cytokine 
signals have been to shown to be delivered specifically at the IS194,197,198.  
 
Of particular interest to this study is the fact γc-family cytokines can especially 
influence T cell activation. γc-family cytokine signals can be delivered to T cells 
either directly, as indicated by IL-15 mediated regulation of T cell proliferation234-238, 
or indirectly, by acting on other γc-family cytokine receptor expressing immune 
cells, such as DCs, which can in turn affect T cell activation. IL-7, for example, 
maintains DCs in an immature state and thereby decreases the homeostatic 
proliferation of CD4+ T cells222. IL-21-stimulated DCs also retain an immature 
phenotype and inhibit antigen-specific T cell proliferation in vitro and contact 
hypersensitivity in vivo219,220. A particularly interesting case is the one of IL-15. 
Owing to the particularly flexible structure of its receptor32, this cytokine can 
promote T cell activation by DCs, by acting either in cis or in trans. In the first 
scenario, DC-derived IL-15 functions in an autocrine manner to increase cell 
survival, upregulation of co-stimulatory molecules and presentation of antigen to 
CD4+ and CD8+ T cells4. Alternatively, IL-15 is assembled intracellularly with  
IL-15Rα in DCs before transport to the surface for transpresentation to neighboring 
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cells expressing membrane γc/IL-2/15Rβ complexes, such as NK and CD8+ T 
cells27,33,239. This is thought to be the main mechanism for IL-15 signaling as 
demonstrated by a study in CD8+ T cells where transpresented IL-15 was found to 
be more effective than soluble IL-15 in augmenting memory CD8+ T cell 
proliferation in response to TCR stimulation240. Remarkably, IL-15Rα-IL-15 
complexes have been shown to enhance proliferation of both naïve and memory 
antigen-specific CD8+ cells in vivo and to participate in tumor clearance241-243 
therefore confirming the importance of IL-15 transpresentation for CD8+ T cell 
priming. 
 
Taken together, these reports provided strong evidence of a critical role of γc-family 
cytokines in regulating DC-mediated T cell activation and pointed to the possibility 
that residual myeloid γc-deficiency in bone marrow transplanted SCID patients 
might contribute to persistent immunodeficiency through defective T cell activation. 
To address this hypothesis, we investigated the role of the γc in DC-induced priming 
of a naive CD4+ T cell response.  
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4.2 Absence of the Common Cytokine Receptor γc in Dendritic 
Cells Impairs Antigen-Specific CD4+ T cell Activation 
 
4.2.1 γc-/- DCs Prime Antigen-specific CD4+ T cells Less Efficiently 
To investigate the role the γc plays in DC-induced priming of a naive antigen-
specific CD4+ T cell response, DCs from wild type and γc/Rag 2-/- C57BL/6 mice 
were combined in vitro with T cells from OTII transgenic mice. The OTII mice 
harbour a TCR which specifically recognizes the ovalbumin peptide 323–339 presented 
in the context of I-Ab. In our experimental system, LPS-matured DCs were pulsed 
with ovalbumin (OVA) and co-cultured with CFSE-stained CD4+ OTII cells. CD69 
upregulation was used as a marker of early CD4+ T cell activation and assessed after 
24 hours whereas T cell proliferation and IL-2 release were taken as late activation 
readouts and analysed 72 hours from initial T-DC coculture. Flow cytometry analysis 
showed that T cells induced to express CD69 were significantly diminished (p≤0.05) 
when cultured with antigen-pulsed γc-/- DCs as compared to WT (≈30% reduction) 
(Figure 4.1 A,B). γc -/- DC-induced proliferation of CD4+ antigen-specific T cells, 
as determined by CFSE dilution, was also significantly lower (p≤0.05) than that 
induced by WT DCs (≈30% decrease) (Figure 4.1 C, D). In addition, OVA-pulsed 
γc-/- DCs supported significantly lower IL-2 secretion in T cell co-cultures (p≤0.05, 
Figure 4.1E). As previously described244, DC IL-2 release under these conditions was 
very low (≅40pg/ml, data not shown) hence, T cells were considered the main source 
of IL-2 release. Taken together, these data suggest that γc-/- DCs are defective in 
inducing antigen-specific CD4+ T cell activation. 
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Figure 4.1 γc-/- DCs fail to induce full CD4+ T cell activation. DCs were stimulated overnight with 
LPS and OVA. The following day, cells were washed and co-cultured with CFSE-labelled CD4+ 
OTII cells. Representative plots of CD69 expression (A) and CFSE dilution (C) in CD4+ gated T cells 
after co-coculture with DCs at 1:1 DC:T cell ratios for 24 hours and at 1:10 DC:T cell ratios for 72 
hours, respectively. Bars represent CD69 expressing (A) and CFSE diluting (C) CD4+ T cells. 
Quantification of percentages of CD69 expression (B) and proliferation (D). (E) IL-2 secretion from 
supernatants of CD4+ T cells cultured with DCs for 72 hours at the indicated ratios. Data are from 4 
independent experiments (mean ± s.e.m). P values, two-tailed students t-test.  
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4.2.2 Antigen Processing and Presentation are not Affected by γc-deficiency in 
DCs 
The initiation of a vigorous antigen-specific CD4+ T cell response requires correct 
antigen processing and presentation by DCs. To exclude the possibility that the 
reduced ability of γc-/- DCs to prime an antigen-specific response might be due to 
defective antigen uptake and processing, LPS-matured DCs were incubated with 
DQ-OVA; self-quenched conjugate of OVA that emits fluorescence upon uptake and 
degradation. Measurement of fluorescence derived from DQ-OVA pulsed DCs 
showed that γc-/- DCs uptake and process antigen as efficiently as WT DCs over a 
period of 16 hours (Figure 4.2A). Furthermore, to test whether γc deficiency 
influences DC capacity to present antigen/MHC II complexes to T cells, the B017.4 
hybridoma was cultured with DCs pulsed with OVA323-339 peptide and assessed for 
IL-2 production. B017.4 T cells have a TCR specific for OVA323-339 peptide presented 
by MHC II and secrete IL-2 independently of costimulation and proportionally to the 
amount of antigen they are presented with. Our data shows that B017.4 T cells 
cultured with either WT or γc-/- DCs secrete comparable amounts of IL-2 thereby 
suggesting that γc deficiency in DCs does not impair antigen presentation (Figure 
4.2B). Taken together, these results indicate that defective antigen-specific CD4+ T 
cell priming by γc-/- DCs is not due to ineffective processing and presentation of 
OVA. 
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Figure 4.2 γc-/- DCs process and present antigen normally (A) LPS-matured DCs were cultured 
for 16 hrs with DQ-OVA. Fluorescence was then measured at 515 nm (B) LPS-matured DCs were 
pulsed with OVA 323-339 for 2 hrs at the indicated concentrations then cultured with B017.4 T cells at a 
1:10 ratio. Supernatants were assayed for IL-2 production by ELISA after a 24hr co-culture. Error 
bars represent s.e.m. of triplicate measurements. P values, two-tailed students t-test. 
 
 
 
 
 
 
 
 
 
0 2 4 6 8 10 12 14 16
0
2
4
11
12
13
no cells
WT
γc-/-
time (hrs)
M
FI
 (x
10
-3
)
0
50
100
150
WT DC
γc -/- DC
OVA323-339             -              0.1µM       1 µM          10 µM
n.s. n.s.
n.s.
IL
-2
 (p
g/
m
l)
  112 
4.2.3 Conjugate Formation is not Affected by γc-deficiency in DCs  
Normal cytokine secretion profiles by LPS-matured γc-/- DCs, as described in 3.2, 
strongly suggested that soluble cytokine factors might not be critical contributors to 
the observed defects in antigen-specific CD4+ T cell activation. Hence, we next 
investigated whether cognate cell contacts might be affected. The most obvious 
interaction to study was LFA-1-ICAM-1 integrin-mediated adhesion as this is well 
described to be the most prominent adhesion interaction at the IS. To determine 
whether inefficient CD4+ T cell activation by γc-/- DCs could be due to defective 
adhesion between these two cell-types, conjugate-formation was assessed by flow-
cytometry as described by others245. CFMDA-labelled CD4+ OTII cells were co-
cultured for 1 hour with DDAO-labelled LPS-matured DCs, which had been pulsed 
with or without OVA. Prior to co-culture, DCs were pre-treated with a blocking anti-
ICAM-1 antibody or with an isotype-matched control antibody and the proportion of 
events positive for both CMFDA and DDAO were then used as a marker of 
conjugate-formation (adhesion) between CD4+ T cells and DCs, as shown in Figure 
4.3A. In keeping with previous reports describing the formation of antigen-
independent synapses246,247, conjugate formation was observed also in the absence of 
antigen, both for WT and γc -/- DCs (3.4% and 4.2%, respectively) (Figure 4.3B). 
The presence of antigen led to an increase in the number of conjugates and this 
occurred to a similar extent in both WT and γc-/- DCs (≈1.4 and ≈1.3 fold increase, 
respectively). Remarkably, ICAM-1 blockade inhibited both antigen-independent 
and dependent adhesion and this occurred similarly in WT and γc-/- DCs (3.4% to 
2.5% and 4.9% to 2.2%, respectively, in WT DCs compared with 4.2% to 2.2% and 
5.5% to 2.2% in γc-/- DCs.). Taken together, these results suggest that a primary 
(ICAM-1 mediated) adhesion defect is not responsible for defective T cell activation 
observed with γc-/- DCs. To be noted however is the fact that the percentages of 
conjugates in our system were lower than those previously described in systems 
using B cell as APCs (≈20%)245. We hypothesise that this may due to the adhesion of 
DC-containing conjugates to the culture plates in our assay, which may not have 
occurred with less adhesive APCs, such as B cells. 
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Figure 4.3 Conjugate formation is not affected by the absence of the γc in DCs. DCs were 
cultured overnight with LPS alone or in combination with OVA. The following day, DCs were 
labeled briefly with CFMDA then treated with a blocking anti-ICAM-1 antibody or with an isotype-
matched control antibody for 1 hr at 37°C. DCs were then mixed at a 1:1 ratio with DDAO-labelled 
CD4+ T cells and brought into contact by centrifugation for 10 min at 600 rpm. After 1 hr incubation 
at 37°C, cells were analysed by flow cytometry. (A) Density plot representation of mixed cell 
populations. Indicated are percentages of double-positive cells (DC-CD4+ T cell conjugates)  
(B) Quantification of conjugate formation under the indicated conditions.  Data are from 3 
independent experiments (mean ± s.e.m). P values, two-tailed students t-test. 
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4.2.4 Conjugate Duration and Stability are not Affected by γc-deficiency in 
DCs  
Long-lived DC-T cell contacts are important for achieving full T cell activation233. 
To exclude the possibility that the inefficiency of γc-/- DCs to prime a CD4+ 
antigen-specific T cell response might be due to altered contact stability between 
these two cell types, the duration of contacts was probed in vitro. To this end, LPS-
matured DCs were pulsed with or without OVA then co-cultured for 30 minutes with 
CD4+ T cells on an environmental chamber on an inverted microscope stage. The 
contacts were then followed by live cell imaging and their duration was quantified. 
Interestingly, this showed that the total contact time established by either WT or  
γc-/- DCs with T cells was not affected by the presence or absence of antigen (Figure 
4.4A). The situation was however different when the dynamics of individual T-DC 
interactions were analysed. In fact, whereas in the absence of antigen, both WT and 
γc-/- DCs established multiple short contacts (1.8±0.16 and 1.7±0.16 minutes, 
respectively) which never lasted over 5 minutes (Figure 4.4B), in the presence of 
antigen DCs behaved quite differently, actively embracing T cells by membrane 
protrusion and establishing stable contacts. Contacts with T cells were in fact 
significantly longer (p≤0.001) for both WT (3.7±0.5 minutes) and γc-/- (4.2±0.48 
minutes) OVA-pulsed DCs and the proportion of long/stable contacts (ie, >5minutes) 
increased to 16% for WT DCs and to 23% for γc -/- DCs. Taken together, these data 
indicate that there are no significant differences in the duration of total nor individual 
contacts formed between T cells and WT/γc-/- DCs, neither in antigen dependent nor 
independent contacts (Figure 4.4B), thereby suggesting that the duration and stability 
of DC-T cell conjugates are not affected by DC γc-deficiency.  
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Figure 4.4 Conjugate duration is not affected by the absence of the γc in DCs. DCs were 
stimulated overnight with LPS alone or in combination with OVA. The following day, DCs were co-
cultured at a 1:5 ratio with CD4+ T cells for 30 min in an environmental chamber on an inverted 
microscope stage. (A) Total contact time of CD4+ T cells interacting with DCs under the indicated 
conditions (B) Duration of individual contacts formed by CD4+ T cells with DCs. Data are from 2 
independent experiments (mean ± s.e.m). For each condition, 40-60 cells were evaluated.  P values, 
one-way ANOVA (Bonferroni’s multiple comparison test). 
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4.2.5 γc-/- DCs induce TCR-evoked Ca2+ signaling in CD4+ T cells Less 
Efficiently 
Sustained TCR signalling culminates in elevation of intracellular  Ca2+ concentration 
and is required for effective T cell activation248. Having demonstrated defective 
CD4+ T cell activation by γc-/- DCs, we were then interested to assess whether γc 
deficiency would alter DC capacity to induce T cell Ca2+ responses. To this end, 
LPS-matured DCs were stimulated with or without OVA and co-cultured with CD4+ 
T cells loaded with the Ca2+ sensitive Fluo-4 dye. Ca2+ fluxes were then monitored 
over 30 minutes at 10-second intervals through live cell imaging. Representative 
images of Ca2+ signals are shown for T cells contacting DCs in the presence or 
absence of antigen; emission intensities are displayed on a pseudocolor scale from 
red (low Ca2+) to green (high Ca2+) (Figure 4.5A). T cell activation was analysed by 
measuring total intracellular Ca2+ levels; ie, a integrated Fluo-4 intensities for a T cell 
when in contact with one or multiple DCs. In keeping with the literature247, antigen-
independent contacts were characterised by low level Ca2+  fluxes whereas interaction 
with antigen-pulsed (WT) DCs led to a significant rise (p≤ 0.05) in total levels of T 
cell intracellular Ca2+ (≈2.5fold increase) (Figure 4.5A,B). In contrast, antigen-pulsed 
γc-/- DCs failed to induce an enhanced Ca2+ response and the total levels of T cell 
Ca2+ were significantly lower (p≤ 0.05) compared to those induced by WT antigen-
pulsed DCs (≈40% reduction), regardless of similar total contact times (Figure 4.4A).  
Ca2+ oscillations were also used as a marker of T cell activation as they have been 
shown to play an important role in regulating lymphocyte effector functions182,249,250, 
and are presented as the variance of Fluo-4 intensities of contacting T cells. 
Representative Ca2+ traces are shown as a function of time for T cells under each 
condition (Figure 4.5C). In keeping with the literature251, Ca2+ responses were also 
observed in the absence of antigen and were characterized by rare and small 
transients. The most obvious difference in single-cell Ca2+ signals was a markedly 
greater frequency of Ca2+ spiking in T cells interacting with WT DCs in the presence 
of antigen, as demonstrated by an increase in Fluo-4 signal variance (Figure 4.5C,D). 
Ca2+ traces of T cells interacting with γc-/- OVA-pulsed DCs showed much lower 
amplitudes, as confirmed by a significant decrease (p≤ 0.0001) in the variance of 
Fluo-4 intensities compared to WT OVA-pulsed DCs (≈70% reduction). Taken 
together, these data suggest weaker TCR activation by γc-/- DCs. 
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Figure 4.5 Decreased TCR-driven Ca2+ signaling in CD4+ T cells stimulated by γc-/- DCs.  
DCs were stimulated overnight with LPS alone or in combination with OVA. The following day, cells 
were washed and co-cultured with Fluo-4 labelled CD4+ T cells for 30 min in an environmental 
chamber on an inverted microscope stage. (A) Time-lapse confocal microscopy pseudocolor 
representative images of Fluo-4 labelled CD4+ T cells interacting with DCs under each of the tested 
conditions (images were corrected with a gamma coefficient of 0.8). The time scale is indicated (min). 
Black arrows indicate CD4+ T cells interacting with DC (B) Integrated Fluo-4 intensities in arbitrary 
units (AU) of individual T cells during interactions with DCs normalized over basal fluorescence (C) 
Representative Ca2+ traces showing the oscillation of Fluo-4 intensities over time for T cells under 
each of the tested conditions. The grey shaded areas indicate periods of contact (D) Quantification of 
variance of Fluo-4 intensities in AU of individual cells contacting DCs. For each condition, 30-45 
cells were evaluated. Data are from 2 independent experiments (mean ± s.e.m).  P values, one-way 
ANOVA (Bonferroni’s multiple comparison test). 
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4.2.5 γc-/- DCs Fail to Induce TCRζ  Recruitment at the Contact Area 
Regardless of Normal LFA-1 Recruitment  
TCR-mediated signaling leads  to accumulation  of TCR and LFA-1 at the IS 151. To 
assess whether γc deficiency alters the  capacity to induce redistribution of such 
molecules at the DC-T cell interface, CD4+ T cells were conjugated with LPS-
matured DCs that had been stimulated with or without OVA and conjugates were 
stained for TCRζ and LFA-1. Figure 4.6A shows the labelling of TCRζ and LFA-1 
in T cell-DC conjugates. Remarkably, under antigen stimulation, unlike WT DCs,  
γc-/- DCs failed to induce redistribution of total surface TCRζ to the T cell contact 
area (Figure 4.6A,B). Significant differences (p≤0.001) were in fact detected 
between the level of TCRζ enrichment at the interfaces formed between T cells and 
antigen-pulsed WT/γc-/- DCs  (≈1.9 for WT versus ≈1.2-fold enrichment for γc-/- 
DCs ). En face reconstructions of the DC-T cell contact area showed multifocal TCR 
polarizations rather than the classical cSMAC configuration, as has been previously 
suggested by other studies of naïve T cell-DC interactions (Figure 4.6D)205. Overall, 
similar patterns of TCRζ clustering were observed at T cell interfaces with either 
WT or γc-/- DCs. 
Analysis of LFA-1 accumulation at the interface instead showed similar enrichment 
of this molecule at the contact area formed between T cells and either WT or γc-/- 
OVA-pulsed DCs (≈3.3. and ≈2.7-fold enrichment, respectively) (Figure 4.6A,B,D) 
confirming our findings that integrin-mediated adhesion is not affected by the 
absence of the γc in DCs.  
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Figure 4.6 Decreased recruitment of TCRζ in T-γc-/- DC conjugates.  DCs were stimulated 
overnight with LPS alone or in combination with OVA. The following day, DCs were mixed at a 1:1 
ratio with CD4+ T cells and brought in contact by centrifugation for 10 min at 600 rpm. After 1 hour 
incubation at 37°C, cells were fixed and stained for TCRζ and LFA-1. (A) Differential interference 
contrast (DIC) acquisitions and representative deconvolved images showing localization of TCRζ 
(blue), LFA-1 (green) and their corresponding overlays in DC-T cell conjugates (B) Quantitative 
analysis of the enrichment of TCRζ (B) and LFA-1 (C) at the T-DC contact area (D) En face XZ 
reconstructions of deconvolved interfaces showing the distribution at the interface of TCRζ (blue), 
LFA-1 (green) and their corresponding overlays. Data are from 2 independent experiments 
experiments (mean ± s.e.m). For each condition, 35–48 conjugates were evaluated.  P values, one-way 
ANOVA (Bonferroni’s multiple comparison test). 
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4.3 Absence of the Common Cytokine Receptor γc in Dendritic Cells 
Impairs IL-15 transpresentation  
 
4.3.1  γc-/- DCs Fail to Induce IL-15 Transpresentation-dependent STAT5 
Activation in CD4+ T cells 
Normal cytokine secretion profiles by γc-/- DCs (chapter 3.3.2) suggested that 
inefficient CD4+ T cell activation might be explained by defects in cognate cell 
contacts rather by defects in release of soluble factors. Having ruled out the 
contribution of adhesion to the observed defects, IL-15 transpresentation therefore 
seemed the other prominent cognate interaction to explore, especially because it 
involves the γc. 
IL-15 transpresented by IL-15Rα has been shown to activate the JAK-STAT 
pathway in trans through the β/γ chain complex expressed on NK and CD8+ T 
cells241. Although the γc is described to play predominantly a signaling role in IL-
15R biology, we wondered whether the absence of DC γc might affect 
transpresentation to CD4+ T cells. To test this, STAT5 phosphorylation was 
examined in CD4+ T cells following 10-minute incubation with DCs that had been 
pretreated with LPS alone or in combination with OVA. Since surface IL-15/IL-
15Rα complexes are induced in DCs upon TLR stimulation33, we hypothesized that 
γc-expressing LPS-matured DCs would activate JAK/STAT signaling though the 
CD4+ T cell β/γ chain. Surprisingly, γc-expressing DCs stimulated with LPS alone 
did not induce STAT5 activation in CD4+ T cells whereas stimulation with LPS in 
combination with OVA resulted in a significant enhancement in STAT5 
phosphorylation (p≤0.05), suggesting that DC-mediated CD4+ T cell STAT5 
activation depends on a cognate TCR:MHC signal (Figure 4.7 A,C). Interestingly, T 
cell STAT5 activation also appeared to depend on DC γc as indicated by the failure 
of γc-/- DCs to induce STAT5 phosphorylation in CD4+ T cells, under any of the 
conditions tested (Figure 4.67A,C). To confirm that the induction of JAK/STAT 
activation observed in CD4+ T cells stimulated with antigen-pulsed γc-expressing 
DCs was dependent on IL-15 transpresentation, DCs were treated with anti-IL-15Rα 
prior to co-culture with T cells. IL-15Rα-blockade in antigen-pulsed γc-expressing 
DCs abrogated CD4+ T cell STAT5 phosphorylation (p≤0.05), therefore suggesting 
that the T cell activation observed occurred through IL-15 transpresentation (Figure 
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4.7B,C). γc-/- DCs were unaffected by treatment with anti-IL-15Rα. Taken together, 
these data suggest that the γc in DCs is involved in mediating antigen-dependent  
IL-15 transpresentation to CD4+ T cells.  
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Figure 4.7 γc-/- DCs fail to induce STAT5 activation in CD4+ T cells.  DCs were either left 
untreated or stimulated overnight with LPS alone or in combination with OVA. The following day, 
cells were washed, treated for 30 min with 20µg/ml anti-IL15Rα or isotype control, then cultured at a 
1:1 ratio for 10 min with CD4+ T cells, which had been serum-starved for 3 hours. Cells were then 
fixed and stained with anti-pSTAT5. (A,B) pSTAT5 expression on CD4+ CD11c- gated  cells 
stimulated with DCs under the indicated conditions (C) Normalized  pSTAT5 fluorescence intensities 
relative to unstimulated control. Data presented are from 3 independent experiments (mean ± s.e.m).  
P values, one-way ANOVA (Bonferroni’s multiple comparison test). 
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4.3.2 γc-/- DCs Express Normal Levels of Intracellular IL-15Rα   
The results above indicated that DC γc is required for IL-15Rα-mediated 
transpresentation of IL-15 to CD4+ T cells. IL-15/IL-15Rα complexes are mainly 
assembled intracellularly prior to delivery to the surface and having previously 
established normal surface expression of IL-15Rα (Figure 3.4), we were then 
interested to verify the levels of intracellular IL-15Rα in γc -/- DCs. Western blot 
and flow cytometry analysis showed that γc-/- DCs express intracellular IL-15Rα 
similarly to WT (Figure 4.8A,B). Furthermore, we observed normal uprgulation of 
IL-15Rα upon LPS stimulation (1.3 and 1.4 fold increase for WT and γc-/- DCs, 
respectively) (Figure 4.8B). In keeping with the literature199, analysis of mean 
fluorescence intensities of IL-15Rα staining showed that intracellular IL-15Rα 
(Figure 4.8B) is relatively more abundant than surface IL-15Rα (Figure 3.4) in both 
immature and mature DCs (≈2 and 2.5-fold increase, respectively). Again, this was 
also unaffected by the absence of DC γc. 
 
A      B 
 
Figure 4.8 γc-/- DCs express and upregulate intracellular IL-15Rα normally. DCs were cultured 
overnight with or without LPS. (A) Immunoblot analysis of total IL-15Rα expression in unstimulated 
DCs. GADPH is used as a loading control (B) Representative plots showing intracellular expression 
of IL-15Rα in CD11c+ gated cells under the indicated conditions (MFI=mean fluorescence 
intensities). 
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4.3.3 TCR Engagement is Required for Efficient IL-15 Trans-signaling in  
CD4+ T cells 
To fully characterize antigen-dependent IL-15 transpresentation to CD4+ T cells, we 
studied the response of CD4+ T cells to stimulation with IL-15/IL-15Rα and 
peptide/MHC complexes by total internal reflection microscopy (TIRFM). To this 
end, CD4+ T cells were incubated for 30 minutes on lipid bilayers presenting  
ICAM-1, CD80, I-Ab/pOVA and IL-15/IL-15Rα as indicated in Figure 4.9A and 
fluorescently-labelled for pSTAT5 and TCR. This showed that, upon interaction with 
bilayers presenting I-Ab/pOVA, naïve CD4+ T cells developed TCR microclusters , 
as previously observed by others205 (Figure 4.9A arrows). Interestingly, upon 
stimulation with IL-15/ IL-15Rα complex in combination with I-Ab/pOVA, CD4+ T 
cells accumulated significantly more pSTAT5 microclusters at the cell-bilayer 
interfaces compared to either stimulus alone (≈1.5-fold difference) (p<0.001) (Figure 
4.9A,B). In addition, we also observed that pSTAT5 microclusters were not recruited 
within TCR-antigen microclusters but were homogenously distributed at the contact 
interface, possibly suggesting spatial segregation of the IL-15R and TCR signaling 
pathways.  
Consistent with the flow cytometry results obtained with DC-T cell conjugates 
(Figure 4.7), these data reiterate the idea that IL-15/IL-15Rα-mediated CD4+ T cell 
STAT5 activation depends on simultaneous TCR engagement. 
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Figure 4.9 IL-15/IL-15Rα  mediated STAT5 activation in CD4+T cells requires TCR 
engagement.  CD4+ T cells were incubated on glass-supported planar bilayers containing ICAM-1, 
CD80, I-Ab pOVA and IL-15/ IL15Rα as indicated in the presence of fluorescent anti-TCR Fab. After 
30 min incubation at 37°C, cells were fixed and stained for pSTAT5. (A) Representative TIRFM 
images showing pSTAT5 (green) and TCR (red) accumulation at the T cell contact interface (B) 
Quantification in arbitrary units (AU) of integrated pSTAT5 fluorescence intensities (mean ± s.e.m) at 
contact interfaces shown in A normalized relative to ICAM-1 control. For each condition, 32-57 cells 
were evaluated.  P values, one-way ANOVA (Bonferroni’s multiple comparison test).  
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4.3.4  IL-15 Transpresentation Does Not Modulate TCR Signaling  
The findings that IL-15 trans-signaling requires simultaneous TCR engagement 
pointed to the possibility that IL-15 transpresentation might act as a costimulatory 
signal to facilitate TCR signal transduction. To study whether IL-15 
transpresentation enhances TCR mediated early signalling events, CD4+ T cells were 
incubated on lipid bilayers described in 4.3.3 and stained for markers of early TCR 
activation, such as phosphorylated PLC-γ1.  Unlike the classical CD28 costimulatory 
signal171, the signal supplied by IL-15/IL-15Rα did not lead to increased PLC-γ1 
phosphorylation compared to stimulation with I-Ab/pOVA alone (Figure 4.10 A,B), 
suggesting that IL-15 trans-signaling does not have an effect on proximal TCR 
signaling events. 
PI3K-dependent AKT activation is considered another marker of early T cell 
activation. Given that PI3K is also activated by a number of different receptors 
alongside the TCR, including co-stimulatory receptors and cytokine receptors252, we 
hypothesized that IL-15 transpresentation might enhance TCR induced PI3K-
dependent AKT activation. Phosphorylation of AKT in response to TCR ligation 
with antigen was very moderately enhanced by simultaneous stimulation with IL-15/ 
IL-15Rα complex (≈1.1-fold increase) (Figure 4.10 C,D). Though statistically 
significant (p≤0.05), the magnitude of this effect was small and therefore unlikely to 
be physiologically relevant. Taken together, these data suggest that IL-15 
transpresentation does not amplify TCR-mediated early signalling events, though this 
might still relate to signal saturation due to the strong TCR stimulation provided in 
this experimental system. 
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Figure 4.10 TCR-mediated signals are not modulated by stimulation with IL-15/IL-15Rα . 
 CD4+ T cells were incubated on glass-supported planar bilayers containing ICAM-1, CD80,  
I-Ab pOVA and IL-15/ IL15Rα as indicated in the presence of fluorescent anti-TCR Fab (red). After 
30 min incubation at 37°C, cells were fixed and stained for (A) pPLCγ1 (green) and (C) pAKT 
(green). Bar graphs indicate quantification in arbitrary units (AU) of integrated pPLCγ1 (B) and 
pAKT (D) fluorescence intensities (mean ± s.e.m) normalized relative to ICAM-1 control at contact 
interfaces . For each condition, 35–65 cells were evaluated.  P values, one-way ANOVA.   
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4.3.5 IL-15Rα  Blockade in γc-expressing DCs Inhibits Antigen-specific CD4+ T 
Cell Activation  
Activation of STAT5 is critical for IL-15 mediated NK and CD8+ T cell survival, 
proliferation and function253,254. It therefore seemed plausible to hypothesise that IL-
15 mediated STAT5 activation might also play a role in the induction of CD4+ T cell 
functions. To address whether IL-15 transpresentation influences antigen-specific 
CD4+ T-cell activation, antigen-pulsed DCs were treated with anti-IL-15Rα prior to 
co-culture with CD4+ T cells. Interestingly, IL-15Rα blockade significantly reduced 
T cell proliferation induced by WT DCs (p≤0.002) and in keeping with defective IL-
15 transpresentation by γc-/- DCs, this did not occur in γc-/- DCs (Figure 4.11A,B). 
Interestingly, treatment of WT DCs with the higher range of blocking antibody 
concentrations (5-10μg/ml) reproduced the γc-deficient phenotype (Figure 4.11A). 
Taken together, these data suggest that inefficient IL-15Rα-mediated IL-15 
transpresentation by γc-/- DCs accounts for the original defects observed in DC-
mediated T cell activation (Figure 4.1). 
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A 
 
 
 
 
 
 
B 
  
  
 
 
Figure 4.11 IL-15Rα  blockade in γc-expressing DCs inhibits antigen-specific CD4+ T cell 
activation. DCs were stimulated overnight with LPS in combination with OVA. The following day, 
cells were washed and pre-treated for 30 minutes with IL-15Rα blocking Ab or isotype-matched 
control  at the indicated concentrations. Cells were then cocultured with CFSE-labelled CD4+ OTII 
cells. (A) Representative plots of CFSE dilution in CD4+ gated T cells after co-coculture with OVA-
pulsed DCs at 1:5 DC:T cell ratios for 72 hours respectively. Bars represent CFSE diluting CD4+ T 
cells  (B) Quantification of % inhibition (relative to isotype-matched control Ab) of proliferation of 
CD4+ T cells shown in B. Data are representative of 3 independent experiments (mean ± s.e.m).  
P values, linear regression analysis. 
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4.4 Conclusions 
Productive T cell activation by DCs depends on coordinated delivery of signals from 
antigen (signal 1), adhesion and co-stimulatory molecules (signal 2) and soluble 
factors (signal 3). In the present chapter, we showed that, despite normal uptake, 
processing and presentation of antigen (signal 1), γc-/- DCs were less efficient at 
inducing full CD4+ T cell activation as indicated by decreased proliferation, 
expression of the CD69 activation marker and IL-2 release. We excluded that this 
defect could be due aberrant DC maturation as, in response to LPS stimulation, γc-/- 
DCs underwent normal upregulation of maturation markers (CD86 and MHC II) and 
secretion of pro-inflammatory cytokines, including IL-2 and IL-12. Interestingly, 
both of these cytokines have been shown to be important for T cell effector 
functions. DC-derived IL-12, for example, is known to be critical for the initiation of 
Th1 responses by promoting the differentiation of naive CD4+ cells into IFN-γ-
producing cells255. Similarly, IL-2 has been proposed to enhance DC-mediated T cell 
activation as suggested by defective CD4+ and CD8+ T cell priming by IL-2-
deficient DCs244,256. Normal IL-2 and IL-12 secretion profiles therefore indicated that 
cytokine release (signal 3) may not be a critical factor in the priming of antigen-
specific naïve CD4+ T cell responses by γc-/- DCs. 
 
Long-lived intercellular contacts are established through adhesive interactions and 
are required to elicit full T cell activation192,233. To rule out the contribution of 
integrin-mediated adhesion to the defects observed, we next studied the LFA-1-
ICAM-1 interaction. Notably, LFA-1 polarization was preserved at the contact 
interface of T cells with antigen-pulsed γc-/- DCs and, as expected, this led to normal 
LFA-1 dependent adhesion. In agreement with these findings, the duration and 
stability of DC-T cell contacts were also unaffected by the absence of DC-expressed 
γc in live cell assays. Taken together, these findings suggested that LFA-1-mediated 
adhesion and related signaling (signal 2) might not account for the observed defects. 
 
Having partly excluded the contribution of signal 1, 2 and 3 to the defects in antigen-
specific CD4+ T cell activation, we next investigated whether other pathways and 
cognate interactions might be affected. The most obvious cognate interaction to 
study involving the γc was IL-15 transpresentation due to its well established role in 
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both NK and CD8+ T cell homeostasis and priming33,36,257. Despite the classical view 
that DC-mediated IL-15 transpresentation is important for the activation and 
homeostatic regulation of these cells, in this chapter we showed that IL-15 is also 
transpresented to CD4+ T cells. Intriguingly, our co-culture experiments 
demonstrated that DC-mediated transpresentation of IL-15 results in STAT5 
activation in CD4+ T cells and that this depends upon cognate TCR interactions, as 
has been recently described for CD8+ T cells242. This was confirmed in a bilayer 
system in which CD4+ T cell STAT5 activation was achieved only upon 
simultaneous stimulation with IL-15/IL-15Rα and peptide/MHC complexes. 
Altogether, our results pointed to the possibility that IL-15 transpresentation might 
have an important costimulatory role in CD4+ T cell effector functions and 
according to our expectations, blockade of IL-15Rα in γc-expressing DCs resulted in 
reduced antigen-specific T cell proliferation.  
 
Having established defective induction of antigen-specific T cell proliferation by  
γc-/- DCs, we investigated the requirement of the γc for IL-15 transpresentation to 
CD4+ T cells. Interestingly, our co-culture experiments showed that, regardless of 
normal levels of IL-15Rα, γc-/- DCs failed to induce IL-15 trans-signaling in CD4+ 
T cells, as demonstrated by lack of STAT5 activation. Similarly, IL-15Rα blockade 
did not result in a marked reduction in CD4+ T cell proliferation as observed for γc-
expressing DCs. In contrast with the widely held view that IL-15Rα is the critical 
subunit for IL-15 transpresentation36,38 while the γc plays predominantly a signaling 
role downstream of β/γc subunit ligation, here we showed that the γc is also required 
for effective IL-15 transpresentation to CD4+ T cells. This suggests that effective IL-
15 transpresentation may require the cis interaction of IL-15Rα with the β/γc 
complex and is in keeping with a previous study in which blocking IL-2Rβ resulted 
in an inhibition of IL-15Rα dependent NK activation37. 
 
In addition to defective induction of IL-15 trans-signaling in CD4+ T cells, the data 
presented in this chapter also suggested inefficient triggering of TCR-mediated Ca2+ 
signaling by γc-/- DCs, as demonstrated by reduced T cell total Ca2+ levels and Ca2+ 
oscillations. Cross-communication between diverse signaling networks represents a 
way of fine-tuning cellular reactions hence we were interested to verify whether  
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IL-15 transpresentation and trans-signaling might regulate TCR proximal events.  
Since both PLC-γ1 and AKT signaling pathways are involved in IP3 generation and 
in intracellular Ca2+ responses, we set out to assess whether IL-15 transpresentation 
might act as a canonical CD28-like costimulatory signal and enhance their activation. 
In contrast to our expectations, phosphorylation of neither PLC-γ1 nor AKT in 
response to TCR ligation was substantially enhanced following stimulation with IL-
15/IL-15Rα complexes in bilayer experiments. It therefore remains unclear how IL-
15 transpresentation might regulate early TCR signaling events. Furthermore, normal 
conjugate formation also led us to exclude the possibility that the interaction 
established through the IL-15R might facilitate membrane apposition and lead to 
enhanced PLC-γ activation and Ca2+ response, as has instead been proposed for the 
CD28-B7 interaction171. In the light of these findings, the TCR Ca2+ signaling defects 
are thus problematic to explain in the context of IL-15 transpresentation. 
Alternatively, it is possible that these results could represent a technical artifact due 
to the type of analysis adopted in this study (ie single-parameter as opposed to 
ratiometric). Our analysis may have in fact been hampered by artifactual differences 
in fluorescence signal due to variations in dye loading or cell size. In contrast, 
ratiometric measurements of Ca2+ signals are considered a more accurate way to 
analyse Ca2+ responses as they involve the measurement of two different 
fluorescence signals from within the same cell. The ratio of emissions at two 
different wavelengths is generally consistent from cell to cell and therefore the above 
described variables tend to be cancelled out resulting in more reliable interpretations. 
Hence, it is possible that, due to analysis with Fluo-4 alone, we may have 
overestimated the differences in the Ca2+ responses elicited by WT/γc-/- DCs. 
Qualification of the data is required to clarify whether the observed differences are 
real. 
  
Through confocal imaging of DC-T cell conjugates, here we also provided evidence 
of defective TCRζ recruitment at the contact interface with γc-/- DCs. Stabilization 
of TCRζ clusters at the centre of the interface is regulated by signaling- and 
cytoskeleton-dependent processes151,258. Despite the unlikely contribution of IL-15-
dependant signals to TCR signal transduction, it still remains possible that IL-15 
transpresentation might promote TCR translocation. This is suggested by the fact that 
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other costimulatory receptor pairs, such as CD28/B7, have been proposed to enhance 
the aggregation of TCR-containing membrane microdomains at the contact interface 
by mediating cytoskeleton-mediated membrane raft movement161,176,189. Intriguingly, 
both TCRζ and γc have been observed to associate with the cytoskeleton in T 
cells259,260 therefore raising the intriguing possibility that the IL-15R receptor pair 
might affect T cell actin remodeling and TCR translocation at the contact interface.  
 
Taken together, these data suggested that IL-15 transpresentation could represent a 
mechanism by which DCs deliver cytokine-related costimulatory signals to CD4+ T 
cells to enhance their activation. In addition, we have provided evidence that TCRζ 
recruitment at the contact interface may also be influenced by IL-15 
transpresentation though this requires further investigation.  
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4.5 Final Conclusions 
• IL-15 transpresentation depends on simultaneous TCR engagement with 
MHC-bound antigen and functions as a costimulatory signal for CD4+ T cell 
activation. 
• DC-expressed γc is involved in regulating IL-15 transpresentation to CD4+ T 
cells. 
• γc-/- DCs are hence defective in inducing full antigen-specific CD4+ T cell 
activation  
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Chapter Five- Analysis of the Role of the Common Cytokine 
 Receptor γc in Dendritic Cells for the Organisation of Molecules at 
the Immunological Synapse 
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5.0 Aims  
• Study immunological synapse (IS) formation by γc-/- DCs through TIRFM of 
DC-lipid bilayer interfaces 
• Characterise the role of the γc in controlling the localization of its related 
receptors at the DC interface 
 
5.1 Introduction 
The IS is a specialised junction between the T cell and the APC characterised by an 
organised clustering of specific signaling and adhesion molecules151,156.  Besides 
being a site of delivery of membrane bound receptors and cytosolic signaling 
proteins, the IS is also a site of polarized cytokine secretion. Cytoskeletal 
rearrangement plays a critical role in the targeted secretion of cytokines at the IS. 
This is achieved through reorientation of the MTOC and consequent alignment of 
intracellular organelles involved in cytokine secretion towards the contact site. This 
process has been well defined in T cells, where it regulates delivery of cytokines, 
such as IL-2, IL-4, IL-5 and IFN-γ and sustains TCR signaling194,198,261. Similarly, 
polarization of IL-12/IL-18 and IL-2 has been observed in DCs at the contact sites 
with NK and CD8+ T cells, respectively137,244,262. Recently, MTOC polarization has 
been specifically implicated in regulating the targeted delivery of cytokines at the 
DC IS with CD8+ T cells, as has been shown for IL-12197. 
 
Whereas the formation of the T cells IS has been extensively characterised, much 
less is known about the molecular events underlying DC IS formation. As already 
discussed in section 1.4.8, there is now growing evidence suggesting that DCs also 
play an active role in IS formation, through cytoskeletal rearrangement. 
 
We therefore hypothesised that inefficient T cell activation by γc-/- DCs could be 
due to defective IS formation. To address this, we specifically investigated the role 
of the γc in regulating molecular events on the DC side of the IS. 
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5.2 Immunological Synapse Formation by γc-/- DCs  
 
5.2.1 Establishment of TIRFM/lipid Bilayer Platform for High Molecular 
Resolution Imaging of the DC Synaptic Membrane   
Given the central role of IS formation for T cell priming263, we hypothesised that DC 
γc might affect the correct assembly of the IS. To study the organization of DC 
synaptic interfaces, a planar lipid bilayer platform was developed in collaboration 
with Prof. Dustin’s laboratory at the Skirball Institute of Biomolecular Medicine in 
New York, and imaged using TIRFM. Bilayers were loaded with LFA-1 and Fab 
fragments specific for I-Ab for ligation of DC ICAM-1 and MHC II respectively, 
thereby modelling the T cell side of the IS. Briefly, LFA-1 was tagged to a His6 tail 
and linked to Nickel-NTA modified lipids whilst monobiotinylated anti-I-Ab  Fabs 
were fluorescently labelled and attached to biotinylated lipids using streptavidin as a 
bridge (Figure 5.1). TIRFM imaging allowed us to follow the spatial-temporal 
dynamics of ligated MHC II molecules at high molecular resolution, ie within 200 
nm of the interface between the bilayer and the DC plasma membrane.  
 
 
 
 
Figure 5.1 Schematic diagram of a planar lipid bilayer containing unlabelled LFA-1 domain and 
Alexa-568 anti-I-Ab  Fabs. 
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5.2.2 Organisation of MHC II Microclusters at γc-/- DC Interfaces 
To study the organisation of MHCII-TCR interactions, LPS-matured OVA-pulsed 
DCs were settled on bilayers described in 5.2.1 and followed through live cell 
imaging using TIRFM. Upon interaction with the bilayers, WT γc-expressing DCs 
spread over the surface and started aggregating MHC II molecules in microclusters. 
These microclusters were highly dynamic and, once the cells had fully adhered to the 
membrane, moved towards the centre of the contact where they underwent 
progressive accumulation.  γc-/- DCs were also observed to cluster MHC II at the 
contact interfaces (Figure 5.2A). Quantitative analysis of fluorescence intensities 
collected by TIRFM at the interfaces revealed similar levels of total MHC II 
accumulation in WT and γc-/- DCs over time (p=0.64, t =20 min; p=0.07, t =60 min) 
(Figure 5.2A,B), thereby suggesting that DC γc does not affect MHC II recruitment 
at the IS.  
  
  140 
A       
 
 
 
 
B 
 
 
 
Figure 5.2 WT and γc-/- DCs recruit MHC II microclusters at the contact interface.  
LPS-matured OVA-pulsed DCs were incubated on glass-supported planar bilayers containing LFA-1 
and Alexa-568-I-Ab  Fab and imaged by TIRFM at 37°C for 1 hr. (A) Representative TIRFM images 
of MHC II (red) clusters at  WT and γc-/- DC interfaces. Counterstaining of cytoplasms with CFMDA 
(green) (B) Time course analysis of MHC II integrated fluorescence intensities in AU at the contact 
interface normalized with respect to fluorescence at t=0 (mean ± s.e.m, n=4). P values, two-tailed 
students t-test. 
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5.2.3 F-actin is Recruited to γc-/- DC Interfaces   
The DC actin cytoskeleton has been reported to play an active role during IS 
formation264 and MHC clustering211. We were therefore interested to compare actin 
recruitment at WT and γc-/- DC contact interfaces. To this end, DCs were transduced 
with a lentivector containing a marker of filamentous actin (F-actin), Life-Act-Ruby 
(kindly provided by Dr. Bouma at Molecular Immunology Unit, Institute of Child 
Health). 48 hours post infection, LPS-matured OVA-pulsed DCs were settled on 
lipid bilayers and followed by live cell TIRFM imaging. Consistently with previous 
reports demonstrating actin polarization at the contact site with T cells206, we 
observed that upon interaction with the bilayers, actin was dynamically recruited to 
the contact interfaces of both WT and γc-/- DCs. Interestingly, actin distribution 
almost perfectly correlated with MHC II and this was also observed to be similar in 
the presence or absence of DC γc (Figure 5.3). 
 
 
 
 
Figure 5.3 WT and γc-/- DCs recruit F-actin at the contact interface. DCs were transduced with 
lentiviral vectors encoding Life-Act Ruby (see Appendix 1 for vector details). 24 hours post infection, 
cells were LPS-matured and pulsed with OVA overnight. Cells were then incubated on glass-
supported planar bilayers containing LFA-1 and Alexa-488-I-Ab  Fab and imaged by TIRFM at 37°C 
for 30 min. Shown are representative TIRFM images demonstrating MHC II (green), F-actin (red) and 
corresponding overlays.  
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5.2.4 γc-/- DC Polarize Less F-actin at the Interface  
Having observed a normal pattern of F-actin recruitment to γc-/- DC interfaces, we 
then set out to investigate whether the levels of polymerized actin at DC interfaces 
might be affected by the absence of the γc. For this purpose, DCs cells were left to 
interact with bilayers for 30 minutes, then fixed and stained with fluorescently-
labelled phalloidin (high-affinity marker of F-actin). Interestingly, F-actin 
accumulation was significantly reduced (p ≤0.05) at γc-/- DC interfaces compared to 
WT (Figure 5.4A,B), despite similar levels of total F-actin (Figure 5.4C).  This was 
confirmed by flow cytometry after cell permabilization and staining with 
fluorescently-labelled phalloidin. Taken together, these results suggest abnormal  
F-actin rearrangement at γc-/- DC contact interfaces. 
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Figure 5.4 γc-/- DCs inefficiently polarize F-actin at the contact interface. (A-B) LPS-matured 
OVA-pulsed DCs were incubated on glass-supported planar bilayers containing LFA-1 and I-Ab  Fab 
for 30 min. Cells were then fixed and stained for F-actin with Alexa-488-phalloidin. (A) 
Representative TIRFM images showing F-actin (green) at contact interfaces (B) Quantification in 
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arbitrary units (AU) of average F-actin fluorescence intensities (mean ± s.e.m) at contact interfaces 
shown in A. For each condition, 20 cells were evaluated.  P values, two-tailed student’s t-test  
(C) LPS-matured OVA-pulsed DCs were permeablised and stained for F-actin with rhodamine-
phalloidin. Representative plots showing intracellular expression of F-actin in CD11c+ gated cells 
(MFI= mean fluorescence intensity). 
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5.3 γc is Recruited to the DC Interface and Controls Localization of 
Related Receptors  
 
5.3.1 Generation of γc-GFP Fusion Protein Variants for Analysis of γc 
Recruitment to the DC IS 
The results presented in chapter 3 indicated that a TCR/MHC signal is needed for 
DC-mediated IL-15 transpresentation to CD4+ T cells. This suggested that the TCR 
and IL-15R might be colocalised at the T cell interface and raised the intriguing 
possibility that one way this could happen was if the γc and its associated receptors 
were recruited to and associated with MHC II at the DC contact interface. 
To visualise γc localization at the DC IS, we made use of a lentiviral construct 
encoding a GFP-tagged full-length γc (γcWT-GFP) (Figure 5.5.). The γcWT-GFP 
construct was kindly provided by Toni Cathomen’s laboratory, Hannover Medical 
School, and was particularly useful not only because of the lack of specific anti-γc 
antibodies but also because it allowed us to follow the dynamics of γc recruitment at 
the interface. Furthermore, to investigate the requirement of the γc 
cytoplasmic/signaling domain for its recruitment to the DC IS, the γcWT-GFP fusion 
protein described above was mutated so as to create a truncated a signaling-deficient 
version (γcmut –GFP). This mutant was designed to retain the γc ecto- and 
transmembrane domains but to lack 77 amino acids at the carboxy-terminus thus 
resembling a stop mutation (R289X) that has been described in an X-SCID patient265 
(Figure 5. 5B).   
γcWT and γcmut expression and signaling were assessed in the γc-null human leukemia 
ED7R T cell line.  Flow cytometry analysis of γc-null human ED7R T cells 
transduced with either γcWT- or γcmut–GFP revealed similar levels of γc surface 
expression therefore confirming that the truncation of the cytoplasmic domain does 
not affect the expression of the γc extracellular domain (Figure 5. 6A). However, in 
contrast to cells transduced with γcWT–GFP, cells expressing γcmut–GFP failed to 
phosphorylate STAT5 following stimulation with IL-2 (Figure 5. 6B), regardless of 
similar levels of transduction (45% versus 40% GFP+ cells following infection with 
γcWT–GFP and γcmut –GFP, respectively). These results therefore confirm that the 
truncation of the carboxy-terminus of the γc abolishes its signaling functions. 
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Figure 5.5 Schematic diagrams of CMV-driven γcWT- and γcmut–GFP encoding constructs. 
Schematic representations of full length (γcWT) (A) and truncated (γcMut) (B) γc proteins attached to 
GFP via an 8 amino acid linker. A truncated γc was created by introduction by PCR of an AgeI site at 
amino acid 289 of the γc. The PCR product was then religated into the original vector to create a γc-
GFP fusion lacking 77 amino acids at the C terminus (γcMut-GFP). See Appendices 2 and 3 for vector 
details. 
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Figure 5.6 γc expression and signaling in ED7R cells infected with γcWT- and γcmut –GFP 
encoding lentivectors. ED7R cells were trasduced with γcWT- and γcmut –GFP encoding lentivectors at 
MOIs of 25. Cells were analysed 72 hours post-infection. (A) Surface expression of the γc in GFP+ 
cells. The percentages of γc-expressing cells and MFI (in parenthesis) are shown (B) Cells were 
cultured with or without IL-2 (100 ng/ml). pSTAT5 expression in GFP+ cells. Untransduced cells 
(GFP-) are a negative control. The percentages of pSTAT5-expressing cells and MFI (in parenthesis) 
are shown.  
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5.3.2 γc is Recruited to the DC Contact Interface and this Does Not Depend on 
its Signaling Function  
To investigate whether γc localizes at the DC IS, γc-/- DCs were transfected with 
γcWT-GFP, γcMut-GFP or with GFP-control vector. Similar transduction efficiencies 
were achieved as demonstrated by GFP expression (Figure 5.7A).  After overnight 
stimulation with LPS and OVA, transduced DCs were settled on bilayers and 
followed by live cell imaging. Figure 5.7B shows representative images of GFP-
expressing DCs interacting with bilayers over time. Notably, γcWT-GFP was recruited 
to the DC interface and accumulated within MHC II clusters. Furthermore, γcWT-GFP 
progressively colocalised with MHC II, as demonstrated by an increase in the 
coefficient of colocalisation (Rr) from 0.6 to 0.9 over 25 minute (Figure 5.7C). In 
contrast, no increase in Rr was seen in GFP control-transfected cells, thereby 
suggesting specific γc transport to and association with MHC II at the DC IS.  
Interestingly, γc recruitment to the DC contact interface did not seem to depend on 
its signaling functions as γcmut-GFP accumulated to the interface to a similar degree 
and with similar kinetics as γcWT-GFP (Figure 5.7D).  Final GFP mean fluorescence 
intensities were significantly higher (p =0.002) in cells expressing either γcWT/mut-GFP 
compared to those expressing the GFP control vector (≈4-fold increase), thus 
indicating specific γc enrichment at the DC interface (Figure 5.7D).  Taken together, 
these data indicate γc recruitment within MHC II clusters at the DC IS and suggest 
that this does not dependent on its signaling function. 
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Figure 5.7 γc is recruited to the DC interface and colocalises with MHC II. γc-/- DCs were 
transfected either with lentiviral vectors encoding γcWT-GFP, γcMut-GFP or with pmaxGFP® Control 
Vector. 4 hours post transfection, cells were LPS matured and pulsed with OVA. 24 hours post 
transfection, cells were (A) assayed for GFP surface expression and (B-D) incubated on glass-
supported planar bilayers and imaged by TIRFM at 37°C for 25 min. (B) Representative TIRFM 
images showing GFP (green) and MHC II (red) accumulation at the contact interface of γc-/- DCs 
expressing GFP control (left) or γcWT-GFP (right) vectors (C) Time course analysis of GFP and MHC 
II colocalisation (Rr=coefficient of colocalisation). Asterix (*) corresponds to lamellipodial extension 
indicated in B and explains drop in Rr  (D) Time course analysis of GFP average fluorescence 
intensities in arbitrary units (AU) at the contact interface normalized with respect to fluorescence at 
t=0 (mean ± s.e.m, n=4). P values, two-tailed students t-test.  
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5.3.3 IL-15Rα Associates with MHC II in DCs 
We next examined whether the γc heterodimer, IL-15Rα, associates with MHC II in 
DCs, as has been reported for lipid rafts of human T lymphoma cells 266. To this end, 
DC lysates were immunoprecipitated with anti-MHC II and immunoblotted with 
anti-IL-15Rα. Interestingly, immunoprecipitation of MHC II yielded considerable 
amounts of co-precipitated IL-15Rα and this occurred comparably in both WT and 
γc-/- DCs (Figure 5.8) thereby suggesting that the γc does not influence the cellular 
association of IL-15Rα and MHCII. 
 
 
 
 
Figure 5.8 Cellular association of DC IL-15Rα  and MHCII occurs independently of the γc. Cell 
lysates of LPS-matured OVA-pulsed WT and γc -/- DCs were immunoprecipitated with anti-MHC II, 
separated by SDS-page and immunoblotted with anti-IL-15Rα. The blot was re-probed with anti-
MHC II (lower lane) to demonstrate protein loading in each lane. 
  151 
5.3.4 γc-/- DCs Inefficiently Recruit and Associate IL-15Rα with MHC II at the 
DC Interface 
Having demonstrated that DC-expressed γc is required for IL-15 transpresentation 
and that it is recruited to the IS, we hypothesised that that the γc might play a role in 
recruiting or stabilising IL-15Rα at the DC IS. To test this, LPS-matured OVA-
pulsed DCs were incubated on lipid bilayers coated with or without fluorescently 
labelled I-Ab then stained for IL-15Rα. This showed that in WT DCs IL-15Rα 
accumulated at the DC interface and colocalised with MHC II (Rr=0.7) (Figure 
5.9A,D). Interestingly, IL-15Rα accumulation at the WT DC contact interface was 
significantly enhanced upon interaction with bilayers coated with I-Ab compared to 
those coated without (p≤ 0.001, Figure 5.9B). Despite similar levels of MHC 
recruitment to the interface (Figure 5.9C), IL-15Rα recruitment upon MHC II 
ligation was significantly reduced in γc-/- DCs compared to WT (p≤ 0.001, Figure 
5.9B). Colocalization of MHC II and IL-15Rα was also significantly reduced in  
γc-/- DCs (p≤ 0.005) (Figure 5.9A,D). Taken together, these data suggest IL-15Rα 
polarization at the IS during MHC II ligation and implicate the γc in regulating this 
process.  
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Figure 5.9 γc-/- DCs inefficiently recruit and associate IL-15Rα with MHC II at the DC 
interface. DCs were LPS-matured and pulsed with OVA. The following day, cells were incubated on 
glass-supported planar bilayers containing LFA-1+/- Alexa-568-I-Ab  Fab. After 15 min incubation at 
37°C, cells were fixed and stained for IL-15Rα. (A) Representative TIRFM images showing IL-15Rα 
(green) and MHC II (red) accumulation at the DC contact interface (B) Bar graphs indicate 
quantification in arbitrary units (AU) of average IL-15Rα (B) and MHC II (C) fluorescence 
intensitites (mean ± s.e.m)  at contact interfaces (D) Quantification of level of colocalization (Rr) of 
MHC II and IL-15Rα at DC interfaces. P values, one-way ANOVA (Bonferroni’s multiple 
comparison test). 
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5.4  γc Restores IL-15Rα Recruitment and Transpresenting 
Functions at the DC Interface 
 
5.4.1 γc is Required for IL-15Rα Recruitment to the DC Interface 
To confirm the requirement of the γc for IL-15Rα recruitment to the DC interface, 
γcWT- and γcmut-GFP were reintroduced in γc-/- DCs. After overnight stimulation with 
LPS and OVA, transduced DCs were settled on bilayers coated with unlabelled  
LFA-1 and I-Ab then stained for IL-15Rα. As expected, reintroduction of both γc-
GFP constructs resulted in the restoration of IL-15Rα accumulation at the interface 
(Figure 5.10A,B). A significant increase in the levels of IL-15Rα was observed in 
cells transfected with γcWT-GFP compared to the control GFP vector (≈1.9-fold 
increase) (p≤0.05). An increase in the level of IL-15Rα recruitment was also seen 
with γcmut-GFP (≈1.7-fold increase), although this did not achieve significance 
(Figure 5.9A,B). A correlation of 0.53 and 0.73 (R2) was observed between IL-15Rα 
and γcWT- or γcmut-GFP, respectively, and in both cases this was significantly higher 
(p≤0.001) compared to GFP control transfected cells (Figure 5.10C). Taken together, 
these data confirm that the defects observed in IL-15Rα recruitment at the DC 
interface can be specifically attributed to the lack of γc expression.  
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Figure 5.10 γc is required for IL-15Rα recruitment to the DC interface. γc-/- DCs were 
transfected either with lentiviral vectors encoding γcWT/mut-GFP or with pmaxGFP® Control Vector. 4 
hours post transfection, cells were LPS-matured and pulsed with OVA. 24 hrs post transfection, cells 
were incubated on glass-supported planar bilayers containing LFA-1and I-Ab  Fab for 15 mins. Cells 
were then fixed and stained for IL-15Rα. (A) Representative TIRFM images showing GFP (green) 
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and IL-15Rα (red) accumulation at the DC contact interface (B) Quantification in arbitrary units (AU) 
of integrated IL-15Rα fluorescence intensities (mean ± s.e.m) at contact interfaces for DCs 
transfected with each construct (C) Linear regression analysis of GFP versus IL-15Rα fluorescence 
intensities (expressed in AU ×106). For each condition, 38-43 cells were evaluated.  P values, one-way 
ANOVA (Bonferroni’s multiple comparison test).  
 
 
5.4.2 γc is Required for IL-15Rα Transpresenting Functions at the DC Interface 
To confirm that the γc is required for IL-15Rα-mediated IL-15 transpresentation to 
CD4+ T cells, STAT5 activation was analysed in CD4+ T cells after coculture with 
γc-/- DCs transfected with γcWT-, γcmut- or control GFP vectors. WT DCs transduced 
with GFP control vector were used as a positive control. Despite similar levels of 
transduction compared to control transfected cells (Figure 5.11A), γc-/- antigen-
pulsed DCs expressing either of the γc-GFP constructs induced higher levels of 
STAT5 phosphorylation in CD4+ T cells compared to γc-/- antigen-pulsed GFP 
control-transfected cells (p≤0-05) (Figure 5.11B,C). Similar restoration of STAT5 
activation was observed in CD4+ T cells by re-expression of γcWT and  γcmut-GFP in 
γc-/- DCs (Figure 5.11B,C), suggesting that γc expression as opposed to signaling is 
required for DC-mediated IL-15 transpresentation. Taken together, these data 
strongly implicate that, by controlling the recruitment of IL-15Rα at the DC IS, the 
γc is required for optimal IL-15 transpresentation to CD4+ T cells. 
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Figure 5.11 γc in DCs is required for STAT5 activation in CD4+ T cells. DCs were transfected 
either with lentiviral vectors encoding γcWT/mut-GFP or with pmaxGFP® Control Vector. 4 hours post 
transfection, cells were either left untreated or stimulated overnight with LPS alone or in combination 
with OVA. The following days, cells were co-cultured with CD4+ T cells, which had been serum-
starved for 3 hours, at a 1:1 ratio for 10 min. Cells were then fixed and stained with anti-pSTAT5.  
(A) Transduction efficiencies measured as GFP expression in DCs transfected with the indicated 
constructs. DCs are gated according to side scatter (SS). The percentages of GFP-expressing DCs and 
MFI (in parenthesis)are shown  (B) pSTAT5 expression in CD4+ GFP- gated  cells. Shown are MFIs 
for CD4+ T cells cultured with OVA-pulsed DCs under the indicated conditions (C) Normalized 
pSTAT5 fluorescence intensities relative to unstimulated control. Data presented are from 2 
independent experiments. * p≤0-05, two-tailed student’s t-test. 
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5.5 Conclusions 
To date, imaging of the DC IS has only been approached through 3-dimensional 
reconstructions of DC-T cell interface. Because of the limitations of fluorescence 
imaging, the molecular events underlying the formation of the DC IS have been 
poorly defined. The TIRFM/lipid bilayer platform developed in collaboration with 
Prof. Dustin’s laboratory thus provided a novel approach to study the DC synaptic 
membrane  at high molecular resolution. The data presented in this chapter is, to our 
knowledge, the first detailed view of DC synapses as they occur in vitro. The 
fundamental findings are twofold. First, DC synapses are very dynamic, as 
demonstrated by active MHC II and actin recruitment and accumulation at contact 
interfaces. Secondly, the DC IS accumulates cytokine receptors which are important 
for effective T cell activation. Collectively, our data highlights the importance of 
events on the DC side for IS assembly and organisation and implicates the γc in 
regulating cytokine receptor recruitment at the DC IS. 
 
Based on early video imaging studies, it has been inferred that DC-T cell synapses 
are very motile structures251,267; however, the spatio-temporal dynamics of these 
events has never been studied. Through live cell TIRFM imaging of DCs interacting 
with our novel lipid bilayer system containing LFA-1 and Fab fragments specific for 
I-Ab, we observed dynamic clustering of MHC II at the interface. MHC II was shown 
to progressively accumulate at the DC IS and interestingly this was not affected by 
the absence of DC γc. Furthermore, in contrast to T cells where TCR engagement 
delivers a stop signal that strongly reduces T-cell mobility268, DC mobility at the 
contact interface never completely stopped, even after MHC II ligation. We observed 
continuous crawling and spreading of the DC along the bilayer, and this probably 
explains sustained T-cell membrane ruffling at synaptic interfaces, as has been 
observed by others269. We hypothesize that continuous DC mobility, which most 
likely relates to the observed dynamic actin rearrangement at the interface, also 
probably influences the patterning of the synapse, and may explain why bull-eye 
structures in antigen-dependent T cell–DC synapses are much less frequent than 
multifocal ones, as has been previously described205.  
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Synaptic delivery of IL-12 by DC197 and of IL-2, IL-4, IL-5 and IFN-γ by CD4+ T 
cells194,198 have previously been reported and suggest that cytokine enrichment at the 
IS might be critical for T cell effector functions. Having established that IL-15 
transpresentation depends on both DC γc expression and on MHC II ligation, we 
hypothesised that the γc might be recruited to the DC IS and influence the synaptic 
localization of IL-15Rα. Using lipid bilayers, we showed that DC γc is recruited to 
the DC interface and progressively colocalises with MHC II. Interestingly, this did 
not depend on its signaling functions as expression of a truncated version of the γc 
lacking the cytoplasmic signaling domain (γcmut-GFP) resulted in similar localization 
to the DC contact interface. Furthermore, we observed that the γc heterodimer,  
IL-15Rα, is also recruited to the DC IS and colocalises with MHC II, as been 
previously been shown on the surface of T cells266. In addition, we demonstrated 
cellular association of IL-15Rα with MHC II and, although we have no evidence for 
this, it might be possible to hypothesise that these two molecules might also traffic to 
the membrane as a complex, as has been proposed for MHC II and the costimulatory 
B7 molecule106. 
 
Of particular note was our finding that IL-15Rα recruitment to the DC IS occurs 
only upon MHC II ligation. This suggested to us MHC-driven lateral surface 
redistribution of IL-15Rα to the synaptic interface and may explain why IL-15 
transpresentation and STAT5 signaling are in seen in T cells only after TCR 
engagement. IL-15Rα polarization to the IS has been previously observed at DC-NK 
cell synapses although here, IL-15Rα was specifically shown to accumulate on the 
NK cell whereas no selective aggregation was observed on the DC199. The 
discrepancy with our findings may relate to the failure to detect specific enrichment 
through confocal microscopy imaging or to inherent differences in the DC:NK 
synapses. However, we think that IL-15Rα must be present at the DC IS to 
transpresent to NK cells so technical explanations remain more likely.  
 
In this chapter we also showed that, despite normal levels of intracellular IL-15Rα 
and MHC II recruitment to the DC IS, γc-/- DCs inefficiently accumulated and 
colocalised IL-15Rα with MHC II at the contact interface. This was also independent 
  159 
of γc signaling functions as re-expression of either γcWT- or  γcmut-GFP restored IL-
15Rα localization and transpresenting functions at the DC interface. Taken together 
these observations raise the exciting possibility that the γc is required for lateral 
membrane redistribution or stabilization of IL-15Rα at the DC interface. We favour 
the prediction that this might occur through direct interaction of the γc and of  
IL-15Rα given that these two receptors have been previously shown to be associated 
and compartmentalized within the same membrane microdomains266 and that γc 
signaling function was shown to be dispensable. Alternatively, we hypothesise that 
this might occur through cytoskeletal-mediated processes. This was initially 
suggested to us by the reported association of IL-2/15Rβ and γc with both tubulin 
and actin and by the fact that inhibition of polymerization of either cytoskeletal 
components resulted in attenuated γc-associated signaling15,260. Interestingly, we 
observed that in the absence of the γc, DCs polymerize less filamentous actin at the 
interface and we therefore hypothesise that defects in IL-15Rα accumulation might 
be due to defective cytoskeletal confinement at the IS. This would be consistent with 
recent reports showing that IL-2R receptor confinement in membrane nanodomains 
is achieved through interaction with the cytoplasmic meshwork15 and similarly, that 
the DC cytoskeleton plays an important role in restricting cytokine delivery at the 
IS197. Further investigation is required to determine which of these plausible 
mechanisms contributes to γc regulation and molecular organization of the DC IS. 
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5.6 Final Conclusions 
• the DC IS is a dynamic structure characterised by active recruitment of  
 MHC II and actin. 
• selective synaptic recruitment of DC IL-15Rα upon MHC II ligation suggests 
that IL-15 transpresentation may represent a mechanism by which DCs 
deliver cytokine signals specifically at the interface with activated T cells. 
• DC-expressed γc is recruited to the IS where it colocalises with MHC II and 
mediates recruitment of IL-15Rα, independent of its signaling functions. 
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Chapter Six- Analysis of the Role of the Common Cytokine  
Receptor γc in Dendritic Cells for Regulating NK Cell Functions 
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6.0  Aims 
• Assess whether DC-expressed γc affects activation of γc-expressing NK cells. 
 
6.1  Introduction 
 
NK cells are innate immune cells that play a key role in protecting the host against 
viral pathogens or transformed cells through recognition of foreign or altered MHC 
molecules. The function of NK cells results from a balance between inhibitory and 
activating signals delivered through a vast array of surface receptors belonging to the 
immunoglobulin-like receptor and C-type-lectin receptor families270 and is also 
affected by pro-inflammatory cytokines140. In addition to their direct effect on the 
activation and proliferation of specific NK cell subsets, cytokines also can modify 
the signals delivered by receptor-mediated interactions by influencing the expression 
of NK-specific receptors/ligands141. 
 
Although their principal function is the activation of naïve T cells, DCs have also 
been shown to participate in the activation NK cells through their secretion of IL-2, 
IL-12, IL-18 and IFN-α140,141,271-273. The γc-family IL-15 cytokine has been found to 
synergise with IL-12 in inducing NK cell IFN-γ production139 and it has been more 
recently recognized that IL-15 exerts it actions on NK cells mainly through DC-
mediated IL-15 transpresentation. This mechanism has been shown to promote NK 
cell activation and proliferation, in vitro and in vivo33,37,243,274.  IL-15 also plays an 
important role in NK cell physiology as evidenced by the fact that IL-15-/- and  
IL-15Rα-/- mice lack NK cells56,57. In keeping with this, IL-15 transpresentation has 
been also shown to be important for the maintenance/survival of NK cells in 
peripheral tissues36,275.  
 
In the light of the findings described in Chapter 4 and 5, there was the possibility that 
DC-expressed γc might play a critical role in regulating NK cell functions, possibly 
through IL-15-related processes as observed for CD4+ 
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6.2  Absence of the Common Cytokine Receptor γc in Dendritic 
Cells Impairs NK Homeostasis and Activation 
 
6.2.1  γc -/- DCs Support NK Cell Survival Less Efficiently 
LPS-stimulated DCs have previously been shown to provide essential survival 
signals to NK cells through upregulation of surface IL-15/IL-15Rα complex 
expression37. Having established defective IL-15 transpresentation to CD4+ T cells 
by γc -/- DCs, it therefore seemed plausible to hypothesise that γc deficiency might 
alter the capacity of DCs to provide survival signals to NK cells. To test this, NK 
cells were cultured with DCs, which had been cultured with or without LPS, and 
quantified for NK cell viability after 24 hours of coculture. In keeping with the 
literature, LPS-stimulation of WT DCs induced a significant increase (p≤0.05) in NK 
cell survival compared to untreated DCs (≈1.8-fold increase). Interestingly, this did 
not occur in γc-/- DCs. Overall, LPS-stimulated γc-/- DCs supported NK cell survival 
less efficiently compared to WT DCs (14±1.5% versus 19±0.6% viable cells), 
although this did non achieve significance (p=0.06) (Figure 6.1A,B). 
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Figure 6.1 γc-/- DCs are less efficient at inducing NK survival. DCs were cultured overnight in the 
presence or absence of LPS. The following day, cells were washed and co-cultured for 24h hrs with 
DX5 selected NK cells derived from spleen of C57BL/6 WT mice. Viable cells are Annexin V-PE 
and 7-AAD negative cells. (A) Representative plots showing Annexin V-PE and 7-AAD staining on 
NK1.1 gated cells (B) Bar graphs of data shown in A. Data are from 3 independent experiments 
(mean ± s.e.m).  P-values, one-way ANOVA (Bonferroni’s multiple comparison test). 
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6.2.2 γc -/- DCs Fail to Induce NK Cell Activation. 
To determine whether DC γc is required for NK cell activation as well as for NK cell 
survival, the supernatants from the cocultures described in 6.2.1 were tested for  
IFN-γ release. Stimulation of WT DCs with LPS induced the production of IFN-γ by 
NK cells (≈2.3-fold increase). Remarkably, LPS-matured γc-/- DCs stimulated 
significantly less (p≤0.001) NK cell IFN-γ production compared to WT DCs 
(0.5±0.4ng/ml versus 2.8±0.6ng/ml) (Figure 6.2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.2 γc-/- DCs are unable to activate NK cells. Supernatants from the experiment described in 
section 6.2.1 were assayed for IFN-γ production by ELISA. Data are from 3 independent experiments 
(mean ± s.e.m). P values, one-way ANOVA (Bonferroni’s multiple comparison test). 
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6.2.3 γc -/-  DCs Induce Normal Proliferation of NK Cells. 
IL-15/IL-15Rα complexes have been shown to induce NK cell proliferation in 
vivo243. To analyse whether γc deficiency alters the capacity of LPS-stimulated DCs 
to induce NK cell proliferation, CFSE labelled NK cells were cultured in vitro with 
DCs and analysed for CFSE dilution after 48 hours of co-culture. Although, minimal 
levels of proliferation were observed, γc-/- DCs induced NK cell proliferation as 
efficiently as WT, at all of the tested ratios (Figure 6.3A,B).  
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Figure 6.3 γc -/- DCs induce normal NK cell proliferation. DCs were cultured overnight with LPS. 
The following day, cells were washed and cocultured for 48 hrs with CFSE-labelled DX5 selected NK 
cells derived from spleen of C57BL/6 WT mice at 1:1 and 1:5 DC:NK cell ratios (A) Representative 
plots of CFSE dilution in NK1.1 gated cells after co-coculture with DCs at 1:1 DC:NK cell ratios. 
Gates are set on NK cells cultured alone (B) Bar graphs represent quantification of NK proliferation 
from 3 independent experiments (mean ± s.e.m).  P values, one-way ANOVA (Bonferroni’s multiple 
comparison test).  
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6.3 Conclusions 
Although there remains much controversy about where the DC/NK cell encounter 
takes place in vivo, it is clear that the outcome of this cellular interaction critically 
depends on the activation state of the DC. Indeed, TLR-stimulated DCs have been 
found to regulate NK cell functions and one way this is thought to happen is through 
secreted cytokines, such as IL-2, IL-12, IL-18 and IFN-α140. In this chapter, we have 
shown that LPS-stimulated γc-/- DCs are inefficient in mediating NK survival and 
activation, despite normal IL-2, IL-12 and IFN-α release (Figure 3.11). This 
suggested that soluble cytokines might not account for the observed defects but that 
these might rather be explained by cell-contact dependant factors. Notably, DC 
expressed IL-15/IL-15Rα complexes have been shown to be critical for NK 
homeostasis and priming33,37,243,274 and in the light of the data presented in Chapters 4 
and 5, we hypothesise that DC-expressed γc might also be critical for efficient IL-15 
trans-signaling and presentation to NK cells. In contrast, NK proliferation appeared 
not to be affected by the absence of DC-expressed γc. However, these results may 
not be very reliable as the levels of proliferation detected were minimal and much 
lower compared to those previously observed243. This may be due to the fact that in 
those systems, NK cells were directly stimulated with IL-15/IL-15Rα complexes, 
which may have provided a stronger stimulus. 
 
Time did not allow further investigation on defective NK cell activation by γc-/- DCs 
but future work could focus on more experiments examining NK cell functions and 
on confirming whether the defects observed here are also due to failure to 
transpresent IL-15, as observed for CD4+ T cells. Of note, polarization of DC-
derived IL-12 at the synaptic interface has been shown to be important for NK 
functions137 and IL-15Rα has been observed to localise at the DC:NK IS, although 
not specifically on the DC side of the synapse, suggesting that IS-restricted cytokine 
signaling might be critical for NK functions. It would therefore be very interesting to 
study the localisation of DC IL-15Rα at the DC-NK cell IS. Furthermore, in the light 
of our findings that IL-15Rα accumulates at the DC/bilayer interface upon MHC II 
engagement, we hypothesise that IL-15 transpresentation to NK cells might also be 
regulated by selective engagement of certain NK-DC receptor pairs.  Notably, 
murine DCs have been shown to express various ligands for NK-cell activating 
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receptors, such as MICA and/or MICB141. Future work could address whether IL-
15Rα recruitment to the DC:NK IS depends on the specific engagement of activating 
receptors.  
 
Altogether, the data presented in this chapter represent a preliminary insight on how 
DC-expressed γc may regulate NK functions and hold promise for exciting future 
investigations.  
 
 
 
6.4 Final Conclusions 
• γc-/-DCs inefficiently regulate NK functions, such as survival and activation. 
• Further work is required to clarify whether this is due to defective IL-15 
transpresentation.  
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Chapter Seven-Discussion 
  
  
  170 
The γc is best known for its importance in T and NK cell homeostasis and 
function4,276. This is demonstrated by the human disease X-SCID where the lack of γc 
expression and function results in failure of T and NK cell development. Although 
there is little data regarding DCs in X-SCID, an increasing body of evidence suggests 
that γc/JAK3 expression and/or signaling are important for their normal function37,216-
220.  In agreement with these observations, here we specifically demonstrate that DC-
expressed γc is important for CD4+ T cell activation during cognate interaction. IL-
15Rα is the heterodimer of the γc and is critical for DC-mediated transpresentation 
of IL-15 to β/γc expressing cells27,36,257, hence we reasoned that the lack of γc might 
affect IL-15 transpresentation with potential influences on CD4+ T cell activation. It 
is already known that IL-15 transpresentation is important for NK and CD8+ T cell 
homeostasis and function33,36,257 but our data intriguingly showed that DCs also 
transpresent IL-15 to CD4+ T cells. Interestingly, this appeared to depend on a 
TCR:MHC signal and is consistent with previous findings in CD8+ T cells where 
simultaneous administration of IL-15 complex together with a TCR signal resulted in 
enhanced proliferation242. Our findings are particularly novel as, although IL-15 has 
previously been reported to enhance the proliferation of CD4+ T cells in response to 
mitogens and TCR stimulation29,277-280, a specific role for IL-15 transpresentation to 
CD4+ T cells has never been documented. Most importantly, here we demonstrate 
that the γc is required for effective IL-15 transpresentation. Our findings therefore 
challenge the widely held view that IL-15Rα is the chain responsible for cytokine 
transpresentation as has been inferred through in vivo studies with IL-15Rα-
competent, IL-2/15Rβ-deficient cells36,38.  
 
Having demonstrated that IL-15 transpresentation depends both on TCR engagement 
and on DC γc expression, we reasoned that the lack of the γc might lead to defective 
CD4+ T cell activation by affecting the specific localisation of IL-15Rα to the IS. 
This was suggested to us by two factors. Firstly, γc-containing receptors have been 
shown to be present in supramolecular complexes of MHC and adhesion molecules 
on the surface of T cells266 and secondly, IL-15Rα has been reported to localise at the 
IS with NK cells199. Using a novel lipid bilayer system mimicking the T cell side of 
the IS, we visualised the DC synaptic membrane at high molecular resolution and 
observed that IL-15Rα is specifically recruited to the DC interface and colocalises 
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with MHC II. Remarkably, we also showed that IL-15Rα recruitment to the IS 
occurs only upon MHC II ligation and this is consistent with the idea that IL-15 
trans-signaling depends on cognate TCR interactions, as proposed above. We 
therefore envisage a scenario in which TCR engagement induces MHC-driven lateral 
surface redistribution of IL-15Rα at the IS thereby allowing correct positioning for 
effective transpresentation to T cells. Most importantly, we also demonstrated that 
the γc is recruited within MHC II microclusters at the DC interface and mediates 
recruitment of IL-15Rα. Interestingly, γc-/- DCs exhibited impaired accumulation of 
IL-15Rα at contact interfaces as well as diminished colocalisation with MHC II 
thereby suggesting that the γc could act as a bridge between MHC II and IL-15Rα. 
DC-mediated IL-15 transpresentation seemed to be independent of γc signaling 
function as a γc –GFP fusion protein lacking the signaling domain (γcmut –GFP) was 
as efficient as full-length γc (γcWT–GFP) in restoring IL-15Rα localisation and 
transpresenting functions at the IS in γc –deficient cells. 
 
Having excluded the contribution of its signaling function, we hypothesized that the 
γc might instead influence DC-mediated IL-15 transpresentation by stabilising the 
assembly of IL-15R subunits at the IS. Although the precise mechanisms of  
γc-family cytokine receptor assembly are incompletely understood, the γc has been 
observed to associate with the IL-15Rα and β chains at the cell surface even in the 
absence of IL-15266, suggesting preassembly of IL-15R. Furthermore, blocking  
IL-15Rα association with IL-2/15Rβ has been shown to inhibit IL-15 
transpresentation37 therefore suggesting that stable interaction between receptor 
subunits might be required for effective transpresentation. Having observed normal 
surface expression of both the α and β subunits of the IL-15R, our data raises the 
exciting possibility that the γc may modulate IL-15 signalling in trans by directing 
the assembly and/or spatial positioning of associated cytokine receptors. Altogether, 
our findings using an in vitro system highlight the importance of DC γc for the 
regulation of molecular events on the DC side of the IS. Further investigation is 
required to dissect possible mechanisms and importantly, to address the relative 
significance of these phenomena for DC function in vivo. Whether the localisation of 
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IL-2Rβ at the IS is influenced by DC γc will also be an interesting area of future 
study. 
 
In addition, it is also possible to speculate that the γc might regulate IL-15 
transpresentation by assisting the binding of IL-15 to IL-15Rα. However, given that 
the intrinsic binding affinity of IL-15 to the γc and IL-2/15Rβ heterodimer (Kd ≅ 
1nM) is much lower compared to IL-15Rα alone (Kd ≅ 10pM)8, we think that this is  
unlikely. IL-15 binding to IL-15Rα has been difficult to assess as most of the 
commercially available anti-IL-15 antibodies bind to epitopes that are masked when 
IL-15 is complexed with IL-15Rα. Free IL-15 was undetectable in culture 
supernatants of both WT and γc -/- DCs (data not shown) and given that assembled 
IL-15/IL-15Rα complexes can either stay cell bound or be proteolytically 
released33,34, our results suggest normal binding of IL-15 to IL-15Rα thus masking 
detection. Definite conclusions to this question will be an interesting area for further 
study and may require competitive binding assays with radiolabelled IL-15. 
 
Taken together, our data supports the idea that IL-15 transpresentation acts as 
costimulatory signal for antigen-mediated T cell activation (Figure 7.1). We favour a 
model in which TCR engagement induces MHC-driven lateral surface redistribution 
of DC IL-15Rα to the synaptic interface. In this scenario, the γc appears to mediate 
the recruitment and/or stabilisation of IL-15Rα at the DC IS and to be necessary for 
IL-15 dependant STAT5 activation. STAT5 activation is known to be important for a 
variety of functions of T cells, including homeostatic proliferation253. We have 
shown that IL-15Rα blockade in γc-expressing DCs results in reduced antigen-
mediated proliferation and thereby suggest that IL-15 transpresentation and 
downstream STAT5 signaling could function as a costimulatory signal to augment 
TCR function. This would be consistent with studies in STAT5A knockout mice 
where defective T cell proliferation was observed in response to TCR stimulation281. 
 
Furthermore, we predict that costimulation provided to T cells through IL-15 
transpresentation specifically occurs through localised cytokine signaling at the IS. 
In contrast to previous reports demonstrating that STAT5 activation can be induced 
by a TCR antibody282, our data indicates that this requires both an IL-15R and TCR 
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signal. This suggests that the ability of IL-15Rα to trans-present IL-15 might depend 
on the appropriate positioning of IL-15R next to sites of TCR engagement. Previous 
reports have also suggested that spatial synergism between IL-15R and TCR is 
critical for enhanced CD8+ T cell responses240. Here, CD8+ T cell responses were 
amplified by co-presentation of IL-15 and anti-CD3 on the same surface. Similarly, 
STAT5 has been shown to assemble with the TCR and interestingly, this appeared to 
be mediated by the Lck kinase through the generation of tyrosine-phosphorylated 
docking sites within the associated TCRζ chains282. However, given that to our 
knowledge, the JAK-STAT and TCR signalling pathways are independent from each 
other, it still remains unclear whether or how cytokine-mediated STAT activation 
can be achieved upon simultaneous stimulation though the TCR. One possibility for 
this could be the creation of a shared signaling environment. A “kinase promiscuity 
model” has already been proposed to explain the synergism between the TCR and 
CD28 signaling pathways whereby TCR-induced activation of downstream signaling 
mediators would be amplified by the activate kinases provided by CD28 
costimulation189,283. Similarly, we envisage that TCR engagement could recruit 
kinases in proximity of the IL-15R and promote associated JAK/STAT signal 
transduction. Alternatively, removal of inhibitory phosphatase activity near engaged 
TCR, ie. “kinetic segregation model”, might contribute to enhancing JAK/STAT 
signaling. CD45 is a candidate molecule as it is excluded from the cSMAC and it is a 
suppressor of JAK kinases therefore a negative regulator of cytokine receptor 
signaling284. Altogether, our data raises the exciting possibility that IL-15 
transpresentation to T cells could require both the TCR and cytokine receptors and 
that spatial coordination between these two signaling pathways might constitute a 
way to regulate cytokine receptor signaling and associated cellular functions. 
Nonetheless, it is still interesting to speculate about why we failed to detect 
colocalisation of TCR and pSTAT5 microclusters in our bilayer experiments. We 
believe that this could be explained by technical reasons. Naïve T cells have been 
recently shown to internalise the TCR very rapidly sometimes even bypassing 
cSMAC formation285 and it is possible that we may have failed to detect 
colocalisation at the chosen timepoint (ie. 30 minutes). Alternatively, as pSTAT5 
leaves the cytokine receptor sites and translocate to the nucleus, we may not have 
detected association of pSTAT5 and TCR within the TIRFM field (≈200nm from the 
plasma membrane). 
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Figure 7.1 Spatial coordination model for IL-15 transpresentation. MHC II ligation induces 
lateral surface redistribution of DC IL-15Rα to the synaptic interface. Effective IL-15 trans-signaling 
may require consequent IL-15R positioning next to sites of TCR engagement. This may be due to 
shared signaling environment/kinetic segregation of phosphatases.  
 
Moreover, our findings have important clinical implications as they suggest that  
X-SCID patients lacking γc expression may also have defects in DC functions. Of 
course this may not be so relevant in a disease which is characterised by lack of T 
and NK cell populations but may instead be more important in patients where 
immune reconstitution is achieved through bone marrow transplant or gene therapy 
but were absence of chemotherapic conditioning results in retention of γc-deficient 
myeloid lineages. Interestingly, some of these transplanted SCID patients have been 
observed to suffer from long-term complications that are independent of lymphoid 
immune reconstitution, including a high incidence of severe cutaneous HPV 
infection62,63, thereby suggesting defects of myeloid immunity. To investigate 
increased susceptibility to HPV infection, we chose to study the functional outcomes 
of DC γc-deficiency using a transgenic CD4+ T cell system. This was mainly 
because of the central role played by CD4+ T cells in the induction of anti-viral286 
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and more specifically in anti-HPV immunity, as suggested by the fact low CD4+ T 
cell counts associated with HIV infection are amongst the strongest risk factors for 
HPV persistence and related malignancies287. Of note, NK cells are also important for 
HPV immunity288 and we have some preliminary data suggesting defective NK 
activation by γc-deficient DCs. Further studies will be required to dissect the 
importance of DC-expressed γc for the induction of both innate and adaptive immune 
responses to HPV, both in vitro and in vivo. This could be approached through the 
use of HPV virus-like particles (VLPs), composed of the immunogenic wild-type L1 
major capsid protein, or of long peptides spanning the HPV E6/E7 sequences. Both 
of these approaches have been extensively employed to examine specific anti-HPV 
responses in vitro 289,290  and would be very useful to examine the role of DC-
expressed γc in HPV-specific immunity.  
 
Finally, it is important to underline that keratinocytes, the HPV host cells, have been 
specifically shown to express and signal through γc-containing receptors69-72. It will 
therefore be interesting to examine whether defective γc signaling in host 
keratinocytes might contribute to the increased susceptibility to HPV observed in 
bone-marrow transplanted SCID patients. One way to address this would be grow 
skin rafts from γc-deficient keratinocytes and assess whether γc-deficiency alters 
HPV life cycle and progression to disease.  
 
Collectively, this study provides new insight into the molecular events that regulate 
cytokine transpresentation in DCs and demonstrates a novel role for IL-15 
transpresentation in the induction of a productive CD4+ T cell response. Clearly, 
further investigations are required to shed light on the relevance of these events for 
anti-HPV immunity. 
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Appendix 1 LiFeAct-Ruby Lentiviral Vector Map 
pLV-SFFV-LifeActRuby
9733 bp
Amp. Res.
gpt (OFR-frame shift)
LifeActRuby
3' SFFV LTR
LTR-HIVdelU3
LTR HIV-1
cPPT
WPRE
RRE-Rev  responsiv e element
SV40 promoter-enhancer
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Appendix 2 γcWT –GFP  Lentiviral Vector Map 
 
 
 
 
 
 
Appendix 3 γcMut –GFP  Lentiviral Vector Map 
 
 
pLV-CMV-hIL2RG-EGFP
10108 bp
hIL2RG
eGFPds
IRES (EM CV)
Neo
WPRE
CM V + intron#AgeI (5856)
XbaI (4737)
pLV -CMV -hIL2RGmut-EGFP
9865 bp
Neo
IRES (EMCV)
eGFPds
hIL2RGmut CMV + intron#
W PRE
AgeI (5613)
XbaI (4737)
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